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Title: Neck Muscle Composition in Persistent Whiplash Associated Disorder: Relationship with 
Neck-Related Disability 
Purpose/hypothesis: Neck pain and related symptoms following a motor vehicle collision 
(MVC) can significantly influence the quality of life for some people. While the MVC related 
mechanics of the head and neck gives rise to the term whiplash, the signs and symptoms of neck 
related disability are often complex and are clinically referred to as whiplash associated disorder 
(WAD). Muscle fatty infiltrate (MFI) has been associated with persistent WAD, but its influence 
on the generation and maintenance of WAD is largely unknown. The purpose of this study was 
to evaluate the relationship between MFI and baseline demographic variables related to 
persistent WAD.  
Methods: 97 Participants presenting to an academic emergency medicine department in 
Chicago, IL enrolled in a parent longitudinal study investigating recovery from whiplash injury 
(ClinicalTrials.gov Identifier: NCT02157038). Within 1-week of the MVC, an MRI of the 
cervical spine was performed to quantify the percentage of MFI. Baseline demographics 
included: Neck Disability Index (NDI) scores, numeric pain rating scale (NPRS), age, sex, sleep 
disturbance scores, and BMI. At 2-weeks, 3 and 12-months post-MVC, NDI and NPRS scores 
were collected along with a co-registered MRI of the cervical spine. Final group membership 
was based on 12-month NDI scores: Recovered (< 10%) or persistent WAD (> 10%). Using 
logistic regression, at each time point, the variables were evaluated to determine significance 
associated with persistent WAD along with effect sizes.  
 
 
Results:  At baseline, variables found to be predictive for the persistent WAD group were: 
Female sex, increased MFI, and sleep disturbance. For persistent group classification, an R-
squared of 0.27 for the model was reported as was odds ratios (OR) for individual variables 
ranging from 1.1 to 4.38. Across the 12 months, except for sleep at 2 weeks, the effects of MFI, 
sex, and sleep disturbance were significant, and R-squared increased to 0.56. 
Conclusion: Results demonstrate an association with females, increased MFI, and sleep 
disturbance on persistent WAD. The variables maintained their significance across time along 
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Chapter 1: Introduction and Problem Statement 
 
1.1 Introduction 
 Following a motor vehicle collision (MVC), occupants of the vehicles often report a wide 
spectrum of problems related to their neck, such as pain, range of motion loss, and tenderness.1,2 
These issues, in addition to other signs and symptoms, including headaches, dizziness, 
unsteadiness, cognitive difficulties, insomnia, depression, fatigue, anxiety, weakness, and other 
neurological deficits are collectively known as whiplash associated disorder (WAD).2,3 Of those 
diagnosed with WAD, approximately 50% are expected to fully recovery within 3 months of the 
MVC, while the other 50% experience persistent pain and disability4 with few diagnostic or 
theranostic options.  
 While evaluating WAD, imaging has not provided consistent information regarding the 
diagnosis and prognosis of WAD.5,6 The lack of findings may be attributed to the variety of 
measures and protocols that have been used to collect the information.7 Radiographs, although 
beneficial in showing gross fractures, are not sensitive enough to detect subtle lesions that may 
be present following a whiplash trauma.8 However, due to high levels of ionizing radiation, 
computerized tomography (CT) is not appropriate for serial use.9 On the other hand, magnetic 
resonance imaging (MRI) allows for greater clarity and tissue resolution,10 but structural 
pathology is often visible even in people that are asymptomatic at the time of imaging,11 thus it 
can be difficult to determine what is clinically meaningful. 
A unique perspective with emerging evidence in imaging of the neck has revealed 




of MFI are related to increased self-reported disability as measured with the Neck Disability 
Index (NDI).13  
In trying to understand WAD, having knowledge about individual variables is beneficial, 
but the next phase in the research process is to appreciate the interactions between variables, how 
these interactions can change over time, and if these variables can be altered to change a person s 
long-term prognosis. This dissertation seeks to gain a deeper understanding of the relationship 
between MFI, self-reported disability, the influence of demographic and psychosocial factors, 
and the changing importance of these relationships over time. 
1.2 Problem Statement 
 WAD is a complex biopsychosocial (BPS) phenomenon that is difficult to evaluate and 
treat. Research does not often consider the heterogeneity of the condition and is regularly 
focused on a single biological,14 psychological,15 and to a lesser extent socioenvironmental 
factor.16 Using this model, many single variables have been found to be prognostic of poor 
recovery with WAD, but they are often of little value to the patient or clinician due to the 
variable being unmodifiable, such as age or sex, or they explain only a small amount of the 
variance in the outcome.17 A more comprehensive understanding of BPS factors and their 
interactions is needed to understand the recovery pathways and to have the potential to be 
modified to assist in treatment planning. 
 From a parent investigation with an existing longitudinal dataset, this study consisted of a 
heterogenous population of 97 participants with varying levels of WAD related disability. With 
data collected from these participants, baseline measurements were used to determine what, if 




relationships were examined at baseline and at repeated points over a 12-month period following 
the MVC to more fully understand their influence on WAD symptoms.  
1.2.1 Relevance 
 MFI has been found to have a significant relationship with the transition to chronicity in 
those with WAD,18,19 as well, increased rates of MFI have been found to be correlated with 
elevated NDI scores.19 This study will address gaps in the literature related to MFI by 
understanding potential interactions with psychosocial and sociodemographic factors that have 
been found to have relationships with the development of chronic WAD symptoms. The study 
evaluated the relationships not just at a single time point, instead, the longitudinal associations of 
these relationships were explored to understand the time-varying differences in magnitude of 
these associations. By studying these links, we obtained a greater understanding of WAD and its 
progression within a person rather than the isolated variables that have been previously found 
and used to describe the presentation of WAD.    
1.2.2 Research questions 
 1) Evaluate the combined relationship between the baseline quantity of MFI and various 
BPS factors on NDI scores. 
2) Assess if the relationships between MFI, BPS factors, and NDI scores changes in 
magnitude at specific time points over a 12-month period. 
1.2.3 Hypotheses 
 MFI has been found to have a relationship with the transition from acute to chronic WAD 
symptoms,19,20 as well, many other variables have been found to be associated with its 




more robust view of WAD has not been adequately examined. Yet at this time, there is no 
evidence to support the idea that combining factors will generate a superior understanding of 
WAD. Therefore, we hypothesize that the interactions between MFI and the BPS factors will 
produce a weak to non-significant relationship with NDI scores at baseline and at the multiple 
time periods over the 12-months following the MVC.   
1.3 Whiplash and Whiplash Associated Disorder 
 The term whiplash is used to describe the transfer of energy from the thorax through the 
cervical spine resulting in a rapid acceleration and deceleration of the head and neck.2,21 The 
most frequent application of this force occurs during an MVC, typically in a rear-end collision, 
but it can also occur during a side-strike MVC, sporting events, and after a fall.2  
 Following a rear-end MVC, 40-67% of occupants of the impacted vehicle will 
demonstrate no signs or symptoms of injury.22,23 However, if someone does develop signs and 
symptoms about the head and neck following an MVC they are most commonly diagnosed with 
WAD. The diagnosis is based upon the clinical presentation of the patient and not on any 
standardized tests or measures as there are currently no objective gold-standards available to 
definitively diagnosis WAD.     
1.3.1 Tissue Trauma and Imaging 
 The role of tissue trauma in the cervical spine following an MVC and its relationship to 
WAD symptoms is a research line that has produced contradictory outcomes with various 
studies. Imaging studies routinely do not find evidence of structural trauma following an 
MVC,5,24,25 but invasive studies, cadaver or surgical based, following an MVC demonstrate 




cartilage, muscles, nerves, and vascular structures.8,26 As well, other studies have shown 
significant relief in WAD symptoms following injections or nerve ablations in the neck6,27 which 
imply that damage to the cervical tissue is responsible for at least some of the symptoms . 
Although these injuries have been visualized in surgery and influenced with injections, there is 
still great debate about their role in chronic WAD symptoms.  
Numerous studies performed over the years have found weak to non-existent associations 
between findings on imaging and self-reported pain, disability scores, and various signs and 
symptoms that people ascribe to the MVC.5,24,25  However, these studies were often exploring a 
single lesion to try and explain the symptoms of WAD. For example, previous author groups 
have explored the alar ligament and cervical facet joints following an MVC for their ability to 
reproduce symptoms related to WAD.14,28 These studies have not traditionally accounted for 
psychosocial factors that can alter the pain experience such as PTSD or pain catastrophizing.17,29 
As well, prior studies did not commonly consider the pre-MVC status of the subjects and how 
these factors can alter the long-term prognosis.30 By not understanding how the pre-injury tissue, 
genetics, and psychological makeup of the person can alter the WAD experience, the research 
outcomes may be incomplete and it is understandable why imaging studies have not been 
beneficial in explaining WAD symptoms. 
The MRI as an imaging modality is the safest choice for patients and provides the 
greatest clarity for evaluating the cervical spine following a whiplash injury in both the clinical 
and research settings.10 However, there are many variables and parameters within the machine 
that can help to create an optimal image. Some of the parameters used to generate images are 
slice thickness, signal-to-noise ratio (SNR), total scan time, the types and positioning of coils 




the processing computers and the applicable software.10 With these parameters, an alteration in 
one will usually result in a change to another which forces researchers to carefully consider the 
most optimal balance between the variables.10 The numerous variations available with the 
parameters demonstrate that there is no perfect scanning sequence for everyone. Instead, all the 
parameters must be considered and modified to determine the most beneficial scan sequence for 
the given problem at hand.    
Although the MRI can provide great clarity, evaluating imaging research can be difficult 
due to the use of variable protocols during scans. The variability can create difficulties with 
comparing the findings of several studies such as with a meta-analysis.5,24 Therefore, a minimum 
set of standards has been proposed to be reported to allow for more direct comparisons between 
studies.31 Within this dissertation, the collected data and images followed a rigorous standardized 
protocol to maximize image clarity as well as allow for co-registration. 
1.3.2 Muscle Fatty Infiltrate 
 MFI is a process where adipose tissue is deposited below fascia, and between muscle 
fibers and muscle groups.32 MFI is a naturally occurring physiological attribute that is present in 
all people and is associated with cellular metabolism, maintaining physiological homeostasis, 
and may be associated with the inflammatory cascade following tissue trauma.32 By depositing 
fatty tissue within the muscle, the muscle contractility may be modified which can alter 
biomechanics,19 and in turn can create abnormal pulling, shearing, and compression throughout 
the tissues and may result in some of the signs and symptoms associated with WAD.33 
 It is unknown specifically why MFI develops, and there is even less understanding of 
why it develops in greater proportions in people diagnosed with persistent WAD.12 There are 




inflammatory processes,32,35 or it may be mediated by a combination of BPS variables and the 
stress response system.29 
The exact role of MFI and the maintenance of WAD is not well understood. In studies by 
Elliott and colleagues, those with persistent WAD demonstrated MFI in significantly greater 
amounts than those with insidious onset of neck pain as well as having a relationship with 
elevated NDI scores.12,18 This discovery promotes the idea that a mechanism related to the 
trauma may initiate the increased deposits of MFI and that it can be a factor to the prolonged 
symptoms associated with WAD.20 
Beyond the decreased use of the neck muscles due to pain resulting in disuse atrophy, 
MFI is theorized to result from several potential mechanisms. The first is an altered stress-
response system due to a distorted activation of the hypothalamic-pituitary-adrenal (HPA) axis 
which can alter the sensory response for those with a whiplash injury.36 The altered HPA axis 
and sensory response can result in increased pain with movement, decreased activity, and 
atrophy of the muscles with deposits of MFI as the final outcome.  
MFI can also result from negative or maladaptive thoughts, attitudes, and actions about 
pain and movement that lead to avoidance of activity.29 There are several theories that describe 
this topic including the pain adaptation model,37 the fear avoidance (FA) model,38  and the pain 
avoidance model.39 All three of these models have subtle nuances that separate each one from the 
others, but in general they describe how maladaptive thoughts and beliefs of pain can alter the 
willingness to move. By demonstrating a decreased willingness to move, patients decrease their 
level of activity, which can lead to disuse atrophy, weakness, more difficulty with movement, 




of fear and anxiety related to movement, and this fear and anxiety can alter the stress response 
system creating a physiological response which can alter their pain threshold.40 
Finally, the role of the sympathetic nervous system (SNS) in the development of MFI 
must be considered.41 The SNS has a primary role of activating the fight or flight system when a 
person is in a stressful situation.40 Numerous stressors are known to alter the SNS, but for those 
that are afflicted with WAD, the most commonly elevated stressors when compared to a non-
injured control group are anxiety, depression, pain catastrophizing, and PTSD.29 It is theorized 
that MFI and its relationship to WAD may be mediated by PTSD,19 but it most likely has 
complex interactions with several BPS variables which can be combined to form a more robust 
picture of the patient.  
1.3.3 Biopsychosocial Factors 
With an MVC, despite the similar rear-end collision mechanism, the signs and symptoms 
associated with WAD are not identical for each person. If the signs and symptoms were based 
upon a single lesion, then a targeted intervention should consistently improve recovery. 
Evaluating WAD with this singular view, the current state of research provides varying levels of 
support for or against numerous treatments including immobilization using a collar,42 
manipulations of the cervical or thoracic spine,43 stabilization exercises,44 reassuring advice to 
act as usual, 43 and injections.28  
Albeit limited, most all treatments have had some level of improvement for the patient, 
but no treatment has been consistently successful. This idea is reflected in the population-based 
studies that demonstrate the rates of recovery for those diagnosed with WAD have not 
significantly improved in 30 years.4,45 It can be argued that the lack of improvement in outcomes 




view of the patient must be obtained that takes into consideration all potential influencing 
domains to allow for proper evaluation and clinical management. 
The term BPS represents the biological, psychological, and social factors that are part of 
an individual. All three areas can affect the WAD experience, therefore, they all must be 
examined to understand the complexities and heterogeneity of the chronic WAD presentation. 
Although each area can be evaluated on its own merits, in the end, there is an understanding that 
all the variables likely interact and come together to form a complete clinical picture that is 
unique for each person. Currently, it is unknown which interactions exist and are relevant, and if 
they are static or fluctuate over time. These interactions may help create the overall makeup of 
the person which may be considered greater than the sum of the individual parts. To generate the 
most relevant information regarding the understanding of WAD, this dissertation discovered how 
various BPS factors interact, specifically the role of MFI and sociodemographic variables, and 
how they change over time to influence the WAD experience.   
1.4 Summary 
 The overall understanding of WAD has transformed in recent years with the most 
prominent change being the acceptance of the role of psychosocial variables in the manifestation 
of a person s s mptoms. For ears, when these variables were described in regards to WAD, it 
was felt that the person was making-up their symptoms as they were either malingering, 
hysterical, faking it for monetary compensation, or to gain attention.46 However, it has been 
shown that the psychosocial factors can effect cognitive and neurobiological processes, including 
the physiological responses to painful stimulation.40 No single variable explains a significant 




in explaining the overall experience. However, currently most of this evidence is correlational 
with very little support for causal associations.   
 Beyond the psychosocial factors related to WAD is the limited understanding of how the 
biological factors can play a part in the WAD experience, specifically the role of MFI and its 
evolving relationship to symptoms. It has been discovered that MFI has a relationship with the 
transition to chronicity, but how MFI interacts with other known psychosocial variables and how 
these relationships change over time is unknown.  
Therefore, instead of focusing on a single BPS factor as the cause of a patients  
symptoms, diagnosis and management of those with WAD will need to consider the potentially 
fluid relationships between numerous variables for each person. Thus, WAD cannot be viewed 
as a single construct that is identical in each person, instead those with WAD should be viewed 
as a heterogenous population whose symptoms will manifest uniquely based on their own 
personal experiences.  
1.5 Definition of Terms 
Acute  Symptoms that are present between 3 and 4 weeks following an initial injury. 
Anxiety  A mental health condition that manifests in an atypical emotional response from the 
anticipation of a future threat.47 
Artifacts  Something observed that is not naturally there, but instead is present due to a 
distortion in the image, hardware/software malfunction, or environmental influences.10  
Autonomic nervous system (ANS)  Portion of the nervous system that manages bodily 




Biopsychosocial (BPS)  An interaction of biological, psychological, and social factors that 
work individually or together to alter the outcome of an injury or disease process. 
Central nervous system (CNS)  Consists of the brain and spinal cord and controls most bodily 
functions including, but not limited to, thoughts, movements, sensations, and body awareness.  
Chronic  Symptoms that persist for more than 3 months.  
Co-registration  Evaluating serial images on a single grid to determine if changes occur over 
time. 
Depression  A mental health condition that results in sadness and accompanies somatic and 
cognitive changes that affect the person s abilit  to function.47 
Fear avoidance beliefs  An exaggerated or fearful reaction to pain perception in which the 
person has an extreme fear of pain related to movement, so much so that they are unwilling to 
move, and they avoid activities that may exacerbate their symptoms.38 
Muscle fatty infiltration (MFI)  A process where fat is deposited below the fascia, and 
between muscle fibers and muscle groups.32 
Magnetic resonance imaging (MRI)  An imaging tool that uses magnets and radiofrequency 
pulses to generate a digital picture of the internal structures of the human body.10 
Motor vehicle collision (MVC)  Occurs when two vehicles strike one another, and the 
collision may or may not cause damage to the vehicles. 
Neck Disability Index (NDI)  A self-report outcome measure for evaluating the functional 




Pain catastrophizing  The belief system that this pain will likely lead to a lifetime of disability, 
and if something is painful that it must be causing damage or making the injury worse, therefore 
the pain should be avoided.49   
Peripheral nervous system (PNS)  The portion of the nervous system that is outside of the 
central nervous system (brain and spinal cord). 
Post-Traumatic Stress Diagnostic Scale (PDS)  A self-report scale measuring the symptoms 
associated with PTSD.50 
Post-Traumatic Stress Disorder (PTSD)  A psychological condition with persistent mental 
and emotional stress because of an injury or severe shock resulting in a constant recall of the 
traumatic experience.47 
Rapid eye movement (REM)  A period with a sleep cycle that is theorized to be important for 
memory consolidation as well as helping to maintain homeostasis across various systems.51 
Slow wave sleep (SWS)  A distinct portion of the sleep cycle which physically contrasts with 
REM cycle, but also is theorized to assist with maintaining the bodies normal physiological 
activities.51  
Sympathetic nervous system (SNS)  One portion of the autonomic nervous system that alters 
numerous hormones and physiological responses in response to stressful events which results in 
activating the fight or flight phenomenon.  
Whiplash Associated Disorder (WAD)  A group of signs and symptoms that a person will 
present with following a whiplash event. The signs and symptoms can include, pain, stiffness, 




Whiplash  A transfer of energy from the thorax to the cervical spine and head through a rapid 





Chapter 2: Review of the Literature 
 
2.1 Introduction 
 Whiplash and its associated disorders (WAD) represent a complex biopsychosocial (BPS) 
condition commonly resulting from a motor vehicle collision (MVC). In the United States (US), 
it is estimated between 1 million to over 4 million people a year will be injured in a MVC,52-54 of 
which only 50% of those with WAD recover within the first 6-12 weeks.4 The other 50% will 
continue to have persistent symptoms at least 12 months after the collision.4 Of those with 
persistent symptoms, up to 25% will have a more severe clinical presentation in the long term4 as 
well as significant medical and legal costs and lost income due to time away from work.55,56 It is 
estimated that these costs collectively can range between 10 and 29 billion US dollars per 
annum.55,56 Lessening the transition from acute to chronic WAD is of the utmost importance to 
decrease the personal, societal, and economic burden related to these injuries 
While the mechanism of bodily injury during a MVC are fairly well understood,57-59 it is 
unknown why 25% of people who report WAD symptoms following an MVC report persistent, 
severe symptoms. Trauma to a number of vulnerable tissues such as ligaments, discs, and joint 
capsules is speculated to be a mechanism for the pain and loss of function following an 
MVC.8,24,60 A vehicle collision can create easily identifiable injuries such as lacerations or 
fractures,61 but, occult pathoanatomical injuries to the vertebral disc or zygapophyseal (z) joints 
may exist and have clinical management implications.62 However, a lack of identification with a 





Beyond the potential physical injuries, numerous psychological and social factors have 
been studied in an attempt to understand their influence on WAD symptoms.17,64 The presence of 
psychological factors, such as post-traumatic stress disorder (PTSD) and pain catastrophizing,17 
have temporally been associated with the subsequent development of chronic WAD 
symptoms.40,64,65 However, recognizing the relationships between these variables and WAD has 
not improved management strategies to reduce the rates of chronic symptoms.4,45 Whether it be 
physical or psychosocial factors, no two situations are exactly alike; thus, finding a single 
mechanism to explain WAD is unlikely. The lack of an easily identified single factor may 
explain our limited understanding of how to assess and manage these cases on a patient-by-
patient basis. 
 The purpose of this chapter is to provide a brief background on the history of WAD, 
including what is currently known about the condition. A description and review of the clinical 
features associated with acute WAD and the transition to chronicity including BPS factors, 
imaging findings, and the potential physical, physiological, and psychological changes will be 
examined. Lastly, a discussion on the importance of combining BPS variables to create a more 
comprehensive picture of WAD will be presented.   
2.2 History of WAD 
Within this historical overview, a comparison will be made between the modern day 
whiplash injury and its associated signs and symptoms with the description of railwa  spine  
put forth in the 19th century by the British surgeon J.E. Erichsen.46,66 What is of interest within 
the historical understanding is that although these injuries have been described for well-over 100 
years, the overall knowledge and management of WAD continues to perplex both clinicians, 




Much like the constellation of symptoms seen with WAD, Erichsen attributed the similar 
signs and s mptoms (neck pain, stiffness, tenderness, and fatigue) to the accident  on the 
railway.46,66 Individuals diagnosed with railway spine often lacked any visible injury that could 
explain their complaints, thus Erichsen provided a vague description of what happened to them 
by stating The whole s stem received a severe shake or shock  which resulted in molecular 
disarrangement. 42,66 It was felt this mechanism was responsible for the variety of reported signs 
and symptoms experienced after the rail accident. Although Erichsen lacked the technological 
advancements of today, his ideas of trauma to the entire system were similar to the current 
theories regarding the heterogeneity of those with WAD.17,30,67   
It was not until a medical conference in 1928 when the term whiplash  was used by H.E. 
Crowe to describe the mechanism of injury (MOI) as a rapid movement of the head and neck that 
occurs during an MVC.46 However, the term was not formally used in the medical literature until 
1945,66 but since then, the meaning has evolved as the term whiplash is currently used to 
describe not only the MOI, but also the injury itself.  
Using the term whiplash as a diagnosis over the years has been problematic, in part 
because there is no gold standard for determining who has the injury. Currently, the diagnosis is 
primarily based on two factors: 1) an association with a trauma affecting the neck, and 2) the 
responses provided by the patient, including reports of neck pain, tenderness, or decreased range 
of motion.2 However, WAD can result in various other signs and symptoms, including fatigue, 
insomnia, or difficulty concentrating;3 thus, basing the diagnosis on the presence of neck pain 
alone may be inadequate.   
The difficulties in identifying those with WAD has persisted despite advancements in 




between trauma and symptoms. As imaging techniques improved, a plausible idea was 
postulated by researchers that a single lesion would be discovered that could explain the 
presenting signs and symptoms. For example, Krakenes reported that damage to the upper 
cervical ligaments, in particular the alar ligament, were correlated with chronic WAD symptoms 
and would contribute  to the patient s presentation.14 However, subsequent imaging studies 
have not corroborated these results nor discovered any other structural lesion that can account for 
the presentation of chronic WAD,5,8,24,25 and this lack of information has fueled the skepticism of 
WAD as a true injury.63   
According to the most current research and theories, the signs and symptoms associated 
with WAD have been speculated to arise from physical, physiological, psychological, and social 
factors.28,40,68,69 Multiple variables within all these domains have been found to be associated 
with WAD symptoms, but identifying a single cause and effect mechanism has been 
unsuccessful. The focus on a single mechanism may have unintentionally limited the evaluation 
of those with WAD, and the ability to clearly identify and understand the interactions of known 
BPS factors.   
With these known limitations, the core focus of this dissertation was to examine several 
of the primary factors regarding the whiplash conundrum. Through a robust data set, the role of 
muscle fatty infiltrate (MFI) and its associations with psychosocial factors were examined while 
attempting to provide a multifactorial picture of WAD during the transition to chronicity. With 
this information, appreciation of the heterogeneity of those afflicted with WAD may be more 




2.3 Clinical Features and Classifications of Persistent WAD 
2.3.1 Mechanism of Injury 
The mechanics of a rear-end MVC have been analyzed using high speed cameras with 
human subjects, cadavers, animals, human analogs, and computer simulations.8,26,62,70 During a 
rear-end MVC the head moves not only in the directions of extension and flexion, but the torso is 
thrust upwards relative to the body which results in a buckling of the cervical spine and the 
generation of a non-physiological S-shaped curve.57,71 The S-shaped curve has the potential, via 
shear and compression forces, to create abnormal stresses within the ligaments, discs, bones, and 
joint capsules.59,72 Individual forces are not necessarily going to cause an injury, as the discs and 
facet joints of the neck are designed to resist some compression and shear.73 Instead, it is the 
combination of the shear and compression forces applied through a non-physiological curvature 
of the neck that has the potential to damage the tissue. If the tissue is damaged, the inflammatory 
cascade may be triggered resulting in increased nociceptive sensitivity and may result in pain for 
the person.74   
2.3.2 Clinical Features of WAD 
 The controversy surrounding WAD is often based on the subjectivity of the clinical 
presentation. Other than neurological changes, such as altered reflexes or loss of strength, most 
of the clinical findings are self-reported, including pain, tenderness, headaches, dizziness, 
insomnia, cognitive difficulties, unsteadiness, depression, fatigue, and anxiety.2,3 It is often 
difficult to say the collision caused these symptoms because many people who have no history of 
WAD or a whiplash injury present with these same complaints. With that in mind, due to the 





To complicate the situation further, patients can often present with a variety of these 
symptoms, and it is uncommon to have two patients present identically. Therefore, instead of 
trying to understand WAD based on symptoms, it may be more beneficial to focus on known risk 
factors associated with chronic WAD. These risk factors and their association with prognosis 
may provide increased benefit for both clinicians and patients who are trying to understand the 
condition and decrease the rates of chronicity.  
2.3.3 Classification of Persistent WAD 
 The Quebec Task Force (QTF) produced a monograph in 1995 with a goal of 
synthesizing the best available evidence and consensus opinions regarding risk, diagnosis, 
treatment, and prognosis of injuries sustained in a MVC, specifically related to whiplash trauma.2 
Of all the findings reported, the creation of the 0 to 4 grading scale used to describe WAD (Table 
2.1) may be the most contentious.2 The scale attempted to create a common language that could 
be spoken by all clinicians and researchers regarding the severity of the injuries sustained, but it 
is based primarily on self-reported signs and symptoms, such as neck pain, tenderness, decreased 
range of motion, or neurological changes. As the determining factors for the grades, it was 
implied the signs and symptoms were related to the trauma itself and the supposed tissue 
damage. In this grading schema there was no consideration given to potential influencing factors 
such as sleep disturbances, the physical or emotional health of the person, or psychological 
factors such as PTSD.  
The QTF examined various prognostic variables, such as sociodemographic variables 
age, sex, income, and collision related data, including crash severity, direction of collision, and 
type of vehicles in the MVC.2 Of these variables, most were found to be inconclusive regarding 




and often only cited significance levels and did not report effect sizes.2,17 Although the findings 
of the QTF were based on the research available at the time, recent data has found collision 
related variables have little to no effect on the prognosis of WAD.17 
Table 2.1 Quebec Task Force Grading Scale For WAD2 
Grade 0 No complaints about the neck; no physical signs 
Grade 1 Neck complaint of pain, stiffness, or tenderness only; no physical signs present 
Grade 2 Neck complaints AND musculoskeletal signs including decreased range of motion 
and point tenderness 
Grade 3 Neck complaints AND neurological signs including decreased deep tendon 
reflexes, decreased sensation, or decreased strength 
Grade 4 Neck complaints AND fracture or dislocation 
Key: WAD  whiplash associated disorder 
 A primary goal of the QTF was to improve the management, outcomes, and rates of 
recovery for those with WAD.2 But, the model of categorizing patients based on their symptoms 
has not produced the desired results given that the rates of transition to chronicity have not 
significantly improved since the grading scale was published.4 A case can be made that it has 
some prognostic value, as there is evidence that the higher the grade of WAD the slower the 
recovery time,75 but it does not provide any benefit for the management or outcomes for those 
with WAD.76 
Moving beyond the QTF grading schemes, a clinical prediction rule (CPR) has been 
derived and validated for classifying a patients probability of transitioning to chronicity.77,78 
When all three criteria of the CPR are present, a positive predictive value of 91% has been 
reported;78 this means that 91% of the people who scored positive on the CPR were in the non-
recovery group. The sensitivity and specificity of the CPR have been reported as 44% and 99% 
respectively.78 The strong value for specificity provides greater confidence in ruling someone in 




strong enough to confidently rule someone out of developing prolonged symptoms if they do not 
meet the CPR.  
Within the CPR, the three primary predictors are a neck disability index (NDI) score of 
40% or greater, 35 years of age or older, and a score of 6 or greater on the hyperarousal subscale 
of the post-traumatic stress diagnostic scale (PDS).77 Although using three variables yields a 
strong positive predictive value, the CPR generates a high false negative rate of 56%, which 
means that 56% of the people who developed chronic WAD did not fulfill the CPR criteria. The 
high false negative is important as it means that people who develop chronic WAD are not being 
distinguished by the CPR and may not be receiving treatment. On the other hand, the high 
specificity results in a 1% false positive rate which means that these mis-identified people may 
end up receiving treatment when none is needed. In looking at the greater good, it seems that 
having a higher sensitivity (and a lower false negative rate) would be more beneficial as more 
people with the condition will be identified; thus, those that may benefit from treatment will 
receive it.  
To improve the sensitivity of a test, the number of positive test results must be increased, 
and this can be accomplished in two ways: 1) lower the threshold for determining what is a 
positive result, or 2) use different factors. In lowering the threshold in an attempt minimize or 
eliminate false negatives, an extreme example would be to assume that all people in an MVC 
will develop WAD, this ensures all people have a positive result and a 100% sensitivity will be 
present. For a variety of reasons this is an unrealistic option, for the CPR, to decrease the positive 
threshold a solution could be to eliminate one or even two of the current factors within the 
model. However, these three factors were determined using a robust statistical analysis and it 




If we cannot eliminate factors, perhaps using different factors that have not been fully 
explored may be of greater value in improving the sensitivity, such factors could include MFI or 
looking for interactions between BPS variables. Searching for these interactions is important 
because they have the potential to strengthen the relationships and prognostic ability more than 
an individual factor.79  By not establishing potential interactions between the variables, it is 
possible the CPR may be incomplete and many people that transition to chronicity are not being 
identified, or treated, early in the process.  
2.4 Current Understanding of WAD: Biopsychosocial and Imaging 
2.4.1 Current Overview 
 After an MVC, a variety of both direct and indirect factors may be related to the signs 
and symptoms associated with WAD. Physical trauma, such as a torn joint capsule or ligament 
damage are some of the possible sequelae that can be attributed to the energy transfer between 
the motor vehicles and the people inside.80 Although traumatic injuries to the neck have been 
visualized during surgery and in cadavers,8 imaging has not been able to aid in diagnosing or 
understanding the relationship with WAD related symptoms.5,24  
 Beyond the initial trauma occurring from an MVC, secondary complications can arise, 
such as the increased levels of MFI, segmental instability, and it is theorized that post-traumatic 
arthritis can develop.34,60,81 The complete understanding of how these issues can alter a person s 
pain experience and their functional abilities is not immediately recognized as the complications 
may take weeks or months to fully develop.   
Outside of the physical injuries related to the MVC, psychological and social factors can 




degree various social factors, such as level of education, have all been found to be associated 
with symptoms.17  
With these prognostic variables in mind, recovery trajectories have been estimated to 
determine who is more likely to progress to chronicity and who is more likely to recover without 
further incident.4 Most variables demonstrate small and inconsistent effects when related to these 
trajectories, but two variables have been found to have a strong and consistent relationship with a 
poor prognosis: one, a high initial pain rating, 5.5 or greater out of 10, and two, an elevated NDI 
score, 14.5 or higher out of 50.82 However, these variables in isolation offer limited usefulness in 
guiding treatment.  
Although not as strong in their relationship to chronicity as the initial pain rating and an 
elevated NDI scores, PTSD, pain catastrophizing, and the development of MFI have a moderate 
association with chronicity, but they need to be understood more thoroughly to fully grasp their 
clinical relevance.17 The underlying mechanisms of how these factors can influence WAD are 
theorized to be related to systems such as neurophysiological stress response,40 altered motor 
control,29 genetics,83 and psychological maladaptive beliefs,84 however the complete 
understanding is purely speculative at this time.   
2.4.2 Muscle Fatty Infiltrate 
MFI is a normal physiological attribute that is present in all people regardless of activity 
level, and it is recognized to have several primary functions including being a local energy 
reserve as well as an endocrine organ associate with maintaining homeostasis across multiple 
physiological systems.32 It is also theorized to be part of the inflammatory cascade following a 
trauma by way of releasing proinflammatory cytokines, which when present for prolonged 




by way of increased MFI occur in two primary forms;32 intra-myocellular where fat replaces 
muscle tissue, and extra-myocellular where fat is deposited between fascia or muscle fibers.32 
Regardless of its origin, MFI is likely to affect the quality of a muscle contraction which can 
result in diminished functional capacity (decreased strength, power, and endurance) for the 
person.85-87 As well, in addition to altered or decreased muscle activation, the potential for 
abnormal mechanics could influence the long term health and function of the cervical spine.88 
Sarcopenia is defined as a decrease in muscle mass and strength that often occurs as we 
age, and as it progresses, a loss of lean body mass and a concurrent increase in body fat and MFI 
is observed.89 It is unknown what the exact biological mechanism is for sarcopenia.89 However, 
it is generally recognized as a normal consequence of aging, although some view it as a disease, 
and the loss of muscle mass and strength, and increase in MFI, has been associated with 
declining scores on physical performance tests.90 Thus, distinguishing between MFI that is 
present as a normal part of aging and that which is related to an MVC can be difficult, but 
recognizing the changes in functional scores as a result of MFI may explain some of the loss of 
function for those with WAD. 
Following an injury, MFI can be deposited throughout the tissue and is theorized to be a 
result of an interaction between macrophages, various components of the inflammatory cascade, 
and fibro-adipoc te progenitors (FAP s).91 The FAP s act similar to a stem cell and can influence 
the pathway in which an injured muscle fiber will either regenerate as a part of the contractile 
unit or differentiate into fatty tissue.91 It is not known wh  FAP s ma  lead to increased levels of 
MFI following an injury, but it is plausible there may be genetic, epigenetic, or a combination of 




Disuse atrophy is another potential mechanism for altering the amount of MFI in tissue,34 
it is theorized that decreased use may result in myofibrillar atrophy and deposits of fat into the 
area.92 However, this reasoning may be an overly simplistic view of the process as it does not 
account for the previously described factors (FAP s) that ma  influence MFI, and it does not 
explain the differences in MFI between two groups, one with WAD and the other with insidious 
onset neck pain.12 It is presumed that the pain would result in similar rates of decreased use of 
their neck muscles and in theory equal amounts of disuse atrophy and MFI. However, the group 
with WAD demonstrated a significantly greater amount of MFI within the cervical 
musculature.12 A second study reported that the amount of MFI in the cervical musculature was 
unrelated to the amount of range of motion lost following an MVC;19 thus, the amount of disuse 
may be irrelevant to the development of MFI. With these observations, it is thought some 
mechanism of the trauma, the inflammator  cascade and interactions with FAP s, a 
neurophysiological response, genetics, an interaction of the stress-response system, an 
undiscovered factor, or any combination of these can influence the rate of MFI.12,19,32,36 
Once MFI is present, it has the potential to propagate itself based on several potential 
mechanisms. The first is the release of proinflammatory cytokines that can promote a continued 
localized inflammatory response.32 The local inflammatory response can have a catabolic effect 
on muscles which may result in increased MFI deposits,93 pain,94 and decreased mobility which 
can result in further atrophy of the muscles and potentially more MFI.32   
Increased MFI following a trauma may also be related to the stress-response system and 
the effects of cortisol on the tissue.36 Following an MVC, it is not uncommon for a person to 
experience transient or persistent distress regarding their physical or financial health, fear and 




Any or all of these factors can alter the hypothalamus-pituitary-adrenal (HPA) axis which is the 
endocrine pathway that controls the release of cortisol.40 Increased levels of cortisol have been 
reported following an MVC, and this hormone, similar to the proinflammatory cytokines, can 
alter the structure of muscle via its catabolic effects on the tissue thereby potentially resulting in 
increased deposits of MFI.36,89   
Assessing the relationship between MFI and a functional outcome following an MVC has 
been observed. For example, all people who were in a recent MVC (less than 1 week) and 
evaluated with magnetic resonance imaging (MRI) of the cervical spine were found to have 
similar rates of MFI at baseline regardless of their long term outcomes.20 However, by two 
weeks post MVC, a difference in the amount of MFI was observed between the three groups: 
recovered, mild, and moderate to severe symptoms.20 With this information, a receiver operator 
characteristic (ROC) curve found a cut point of MFI at 2-weeks of 20.5% of cervical 
musculature to have a sensitivity of 87% for identifying the moderate to severe group, and a 
specificity of 92.9% for identification of the recovered group at 3-months.20   
Currently, it is impossible to determine a cause and effect relationship between MFI and 
outcome measures, although an association between the two has been reported.19,20 However, 
this relationship appears to be mediated by PTSD which means that the strength of the 
association between the two variables is stronger when these symptoms are accounted for.20 The 
relationship between MFI, NDI, and PTSD is not understood, one theory is the quantity of MFI 
may be a result from the physical trauma of the MVC, and can result in PTSD along with 
increased pain and decreased function.95 Conversely, the opposite may be true as higher levels of 




The gold standard for assessing MFI is with a biopsy of the tissue, which is an invasive 
procedure, and currently, the best way to evaluate it conservatively is with MRI. However, with 
both methods, they must be assessed serially to determine if changes are occurring over time. 
Given the cost, time commitment, and observation that 50% of people will not develop long-term 
symptoms, it is unrealistic to believe all people involved in an MVC should obtain serial imaging 
or muscle biopsy as part of a routine standard of care.   
Considering the relationship between MFI and chronic WAD symptoms, a clinical analog 
for MFI may prove important for identifying individuals at risk of developing long-term 
symptoms at a time when rehabilitation treatments may be more beneficial for the patient. 
Although preliminary, a small study of patients with WAD, who completed a 10-week exercise 
program, demonstrated significant changes in muscle structure with increased muscle cross-
sectional area and decreased MFI in the cervical multifidus. The subjects also reported a 
subsequent decrease in NDI scores.96  
Although MFI demonstrates significant prognostic value for people with WAD, it is only 
one component of the BPS profile. Understanding how MFI may be associated with other 
variables, such as age, sleep disturbances, or PTSD, may help develop a more complete clinical 
picture of WAD. However, it is unknown which variables will be the most beneficial for 
determining the prognosis of WAD, and it is not understood how variables may interact with 
each other or how the relationships evolve over time.  
With that in mind, a focus of this dissertation is to evaluate how the interaction of several 
variables influence WAD, as well as how these interactions change over time. Ideally, a single 
measure would be provided soon after the MVC that could capture all domains and predict who 




However, given the heterogeneity of patient presentation, pre-existing factors, and the changes 
that occur throughout time, (including neurophysiological, morphological, social, and 
psychological) it appears multiple measures will be needed to capture the evolving presentation 
of WAD. It could potentially be of benefit to understand which measures, when used together, 
create the most comprehensive and clinically meaningful assessment for those with WAD both 
cross-sectionally and longitudinally. 
2.4.3 Biological and Psychological Factors 
There are a numerous biological and psychological factor that have been reported to be 
associated with poorer outcomes for those with WAD. However, especially the biological 
variables, there have been none that have been noted to have consistent significant effects, as one 
report may cite an association while a follow up study finds no relationship. It is not fully 
understood why these varying results exist as it may have to do with populations within the 
studies, the determination of what it means to be recovered, or only looking at individual 
variables at single points in time. To fully understand the influence on WAD symptoms, several 
biological factors associated with MFI will be evaluated to fully elucidate the effect they have on 
outcomes.  
An increase in a person s bod  mass index (BMI) has been associated with increased 
levels of MFI,32 this may lead to morphological changes in the tissue and altered biomechanics 
and potentially prolonged symptoms that are present even before the MVC.19 In addition to 
increased MFI, an elevated BMI may cause issues with persistent symptoms due to a larger 
habitus as well as systemic inflammation.32 A larger habitus may limit joint or tissue mobility 




symptoms due to persistent proinflammatory cytokines within the cells which can perpetuate a 
nociceptive pain response.32  
Age is another biological factor that has been theorized and evaluated to determine its 
effect on WAD, and the results reported range from inconclusive, to no significant or small 
effects.17 With age comes changes in our bodies including the previously described sarcopenia, 
disc degeneration,97 decreased muscle mass,98 and increased rates of chronic pain.99 Based on 
conjecture at this time, all of these factors have the potential to create a symptomatic response 
following an MVC, but it is not certain if someone has one or all of these traits they will develop 
chronic WAD. Therefore, understanding how age and MFI may be related and associated with 
WAD may provide a greater understanding of long-term prognosis.  
Psychological factors have long been evaluated and known to influence WAD symptoms, 
42,46 but studies have tended to only evaluate single psychological variables to understand WAD 
and its various symptoms.100 A few studies have attempted to address multiple variables with 
regard to prognosis, for example, Gargan combined neck range of motion and the scores on the 
General Health Questionnaire to help determine chronicity.101 It was reported that the scores 
were much more beneficial at predicting the recovered group, 94% accuracy, than the group with 
chronic symptoms, 56% accuracy;101 thus, it was not very useful clinically. A second study using 
a multivariate analysis reported several variables to be predicative of long-term symptoms.102 
However, a number of these variables, direction of impact and position of the occupant in the 
vehicle, have been found to not be associated with the prediction of symptoms.17 As well, the 
measures of psychological distress were based on generic health outcome measures rather than 




Psychological issues such as depression and anxiety have been studied extensively in 
relation to WAD, but their presence is generally inconclusive in predicting the outcome.17 These 
findings, much like the imaging and clinical studies evaluating WAD, tend to find small and 
inconsistent effects on the measured outcomes.17 Other psychological factors, such as PTSD, 
have been found to have a moderate effect size and are deemed to be a significant risk factor for 
a poorer prognosis in a person with WAD.103 It is unknown why these results vary so much, but 
it may be due to an incomplete understanding of the interaction of psychological factors and 
other bodily systems. To understand why some factors have a stronger influence than others, it 
may be necessary to look beyond the variables themselves.   
 Psychological factors are constructs that are not directly observable and are associated 
with signs and symptoms that can be physiological (i.e. weight loss) or psychological (i.e. 
feelings of sadness).47 Certain factors may be responsible for some of the signs and symptoms 
associated with WAD, for example, the stress response system may play an important role in the 
mediation between psychological factors and chronic WAD symptoms.64 In the stress response 
system, in particular the HPA axis, the release of hormones such as cortisol and catecholamines 
may influence the pain experience of the person.40 The hormones can increase the sensitivity 
within the peripheral nervous system (PNS) as well as produce changes within the central 
nervous system (CNS),36,40,65 potentially resulting in an atypical pain experience or the 
development of chronic WAD symptoms.   
 Psychological disorders occur on a spectrum,47,104 some people demonstrate mild 
symptoms that barely rise to the level of the standard diagnostic criteria, while others are 
severely affected and have their lives significantly altered due to their condition. The primary 




chronic WAD symptoms is PTSD,17,64 which is a long term psychological stressor that has the 
potential to alter the HPA axis.40  
PTSD is a primary psychological disorder that can be present following a traumatic or 
threating event that results in avoidance of activities, recurrent and persistent thoughts and 
feelings related to the event, and hyperarousal of their senses.47 The extent to which PTSD can 
alter the HPA axis relative to other stressors, such as depression or anxiety, or why PTSD is 
more strongly related to a poor prognosis with WAD is currently unknown. However, the 
argument can be made that PTSD has a stronger relationship because it is viewed as an 
immediate threat to the body and may increase the stress response system to a greater degree 
than depression or anxiety. With long term activation of this pathway and a consistently elevated 
stress response system, including sleep disturbances,47 perpetual PNS and CNS activation can 
create increased sensitivity and symptoms.17 For some people, this pathway may be enough of a 
stimulus to generate long-term WAD symptoms, whereas for others it may not.  
 The various pathways in which psychological factors can affect the WAD experience 
offers a deeper understanding of the BPS presentation in patients. These variables are not meant 
to be evaluated on their own as all symptoms originate from an MVC which can stimulate the 
peripheral and central nervous systems as well as psychological stressors. Thus, because both 
physical and psychological factors are related to the prognosis of those with WAD, the 
interactions between them must be understood in order to fully comprehend the condition and 
assist in improving outcomes.  
2.4.4 Social Factors 
 For as long as researchers and clinicians have been studying and treating WAD, social 




been found to have a strong relationship to symptoms.17 Not dissimilar to the psychological 
variables, they have generally been evaluated in isolation and their effect sizes tend to be small 
and inconsistent.17 Instead of evaluating the factors individually, it is possible that via mediation 
with other factors that their existence can be a factor in chronic WAD with a stronger association 
than has been previously reported.  
For years, the notion of WAD as an injury has been questioned by authors of books and 
articles who present arguments against it as a legitimate pathology.66,105 The concept of WAD 
being a falsified injury is advanced by the lack of findings on imaging studies, inconsistent signs 
and symptoms presented by individual patients, and even by the lack of a gold standard 
diagnostic test. Arguments that reinforce the idea that WAD is not a real injury tend to discount 
what the victim knows about their body; they hurt, and something is wrong. With cynicism 
regarding their injury, the person has to prove they are truly injured, and when their focus is 
shifted from learning how to cope and heal, to defending themselves regarding their injuries, 
very few will recover.106  
Questioning the legitimac  of the injur  is strongl  encouraged b  the whiplash culture  
theory.66 The term whiplash culture was used to describe and understand why developed 
countries such as the US, Australia, and the UK report an almost epidemic of WAD, whereas 
other poorer countries such as Lithuania, and Greece have almost no reported incidence of 
WAD.66 Beyond questioning the statistical and research design of the studies to explain the 
findings,55 several theories attempt to make sense of the purported whiplash culture, even though 
it is unknown what the exact mechanism is for the differences between the countries.66 There is 
the belief that it is as simple as the people of some countries do not recognize a whiplash event 




cases of chronic WAD.107 Others feel the drive for compensation and litigation, which is more 
prevalent in developed countries, can increase the rates of prolonged symptoms.108 Finally, some 
see the system itself as an issue where the health care providers, insurance companies, or 
attorneys do not believe the patient is injured and thus patients spend all of their efforts proving 
they have been harmed rather than focusing on their own recovery.106 
Regardless of the underlying reasons for the varying results between the countries, the 
studies that have evaluated these cross-cultural differences often come to similar conclusions: 
because the signs and symptoms of WAD are not identical across all cultures, then the premise 
of WAD as an independent injury is false and the disorder cannot truly exist.66,109,110 With the 
differences in presentation, it is thought WAD is a result of the environment the person lives in, 
and it is not related to any specific biological injury or trauma sustained in the MVC. With this 
singular viewpoint of WAD, it is feared that countless people have had their symptoms 
marginalized and their injuries have been discounted which has resulted in increased suffering, 
pain, and prolonged disability. 
A primary issue in these studies is the viewpoint that WAD is a homogenous condition 
that manifests similarly across all people rather than recognizing the heterogeneity and multiple 
variables that may influence the individual WAD experience. An argument can be made that 
these cross-cultural studies, instead of showing WAD as a single entity, demonstrate the 
heterogeneity in WAD and the influence of BPS factors. They accomplish this by showing the 
differences in various cultures and settings and how different social factors can affect outcomes. 
Some of the previously described biological factors, age and BMI, can also be recognized 
as social factors that may influence WAD outcomes. As we age, there is often increased 




and be active and this ma  impair the bod s ability to heal.99 As well, an elevated BMI may 
have a negative social stigma which can result in various psychosocial issues including but not 
limited to depression and anxiety,111 both of which have been associated with chronic pain. 
Another factor that is biological that also needs to be examined from the social 
perspective is the sex of the patients. Most reports on WAD that evaluate sex as a prognostic 
variable generally show that females are more likely than males to develop persistent symptoms, 
but this association usually ranges from weak to non-existent.17 From a biological perspective, 
females are generally smaller than males and have less muscle mass, and the decreased muscle 
mass may be a predisposing factor in their higher rates of WAD than their male counterparts.112 
However, on the social side, car seats are generally designed to fit the average sized male driver, 
thereby the safety features of the seat may be inadequate to minimize the forces delivered to a 
female occupant.112  
Therefore, it is not necessarily female sex, increased BMI, or age that increases the rates 
of WAD, instead, it is factors associated with these variables, biological or social, that may 
predispose someone to develop chronic symptoms. Because it is not uncommon for these factors 
to have multiple avenues in which they may influence outcomes, we need to ensure that we fully 
evaluate them for their individual and combined contributions to persistent symptoms. 
 Other social constructs that have been researched are the education and socioeconomic 
level of the injured person.113 However these factors, much like the previous ones, have 
inconsistent findings with small to non-significant effect sizes.17 With variables like these, there 
are potentially many mediating factors that can be related to a poorer prognosis. Social factors 
such as missing medical appointments due to an inability to leave work or attain childcare may 




neurophysiological and psychological variables previously described, may demonstrate stronger 
effect sizes than have been previously reported.  
2.4.5 Sleep and Chronic Pain 
 Sleep is an activity that all people partake in, we spend approximately one-third of our 
life in a sleep state, but its purpose is not fully understood.51,114  Sleep is believed to be a key to 
maintaining homeostasis across multiple bodily systems115 including memory consolidation,114 
brain development,51 cellular repair,51 and facilitating immune functions.116 It is likely that sleep 
has some capacity to affect all of these functions, and a lack of sleep may potentially facilitate 
adverse consequences.  
 Lack of sleep, in particular insomnia defined as 30 minutes or more of sleep latency 3 
times or more per week for 3 or more months, has been found to have a relationship with chronic 
pain.117 In particular, it was reported that increased nociceptive hypersensitivity and the low 
grade inflammatory reactions were a consequence of decreased sleep and may be a contributor to 
the development of chronic pain.116 Thus, the amount of sleep interference plays a role in a 
person s chronic pain with a small and significant effect.118 
Historically, the relationship between chronic pain and lack of sleep has been viewed as 
bidirectional as it was believed that each one equally influenced the other.115,117 However, a 
review by Finan reported that the relationship may be more strongly associated with sleep 
affecting pain than pain influencing sleep.115 Although the literature is quite extensive on the 
relationship between chronic pain and sleep disturbances, the evidence between chronic WAD 
and sleep is not fully developed. Sleep disturbances have been found to be prognostic of poor 
outcomes at 4 and 12 weeks post MVC, but the amount of explained variance is small ranging 




disturbances in sleep when compared to those with insidious onset mechanical neck pain.120 As 
well, in those with WAD, a statistically significant correlation between pain and sleep quality (r 
= 0.693, no CI provided) and sleep duration (r = 0.433, no CI provided) was discovered; there 
was no significant correlations with those variables for people with insidious onset neck pain.120 
Thus, sleep may be recognized as a small but significantly important factor in the patient with 
chronic WAD symptoms.  
2.4.6 Tissue Trauma and Imaging 
 Damage to tissues in the neck following a whiplash incident has been observed in 
cadavers,8 animal models,26  and computer simulations,70 and the results from these studies are 
consistent in their findings. However, imaging studies on patients with WAD have been unable 
to corroborate consistent results.5,24,25 When imaging studies do find abnormalities, they are 
either not significantly different from a non-injured control group, or the findings are so rare they 
cannot explain the large numbers of people with WAD.24 Yet, it may be argued the findings are 
rare due to the inconsistent protocols used across a number of imaging studies.7 
Reading radiological images can be a difficult endeavor given the various shades of gray 
and illuminated voxels making up the images, especially when combined with the multiple 
sequences available for viewing the anatomy.10 These shades of gray represent the anatomy of 
the patient and based on the reading of the radiologist can represent a normal or pathological 
finding. Reading images does not always provide consistent results, for example, a study by 
Anderson evaluated 4 different readers of 10 separate pathologies on 200 subjects with WAD 
and reported a 0.328 sensitivity and 0.728 specificity for all combined pathologies.24 According 
to these result and the reported sensitivity, imaging is not efficient at ruling people out for the 




following the MVC as they may be requiring care, but with a negative test result, they are not 
receiving it. 
It is not fully understood why there was a low sensitivity; one theory is that it may be a 
result of the limited scoring flexibility within the protocol. For example, in the Anderson study,24 
they attempted to quantify various pathologies with a dichotomous result, a yes or no for having 
the pathology. Disc degeneration was defined as a loss of signal intensity on T2 weighted spin 
echo images, and high grade foraminal stenosis had no specific criteria listed.24 However, given 
there are varying degrees of disc degeneration and the concept of high grade foraminal stenosis 
was not clearly defined, it is possible this lack of criteria led to inconsistencies and low 
sensitivity. Therefore, a scale that labels pathologies a dichotomous variable may not be useful in 
the interpretation of images as the results can be inconsistent and perpetuate the notion that 
imaging is of little use in assessing damage in the neck following an MVC. 
To avoid these ambiguities, it can be helpful to have set criteria that allows the radiologist 
the opportunity and flexibility to read, interpret, and report based on what they are seeing. For 
example, a study by Pfirrmann evaluated the lumbar spine in which a particular scale was 
established for disc degeneration ranging from 1-5 with specific criteria for each level.121 The 
authors reported the intrarater reliability to be excellent (Kappa, 0.84  0.90) and interrater 
reliability was substantial to excellent (Kappa, 0.69  0.81).121 Also using this scoring criteria 
during an MRI of the lumbar spine, researchers reported those with a grade 3 or above had a 
higher likelihood of developing back pain when compared to those who had a grade 2 or 
below.122 With these results, it is possible that not all disc degeneration is the same, and the need 
to reliably and consistently grade the discs (or any anatomy) may be an important factor in 




  Beyond the scoring criteria and subjectivity of the readings, other theories exist about 
why imaging studies are unable to find consistent pathology following a whiplash trauma. The 
first idea has to do with the protocols followed regarding the parameters for the machine. A 
second theory is related to the role of technology and whether the machines are sensitive enough 
to detect the subtle damage that can occur with an MVC. 
 To establish internal validity, a consistent protocol must be created from two primary 
components: the parameters of the machine and the readings by the practitioner. For the 
machine, there are numerous variables that must be accounted for when trying to determine the 
most optimal set up for acquiring images. Each variable has positive and negative attributes in its 
ability to improve the consistency and resolution of the images,10 but they must be used 
repeatedly if co-registration of the images is going to be possible.123  
 After the protocol for the machine is established, procedures for those reading the images 
need to be consistent. The importance of identifying methods that demonstrate strong interrater 
reliability cannot be understated; if the results are not consistent from clinician to clinician then 
the test is of limited use. Therefore, having a standardized protocol or a checklist to assist with 
reading and interpreting images could be of great value.   
It is not known if imaging technology is sensitive enough to detect injuries that can occur 
from an MVC. However, the results from this dissertation and the protocols used to obtain the 
images will hopefully assist in the standardization of future studies to allow for comparisons 
between various groups. With improved standardization, statistical methods such as meta-
analyses can be used to answer the questions regarding anatomy and its relationship with 





2.5.1 Diagnosis vs. Prognosis  
 The notion of creating a diagnosis in cases of a whiplash injury is something that needs to 
be reconsidered based upon the limited objective diagnostic markers available. Without a gold 
standard to make the diagnosis of WAD, and with little to no clinical benefit regarding a change 
to the patient s outcome based on this diagnosis, the idea of evaluating their prognosis based on 
several variables may be of greater clinical value.  
 Recognizing the three distinct pathways in which a patient can progress after they are 
injured, and the prognosis associated with each one, has the potential to guide and improve 
clinical care. The three pathways are: 1) no long term to symptoms 2) mild symptoms 3) 
moderate to severe symptoms.124 Each one of these pathways can be influenced by any or all the 
previously discussed BPS factors. By having a greater understanding of all variables strongly 
correlated with the moderate to severe pathways, clinicians and patients can have a clearer 
picture of the patient s future.  
 As determining the proper prognosis is of great interest, a novel concept referred to as 
triangulation has been proposed to help understand where the patient is located in relation to 
their recovery pathway.125 Using the process of triangulation to determine a prognosis is 
analogous to using multiple cellular towers to determine the location of a cell phone (where each 
WAD variable is equivalent to a different tower). If only one variable is used to determine the 
patient s prognosis, then all outcomes related to that factor are possible. However, if two 
variables are used to determine the prognosis of the person, then wherever there is overlap 
between the two factors is where the person is located along the recovery trajectory. The second 




is used. Greater precision can be accomplished when a third variable is used, as the person s 
location is further developed based on the overlap of all three variables.  
2.5.2 Vulnerabilities and Resilience 
 In addition to the BPS factors that can influence the prognosis of WAD, the timeline of 
WAD must be examined to fully comprehend all the possible influences on symptoms. In 
general, the progression of WAD is viewed on a continuum where the MVC provides a starting 
point for the signs and symptoms and hopefully a resolution. However, there is increasing 
evidence that factors present prior to the MVC can affect prognosis and the recovery trajectory.30 
These pre-MVC factors are referred to as vulnerabilities,30 and although they are unrelated to the 
MVC in the sense that they were not caused by the collision, their presence may have a 
significant effect on the outcome.  
 The vulnerabilities are part of the diathesis stress model, where the term diathesis refers 
to the increased tendency or susceptibility to a particular medical condition.30 The diathesis can 
be based on any or all of the potential vulnerabilities and when combined with a particular stress, 
an MVC for example, can lead to a maladaptive pain response. Given each person has their own 
set of vulnerabilities and the pain experience is individual, it is understandable why researchers 
have been unable to create a single standardized picture of those afflicted with WAD.  
Vulnerabilities can come in various forms including but not limited to psychological, 
physical, and genetic.30 Any of these variables, and most likely it is a combination of them, can 
lead to a maladaptive response following an MVC and can influence the recovery pathway 
leading to chronic moderate to severe WAD. Therefore, being aware of these vulnerabilities may 




 For those diagnosed with WAD, several variables have been found to have moderate to 
strong associations with the transition to chronicity (Table 2.2). Some of these factors may be 
attributable to the MVC, such as the initial pain rating or their NDI score (in the sense that had 
they not been in the MVC then they may not have any neck pain or an elevated NDI score). On 
the other hand, factors such as quantity of MFI may be present prior to the MVC based on 
previous experiences or even genetics. Because of these pre-MVC vulnerabilities, some people 
may be at a greater likelihood of developing long-term symptoms and if they can be discovered 
early in the process then perhaps their treatments can be modified to enhance recovery.  
When evaluating the potential for treatment, some factors such as age, sex, or 
socioeconomic status are non-modifiable, whereas other factors such as a high initial pain score 
or elevated initial NDI score cannot be easily modified if they can be changed at all. Although 
the pain rating and NDI score are strongly associated with a recovery trajectory, without a 
clinically feasible method to alter these variables, this knowledge does little to changer a 
person s treatment or their prognosis. However, other factors are modifiable and if changed 
could lead to improved outcomes, for example, MFI has the potential to be modulated with 
specific exercises,96 and PTSD can be managed with psychological or educational 
interventions.126 It is unknown if treatments focused at these variables for a specific subgroup of 
people with WAD can decrease pain or the rates of disability.  
With the interconnectedness of the BPS model and the heterogeneity of each person, it 
must be recognized that treatments will not be as simple as addressing individual issues or 
symptoms. Instead, all BPS factors, as well as pre-existing vulnerabilities may need to be 
considered, and their relationships with each other will be evaluated to determine and help 




Table 2.2 Prognostic Variables and the Strength of Relationship to Chronic WAD17,20 
Prognostic Variable Strength of Association 
High initial pain intensity; greater than 5.5/10 Strong 
High disability score; NDI greater than 
14.5/50 
Strong 
Presence of Post-Traumatic Stress Disorder Moderate 
Elevated quantity of MFI Moderate 
Key: WAD  Whiplash Associated Disorder; NDI  Neck Disability Index; MFI  Muscle Fatty 
Infiltrate 
2.6 Underdeveloped Factors Related to Chronic WAD 
Even with the current knowledge regarding prognostic variables and recovery trajectories 
related to WAD, a significant amount of information is still unknown. The inability to generate 
meaningful clinical information may be due to prognostic variables being studied in isolation 
with the results focused on how individual factors influence outcomes at a specific point in time. 
With all this specificity, it is not understood how these factors interact with one another or how 
these relationships can change over time. For example, the stress response system can vary over 
time as some variables can take weeks to months to fully manifest which means the effect of 
these interactions will fluctuate. With this changing influence, the relationships must be 
understood throughout the entire timeline of the WAD experience if we are able to provide a 
meaningful understanding of the condition to the patients.  
The influence of psychosocial factors and how they can interact with biological changes 
and other known prognostic variables is not fully developed in the literature. In addition to these 
BPS variables, there are pre-existing vulnerabilities that may predispose someone to developing 
WAD. Therefore, evaluating and understanding how these vulnerabilities can influence 
outcomes, and how they can be measured and put into a model to assist clinicians and patients to 




and the various factors that can contribute to their symptoms, we may begin to have truly 
individualized treatments that can focus on minimizing the transition to chronicity. 
The biological underpinning of WAD has been addressed in numerous studies, but 
conclusive results continue to evade patients, clinicians, and researchers. With inconsistent 
protocols between studies, and an understanding that a single lesion for all WAD symptoms is 
unlikely to be discovered, there is the increasing need to determine the role of structural changes 
in the tissue and how it can affect symptoms. With improved technologies and structured 
protocols, changes in the tissue such as the deposits of MFI may be more readily recognized as 
playing a part in the manifestation of WAD. By recognizing multiple variables that may 
influence WAD, an aggregate score of these factors may be of greater importance than trying to 
isolate a single lesion to explain the symptoms.  
2.7 Contributions to the Literature 
 The crux of this dissertation was to evaluate MFI and its relationship to various BPS 
factors regarding the incidence and recovery of WAD at baseline and across a 12-month 
timeline. The detection and grading of MFI on MRI was evaluated and related to psychosocial 
factors associated with outcomes in a heterogenous population enrolled in a separate NIH-funded 
parent study (RO11HD097076). From this study, the theoretical construct of MFI that occurs due 
to an MVC and its influence on symptoms was examined.  
 Initially, the study focused on understanding how MFI may be related to the transition to 
chronicity based on its presence at baseline. The understanding was evaluated by recognizing the 
association between MFI and NDI. Once this relationship was established, an evaluation of how 




Evaluating MFI as a single predictor of explaining WAD signs and symptoms will more 
than likely will not yield clinically meaningful results. As was previously stated, known BPS 
factors should be considered to understand how and why a person with WAD can transition to 
the moderate to severe pathway. The variables that may influence the signs and symptoms 
associated with WAD are individual and can change over time, and the changes in these 
variables may explain the variety of symptoms that people with WAD often describe. Therefore, 
a second phase of the dissertation will be to explore how the relationship between MFI and NDI 
over time is altered when considering known influential BPS factors.  
The results from this dissertation will benefit in developing a more complete 
understanding of MFI and the biological sequela of an acute injury through the development of 
chronic WAD and the relationship with known prognostic variables. To accomplish this, 
multiple BPS domains and their interactions with other areas need to be evaluated to determine 
which areas explain the greatest variance of WAD symptoms. When their interactions are 
understood, future research and treatments can be focused at modifying these variables to help 





Chapter 3: Methodology 
3.1 Introduction 
 The purpose of this chapter is to describe the methods used for data collection and detail 
the statistical analysis that used to generate results. Recruitment procedures, inclusion and 
exclusion criteria, demographics, and variables collected for study participants are included. 
Protocols used to acquire imaging data, including user prescribed parameters to ensure quality, 
as well as the methods used by researchers to determine the quantity of muscle fatty infiltrate 
(MFI) are described. A description of the self-report outcome measures collected at each time 
point as well as psychometric properties, including reliability and validity for each outcome 
measure are provided. Statistical methods to discover potential relationships between known 
prognostic variables, the quantity of MFI, and the participants recovery pathways are described, 
and these methods were used to help determine results for each specific aim of the study.  
3.1.1 Specific Aim #1  
 The first aim of this study is to determine the combined relationship between baseline 
MFI values and prognostic variables believed to influence the outcome of participants diagnosed 
with whiplash associated disorder (WAD) on neck disability index (NDI) scores.  
3.1.2 Specific Aim #2 
 The second aim of this study is to determine if there are changes in magnitude in the 




3.2 Research Design and Outcomes 
3.2.1 Research Design 
 Data for this study was collected as part of a National Institute of Health (NIH) funded 
research project clinicaltrials.gov Identifier: NCT02157038. From this study, a secondary 
analysis of the data was performed to discover the results associated with the previously 
described aims.  
 The NIH project was a longitudinal observational study in which participants were 
recruited immediately (within one week) following a motor vehicle collision (MVC) and 
followed over a 12-month period. During those 12 months, magnetic resonance imaging (MRI) 
of their cervical spine was obtained at 1-week, 2-weeks, 3-months, and 12-months post-MVC. In 
addition to imaging, enrolled and consented participants were invited to complete a variety of 
self-report measures at each time point evaluating their functional impairments, signs of post-
traumatic stress, anxiety and depression, distress associated with the MVC, and pain intensity. 
Although no treatments were offered to the participants, they were not restricted from seeking 
and receiving any treatment for any MVC related complaints.   
3.2.2 Image Acquisition  
 Images of the cervical spine were acquired using a 3-Tesla (T) Siemens MRI scanner. For 
the scan, a 3D-multi-echo, Dixon fat/water separation gradient echo approach was used to 
quantify the total percentage of MFI.127 The 3D-multi-echo method has been found to be as 
reliable as a T1 weighted image in determining the amount of MFI present in the musculature128. 
However, the 3D method acquires the images at a significantly faster rate thereby decreasing the 




 During each of the four MRI examinations, images were obtained from the most superior 
portion of C3 to the most inferior portion of C7. To maximize co-registration, a standard 12-head 
channel coil and neck specific receiver coil were used to obtain images. Previously established 
parameters for obtaining the images related to maximizing the distinction between fat and water 
included using a T2-weighted sagittal turbo spin echo sequence with a TR of 23.81 ms, 8 echo 
times with a spacing of 1.78 ms starting at 1.36 ms, as well as a slice thickness of 3mm for each 
image with 22% overlap to prevent aliasing.127 Finally, a rectangular field of view of 75% with a 
1.4 mm in-plane resolution was used to view the area. Regions of interest of MFI were drawn 
with Analyze Software (v. 11) at the most superior portion of each vertebrae from C3-C7 for 
bilateral muscle groups: multifidus, semispinalis cervices, semispinalis capitis, and splenius 
capitis. Bilateral muscles were evaluated and used to determine the total amount of MFI.  
 Using the Dixon method, the images can show water or fat only, as well as water and fat 
combined. This ability to isolate each one makes it possible to determine the amount of MFI 
present. The following formula was used to calculate total amount of fat as a percentage: 
Percentage of Fat = 100 * fat/ (fat + water) 
The amount of MFI was measured and recorded by a single researcher blinded to the 
outcome of the participants. The information from the researcher s measurements, data from the 
self-report measures, and the participants demographic information were transferred to a 
Microsoft Excel (2016) spreadsheet for analysis.   
3.2.3 Sample Size Estimation 
 The estimated sample size for this study was determined to be 100 participants with the 




symptoms, and 63 will fall into the recovered/mild category.4 The one-hundred participants 
allows for a 10% dropout rate yet still provides sufficient statistical power for data analysis based 
on an 80% power to detect a change in MFI of 0.66 standard deviations between the groups and 
a Type I error significance level of 0.05.  
3.2.4 Recovery Pathways 
 Recovery pathways, or predicted recoveries, are classification schemas that attempt to 
determine homogenous subgroups of people who are likely to report similar outcomes over a 
period of time.4 The pathways are determined by group based analytical techniques in which 
participants are followed and the outcome of interest is measured over time.4 With similar 
outcomes, participants are grouped together based on their recovery pathway and common 
variables are examined to determine the influence of these factors on the trajectory.4 
 In those with WAD, three distinct recovery pathways based on NDI scores have been 
reported: 1) recovered < 10%; 2) mild symptoms 10 to 28%; 3) moderate to severe symptoms 
greater than 30%.4,124,129 Several studies have used different outcome measures to evaluate the 
presence of these pathways,4,129 and they collectively report three distinct groups. The NDI is the 
most frequently cited outcome measure associated with these pathways. (Table 3.1)  
While these pathways may provide prognostic value associated with long-term recovery 
rates, the greatest amount of recovery occurs during the first three months following the MVC 
with little to no improvement after that timeframe.4,124 The lack of improvement after three 
months may have clinical implications because it is not uncommon for a person with WAD to 
delay initiating a formalized rehabilitation program. Therefore, if there is limited improvement 
after three months then the initial delay may limit their recovery.129 For this reason, having a 




trajectory a person may follow could be beneficial to focus resources and treatments towards 
subgroups that may have the greatest potential to transition to chronicity.  
Table 3.1 Recovery Pathways Based on NDI Scores4,124 
Group NDI score 
Recovered 0-8% 
Mild symptoms 10-28% 
Moderate to Severe symptoms >30% 
NDI: Neck disability index; scored as a percentage. 
3.2.5 Institutional Review Board 
 As this is a secondary analysis of data collected through an NIH study, Neuromuscular 
Mechanisms Underlying Chronic Whiplash, the institutional review board (IRB) of record for 
that study is Northwestern University (NU) in Chicago, Illinois (IRB# STU00040759). However, 
the current PhD dissertation study was run through Nova Southeastern University (NSU), so 
prior to execution of the primary actions of this study including the use of data for computations 
and analysis IRB approval was evaluated. As this was a secondary analysis, it was deemed that 
this study was exempt from the IRB approval process. (Appendix A) In addition, as the data was 
collected at NU, a data sharing agreement between NSU and NU was obtained. (Appendix B) It 
is also recognized that NSU will oversee the actions of this PhD dissertation but no other past, 






3.3.1 Inclusion and Exclusion criteria 
 The primary factors for inclusion in the study was an MVC within the past week which 
resulted in a diagnosis of WAD. For the diagnosis of WAD, participants had to meet the criteria 
for the Quebec Task Force (QTF) grades 2 (neck pain, decreased range of motion, and 
tenderness) or grade 3 (same as grade 2 in addition to neurological changes in reflexes, 
sensation, or strength). Potential participants had to be between the ages of 18-55 and both males 
and females were eligible. 
 A participant was excluded from the study if they had a fracture of the spine related to the 
MVC, a previous MVC, history of spinal surgeries, or prior diagnosis of cervical or lumbar 
radiculopathy. A history of neurological disorders (e.g. multiple sclerosis, Al heimer s, stroke, 
or myelopathy) inflammatory diseases (e.g. hepatitis, systemic lupus erythematosus, rheumatoid 
or osteoarthritis, ank losing spond litis, Chron s disease, fibrom algia) or metabolic diseases 
(e.g. diabetes mellitus, hyper or hypo thyroid) eliminated potential participants from the study. 
Inability to tolerate (claustrophobia) or be medically cleared (metal implants, pregnancy, or a 
pacemaker) for the MRI procedure also rejected potential participants from the study. 
3.3.2 Recruitment  
The participants were recruited from the Chicago area, primarily through the emergency 
department (ED) at Northwestern University (Northwestern Memorial Hospital) as well other 
EDs in the surrounding region. Potential participants were contacted either in the ED or by a 
phone call the following day by a member of the research team to determine their level of 
interest, explain the general procedure of the study, and expectations for participation. To recruit 




inclusion and exclusion criteria for the study. Interested parties could contact the research team 
via email where they could state their desire to participate. Upon follow-up communication, or in 
person in the ED, a brief screening examination reviewing the inclusion and exclusion criteria 
was performed with each potential participant to determine their suitability for the study.  
3.3.3 Demographics 
 Patient demographics such as age, sex, height, weight, race, socioeconomic level, 
education level, and litigation status were collected via a standardized intake form (Appendix C). 
A basic health history form (Appendix C) was also collected to determine any potential medical 
complications, headaches, or injuries that existed prior to the MVC. 
3.3.4 Informed Consent 
 All participants who were candidates and elected to participate in the study were required 
to sign an informed consent form (Appendix D) which outlined their rights as a research 
participant, potential risks associated with their participation, and the expectations placed upon 
them.  They were informed that their participation was voluntary, and they could withdraw at 
any time. 
3.3.5 Privacy Protection 
 The collection and storage of all participants information was treated and protected with a 
standard protocol as established by the Health Insurance Portability and Accountability Act 
(HIPAA). Once collected, all original forms were scanned into a computer for storage and all 
hard copies were stored in a secured cabinet. Prior to inputting the data into the Excel 
spreadsheet, the participants name and identifiable information was deidentified by way of 
creating a participant ID number. All digital information was secured on a password protected 




3.4 Self-Report Measures 
3.4.1 Neck Disability Index 
 The NDI is the most widely used self-report outcome measure for determining limitations 
due to cervical spine pain.48 The NDI is a 10-item survey with seven items assessing activities of 
daily living (ADL), one for neck pain, one for headaches, and one related to concentration; the 
items are scored on a 0-5 scale with 0 meaning no disability and 5 representing full 
disability.130,131 (Appendix E) There are two ways to score the NDI: 1) The raw score provided 
by the patient is out of 50 points if all 10 questions are answered or fewer points if they do not 
answer all of them; 2) The participants total score is divided by the total points possible to 
generate a percentage of disability.130 The percentage of disability method works well when 
questions are not answered on the form,48 for example, someone may not drive and therefore 
cannot provide a response to the question that asks about symptoms while driving. However, if 
three or more items are not answered then the tool is considered invalid.132 For this study, the 
percentage of disability will be used for analysis. 
 There is debate as to the number of dimensions that are evaluated by the NDI. The intent 
of the NDI was to create a unidimensional scale to measure the functional status/disability of a 
person with neck pain related to their ADLs.130 However, it has been proposed that the NDI may 
evaluate two separate dimensions: 1) functional disability and 2) pain and interference with 
cognitive functioning.133 Although the number of dimensions that are evaluated is not agreed 
upon, the NDI is considered an adequately valid, reliable, and responsive outcome measure for 
people with neck pain.48 
 The NDI has been used across multiple subgroups of people with neck pain including 




has reported an internal consistenc  with a Cronbach s alpha 0.87,133 which is considered 
acceptable.135 In a systematic review, the authors reported the test-retest reliability correlation 
coefficient r ranged, based on acuity and time between measurements, from 0.73 to 0.93, and 
specifically for those with chronic neck pain r = 0.89 to 0.99.48  
Instead of calculating a standard correlation coefficient, Cleland performed an intraclass 
correlation coefficient (ICC2,1) which evaluates not only the degree of correspondence but also 
the agreement among the ratings.136 With the ICC, the authors reported results 0.50 for people 
with mechanical neck pain (95% confidence intervals (CI), 0.25 to 0.67) and for cervical 
radiculopathy 0.68 (95% CI, 0.30 to 0.90).131,137 Although the results reported by Cleland are not 
as robust as previous authors, the test-retest reliability of the NDI is still considered fair to 
moderate and is deemed acceptable to use in both clinical and research settings.48  
 The validity of the NDI has been studied extensively and in general it is found to have 
good to excellent results.48 The convergent validity between the NDI and other outcome 
measures has been evaluated and a correlation coefficient of 0.70 and greater has been 
reported.48 These results infer that the NDI is acceptable to use for evaluating both pain and 
functional disability for someone with neck pain.  
 The responsiveness, both the minimum detectable change (MDC) and minimum 
clinically important difference (MCID) of the NDI has been reported with a wide range of 
results. The MDC is the amount of change that must occur to ensure that it has exceeded the 
standard error of measurement (SEM);136 the lowest reported MDC for the NDI was 2/50 
points,138 while the highest was greater than 10 points out of 50.131,139 The wide variation in 




determination of what constituted a change in a person s status.132,139 Even with this variability, 
the use of 5 points out of 50 for the MDC is generally deemed acceptable.132 
 A receiver operator characteristic (ROC) curve has been used to determine the MCID for 
the NDI. The ROC curve is a graphical representation of a balance between sensitivity and 
specificity that helps to determine a cut point based on the relative importance desired by the 
researcher.139 From the ROC curve the area under the curve (AUC) can be calculated. The AUC 
is a measure of responsiveness represented by a single number as a probability of correctly 
predicting an outcome; an AUC of 1.0 is a perfect prediction and 0.50 is equal to simply 
guessing.136  
For the NDI using a ROC curve, authors have reported a MCID of 7.0 out of 50 points 
with sensitivity of 0.52 (95% CI, 0.32 to 0.71) and specificity of 0.59 (95% CI, 0.36 to 0.78) and 
an area under the curve (AUC) of 0.57 (95% CI, 0.38 to 0.75).131 A second report of the MCID 
using a ROC was 3.5 points out of 50 with sensitivity of 0.9, specificity of 0.7; neither the CI or 
AUC were reported.139 Although there is a spread of points for the MCID between these two 
studies, the use of 5 points as the MCID in studies tends to be accepted.132 However, some 
subgroups may be more resistant to improvement and may therefore require greater changes in 
scores to generate a meaningful MCID.132  
 One other area in which the NDI has limitations is in the floor and ceiling effects. The 
NDI can have difficulties in its responsiveness when a person is near the extremes of the scale.48 
For example, if a person has low disability, 3/50, it may be difficult for the NDI to capture 
improvements made by the person. In addition, the validity, reliability, and responsiveness have 
not been assessed at various scores (low, medium, and high) as the scale may act differently 




Although the NDI is deemed appropriate to use as a measure of functional loss in those 
with neck pain, it may not capture all the domains that are important to those with WAD as they 
often present with emotional or social issues that may complicate their presentation.134 
Therefore, using multiple measures to evaluate a person s function and emotional health ma  be 
of benefit in accurately describing their complete presentation. 
3.4.2 Post-Traumatic Stress Disorder 
 PTSD is a mental health disorder that manifests with psychological distress after a person 
is involved in, or witnesses, a traumatic event, including an MVC.47 From the traumatic 
experience, three primary domains of their symptoms will arise: 1) The person may develop 
recurring thoughts or feelings about the event (intrusion); 2) They may avoid situations that they 
fear may trigger their memory of the event (avoidance); 3) They tend to be always on alert or 
looking out for danger (hyperarousal).47 With these symptoms, many people find it difficult, if 
not impossible, to manage their everyday activities, which can lead to further mental and 
physical health issues. For this study, symptoms associated with PTSD were measured using the 
Post Traumatic Diagnostic Scale (PDS). 
3.4.2.1 Posttraumatic Stress Diagnostic Scale 
 The Post-traumatic stress diagnostic scale (PDS) is a self-report questionnaire that is 
designed to measure the severity of PTSD symptoms related to a specific incident or trauma and 
assist in generating a diagnosis of PTSD.50 For data collection related to this study, the MVC was 
considered the traumatic event of record. The PDS consists of 49 items with 17 specifically 
about the symptoms associated with PTSD and the other 32 about the traumatic event and the 
interference of the symptoms on activities.50 The PDS has been found to demonstrate adequate 




 The internal consistency of the entire scale has been estimated at  = 0.92.50 The test-
retest reliability has been calculated for both the generation of a diagnosis of PTSD and the 
symptom severity. For the PTSD diagnosis and symptom severity, between 2 and 3 weeks, kappa 
values for the PDS have been reported as 0.74 and 0.83 respectively.50    
 For the diagnosis of PTSD, the results of the PDS have been compared to the structured 
clinical interview which is the most commonly used criterion on which to validate a PTSD 
measure.50 For convergent validity of the PDS and the interview, a kappa value of 0.65 with 
sensitivity of 0.89 and specificity of 0.75 have been reported which indicate satisfactory 
agreement between the two measures.50 The symptoms of PTSD as measured with the PDS 
correlated with the Impact of Events Scale-Revised subscales of intrusion and avoidance with r = 
0.77 and 0.69 respectively which also demonstrates adequate agreement between the scales .50 
 The full PDS score was not a part of this study but will be used within the parent NIH 
study. In this dissertation, only the score from the PDS related to sleep disturbance was used as 
an isolated variable.  
3.4.3 Numeric Pain Rating Scale 
 The Numeric Pain Rating Scale (NPRS) is a commonly used tool to determine the level 
of pain a person is experiencing.141 The NPRS is an 11-point scale that ranges from 0 to 10 with 
scores on each whole integer.141 The anchors for the scores are no pain at 0 and the worst pain 
imaginable for the score of 10.  
 The psychometrics of the NPRS has been reported across various subgroups and in 
general it is found to be a valid, reliable, and responsive tool.137,142 The validity of the NPRS has 




0.93 to 0.95) was reported.142 In a group with mechanical neck pain, the 3-day test-retest 
reliability as measured with an ICC2,1 was reported as 0.76 (95% CI, 0.52 to 0.87).137 For 
determining the responsiveness of the NPRS, the standard error was 0.91, with MDC of 2.1, and 
1.3 for the MCID.137 When the NPRS was correlated with the self-report global rating of change, 
the 1.3 MCID demonstrated a sensitivity of 0.88 and specificity of 0.71.137  
3.5 Data Analysis 
3.5.1 Descriptive Statistics and Data Screening  
 All data in this study were analyzed using SPSS version 24.0. Prior to analysis, the data 
were screened to assess for normal distribution. Participants were placed into one of two groups 
based on their NDI score at 12-months: 1) Recovered less than 10%, 2) Persistent symptoms 
greater than or equal to 10%. Group membership was based upon findings from previous studies 
determination of recovery trajectories.103 
 For all variables the skewness and kurtosis were reported, and for those with multiple 
time points it was reported at each one. A value of zero will be recognized as normally 
distributed for both skewness and kurtosis. However, there is no consensus on how much 
variability is acceptable before data is determined to skewed or kurtotic.143 Within the output for 
each variable, any number above 1 or below -1 will be deemed skewed or kurtotic.143  
To assess normality for each variable using a numerical method the Shaprio-Wilks test 
was employed. A significance value below 0.05 was considered a departure from normal. 
Graphical representations of normality were assessed using histograms, Q-Q plots, and box plots 
to determine the spread of the data and determine if any outliers are present. If any outliers were 




inputted properly 2) if there were no errors their chart was reviewed to evaluate if there are any 
reasons (i.e. medical conditions) that may have influenced the outlier status and a determination 
was be made about retaining or discarding their data. 
 Baseline characteristics between the groups was established for each variable. At the 
interval/ratio level an independent t-test was used, a Mann-Whitney U test was used for ordinal 
level data, and for nominal level data, a chi-square ( 2) test was calculated to determine if 
differences in proportions exist between the groups. An alpha level of 0.05 was used to 
determine significance for all group differences. 
 For missing data, the individual cases were handled in one of two ways. If the data that 
was absent was related to a previous time point, similar to an intention to treat analysis, the last 
measured number was carried forward to the missing variable. If the data missing was related to 
a non-repeated measured variable, for example age, the mean for the final group membership in 
which the participant is a part of was used in its absence. 
 Finally, multicollinearity of the variables was assessed using a correlation matrix. As 
there were interval/ratio level data as well as ordinal level a Spearman Rho correlation was used 
to evaluate the variables. Any r value at or above 0.75 for two variables was considered to 
demonstrate multicollinearity.143 If any two variables demonstrated an r value at or above the 
designated level, based on careful consideration and reasoning, one of the two was removed from 
the analysis.  
3.5.2 Aim #1  
 A logistic regression analysis was used to determine the relationship between the 




listed for the baseline data. Interaction effects between the variables that were found to be 
different between the groups at baseline were also included as IVs. Prior to entering the variables 
in the model, a decision was made on how to handle ordinal level data. Logistic regression is 
adept at managing categorical and continuous level data, bur ordinal level data must be classified 
as either categorical or continuous in order to be properly analyzed.144 Therefore, each IV that 
was recorded at the ordinal level was evaluated via statistical methods as well as using logical 
reasoning to determine which path, categorical or continuous, the variable would be categorized.  
Once all variables were established, a backwards conditional method was used for 
determining which IV s to include in the final model, a p-value of < 0.10 was used as the alpha 
level for inclusion into the model. From the final model, the Nagelkerke R2 was reported, as 
well, for each variable the unstandardized beta weights, odds ratios (OR), and 95% CIs for the 
beta and OR were stated. In addition, sensitivity and specific were calculated along with ROC 
and AUC to assist in determining group discrimination. 
3.5.3 Aim #2 
 Using only the variables that were found to be significant at baseline, separate analyses 
were run for each subsequent time point described in section 3.2.1: 2 weeks, 3 months, and 12 
months. To evaluate the influence of the IV s at each time point during the 12-months following 
the MVC, the OR and its CI were compared to one another to determine if the strength changed 
in magnitude or direction. A graphical representation of time and the OR and CI were evaluated 





 This chapter establishes the methodology for this project including the research design, 
acquisition of data and participants, protocols followed, self-report measures used, data analysis 
carried out, and their potential limitations. Every attempt has been made to base all decisions on 





Chapter 4: Results 
4.1 Introduction 
The purpose of this chapter is to report the results of the statistical analysis from the study   
Neck Muscle Composition in Persistent Whiplash Associated Disorder:  
Relationship with Neck-Related Disability 
The chapter describes the data cleaning and screening used to assess for normality; discusses the 
results for evaluating variables to include into the logistic regression model; reports on how the 
variables and model changed over time; and examines if there were any interaction effects 
between the variables. The statistical analysis was performed using SPSS version 24 (IBM Corp., 
Chicago, IL.) 
 The questions guiding this analysis were 1) What factors have a statistically significant 
influence on predicting neck-related disability in persistent whiplash disorder? 2) What is the 
magnitude of the influence for each variable? 3) How do these factors interact at baseline and 
potentially change over time?  
Initially, the variables at baseline were assessed to determine which ones were 
significantly different between the groups with persistent symptoms and those who later reported 
they were recovered based on their 12-month scores from the Neck Disability Index (NDI). For 
evaluation of the data, continuous-level variables were examined using independent t-tests, 
Mann-Whitney U tests for ordinal level, and Chi-square tests for nominal level. Following these 
tests, a logistic regression model was built by assessing all variables and determining those that 
were statistically significant predictors of persistent symptoms; the individual strength and 




by way of the Nagelkerke R2, sensitivity and specificity, a receiver operator characteristic (ROC) 
curve and the area under the curve (AUC)  
 The second group of questions evaluated the logistic regression model s prediction, as 
well as the variables within the model for their influence over pre-determined time points. The 
variables were assessed based on their unstandardized beta value, odds ratios (OR), and 95% 
confidence interval (CI). The OR and 95% CI were assessed to determine if a significant change 
occurred at any of the time intervals. Finally, interaction effects of the variables were assessed to 
determine if any group by time interactions occurred that may not have been visible viewing 
only the simple main effects.  
4.2 Data Screening 
 Prior to running the analyses, the data were cleaned for missing records, screened for 
normal distribution, and assed for outliers. Currently, there is no single method used to determine 
normality, therefore, in this report multiple methods including numerical (skewness and 
kurtosis), graphical (histograms, Q-Q plots, and box plots), and formal normality tests (Shapiro-
Wilk) were used to determine if the data were normally or abnormally distributed.143,145 The 
accumulation of all the tests were used to make the final determination of normality.  
The variables of interest for this analysis were sex, body mass index (BMI), age, neck 
muscle fatty infiltrate (MFI) measured from dual-echo fat/water (Dixon) magnetic resonance 
imaging (MRI) scans, numeric pain rating scale (NPRS), NDI score, sleep item response on the 
NDI (sleep NDI), and the sleep item response on the post-traumatic disability scale (sleep PDS). 
Sex, BMI, and age were collected at baseline; within 1 week of the MVC. For the variables MFI, 




collection process: within 1 week (T1) post-motor vehicle collision (MVC), 2 week (T2) post-
MVC, and both 3 months (T3) and 12 months (T4) post-MVC.  
Sex was collected on the intake form with the options of male and female. It is 
recognized that the sex of a person is often not simply defined as male and female.146 However, 
for the purpose of this study, it was determined that the contemporary designations of male and 
female would be used as the determinants of a person s sex-at-birth.17,59,147 Because the 
responses were categorical and could not be distributed normally, it was not included as part of 
the data screening. 
4.2.1 Data Cleaning 
 Prior to analyzing the data in SPSS, missing records were identified and managed in 
Microsoft Excel 2018 (Redmond, WA). Each participants information was entered in the 
spreadsheet and every variable was assessed for missing data by looking for empty cells within 
the table. For any variable recorded at baseline, if data were missing then the average of that 
variable based on group membership was used in that space. For missing data related to T2, T3, 
or T4, the data in the previous cell would be carried forward and used for all empty cells.  
 For the variables sex, age, and BMI there were no missing data points. For NDI, the only 
missing data were at T4; 8 participants in the persistent group and 11 in the recovered group. 
Neck MFI in the persistent group had 3 participants with no data available at any time (they were 
either claustrophobic and could not undergo the MRI scan, or other institutional policies 
prohibited them from having an MRI) along with 6 participants without available data at T4 as 
they were lost to attrition. For neck MFI in the recovered group, 1 participant had no data 
available due to claustrophobia and 10 participants were missing data at T4 again due to attrition. 




along with 7 other participants without data at T4, and in the recovered group 1 participant had 
no data at any time, and 10 others lacked data at T4. Finally, sleep NDI and sleep PDS responses 
were identical for both groups regarding missing data. For these variables, missing data was only 
an issue at T4, the persistent group had 8 participants along with 10 participants in the recovered 
group. For all variables, participants who had no data at T4 were lost to follow up. 
 For the group of participants that developed persistent symptoms, the 9 people who did 
not complete all the MRI data collection were compared to the 51 that did complete all data 
points to assess if there were any differences in their age or BMI. An independent t-test was used 
to evaluate for any differences for these two variables; for age there was no difference noted 
between those that completed all data points and those that did not, but the BMI was 
significantly higher in the group that did not have the MRI when compared to the group that did 
complete the scan (p = 0.024). For the recovered group, the 11 participants that did not complete 
all MRI data points were compared to the 26 that did to determine if a difference existed between 
them for the variables BMI and age. The independent t-test was used, and there were no 
significant differences between the groups on any variables.   
 In evaluating the difference in BMI between those that completed all the data points and 
those that did not, it was discovered that of the participants in the non-completion group, one had 
a BMI of 39.7 and another had 34.8. Of all 97 participants in the study, the BMI of 39.7 was the 
highest value recorded and the 34.8 was the 5th highest value. Therefore, although there was a 
difference between the BMI of the people that were able to provide data points at all time points 




4.2.2 Numerical Methods 
Skewness and kurtosis were evaluated for each of the variables; for the variables with 
four data points each was evaluated individually. There is no gold standard for what constitutes 
skewed or kurtotic data.143,148 For determining if the data are skewed or kurtotic, the output of the 
SPSS analysis was used. In the output, total skewness and kurtosis were reported as a numerical 
value and if the range was within -1 to 1, the data were considered to have a normal 
distribution.143  
Using the standard error is another option for assessing the numerical evaluation of 
skewness and kurtosis.143,148 However, when evaluated across time and groups, the data would 
likely be bimodal with numerous high and low data points and not many in the middle. Thus, the 
distribution will create a large standard error and numerous variables will be deemed skewed or 
kurtotic. Because of this distribution pattern, the method of using the standard error for 
evaluating skewness and kurtosis was not used.  
Using the range of -1 to 1 for evaluating skewness, 4/23 variables were found to be 
skewed: NDI at T3 and T4, sleep PDS T4, and MFI T1. In looking at these variables, it is 
recognized that 3 of the 4 were present at T3 and T4, which by this time point the differences 
between the groups, persistent symptoms and recovered, had been well established and thus the 
data were expected to be non-normally distributed.  
Kurtosis was evaluated the same as skewness using the -1 to 1 scale, and in the SPSS 
output 4/23 variables were outside this range. The variables were MFI T1 and T2, NDI T4, and 
sleep PDS at T4. Similar to the skewness, 2 of the 4 variables were related to the most distal time 
points and would thus be expected to not be distributed normally. Only MFI at T1 and T2 




is robust to minor deviations of normality, it was determined to retain the data in a raw (non-
transformed) format.   
4.2.3 Graphical Methods  
Q-Q plots were used to evaluate the normal distribution of each variable. Most of the 
variables showed a proper distribution along the primary diagonal line with the exceptions being 
NDI at T3 and T4, and MFI at T1 and T2. The results for the NDI were expected based on the 
skewed data previously described and the groupings of the participants at these times. For the 
MFI, although it was found to be abnormally distributed at T1 and T2, it was not seen at all 4 
time points: thus, it does not appear to be a systemic issue related to MFI. 
In addition to the Q-Q plots, histograms of the spread of the data were examined to assess 
normality. The histogram for the variable NDI at T3 and T4 showed that the data were not 
normally distributed, which agrees with the Q-Q plot. However, MFI at T1 and T2 showed a 
normal distribution with the histogram, which is in opposition to the Q-Q plot, but with the Q-Q 
plot the deviation from normal appeared to be minimal. Histograms for the variables at T3 and 
T4 NPRS, sleep NDI, and sleep PDS showed a non-normal distribution. However, like the NDI 
at T3 and T4, these results would be expected based on the widely acknowledged assumption 
that 50% of those injured should recover within the first 3 months, as well, given these variables 
are ordinal level data, a non-normal distribution can be expected.149  All other variables with the 
histogram showed a normal distribution. 
4.2.4 Formal Normality Tests   
The Shapiro-Wilk test is considered the most powerful normality test145 and was used in 




distribution:143 its results should be considered in combination with the previous assessments of 
normality.  
For the Shapiro-Wilk test, the alpha level of 0.05 was used, and the null hypothesis was 
that the data were normally distributed: therefore, a probability lower than alpha were considered 
not normally distributed. For all the variables, only the NDI at T1 and NPRS at T1 were above 
the 0.05 level of significance with levels of 0.547 and 0.059 respectively. Thus, all the other 
variables, per the Shapiro-Wilk test, were considered non-normally distributed.  
4.2.5 Outliers 
 To determine if there were any outliers in the data, box plots were created, displayed, and 
assessed. For each variable, the interquartile range (IQR) was reported as the quantity of the 25th 
and 75th percentile of the total score. The IQR was multiplied by 1.5 and added to the 75th 
percentile and subtracted from the 25th percentile to determine the highest and lowest scores that 
are not deemed to be an outlier. Any number above or below the 1.5 IQR is considered an 
outlier: if it is between the 1.5 and 3 IQR it is a mild outlier, whereas extreme outliers are 
reported if it is above 3.143 
 In the output, there were several outliers, all of them were above the 75th percentile, and 
none were below the 25th percentile: they were all considered mild outliers as none were beyond 
the 3 IQR. The outlier variables were BMI (1 participant), NDI at T3 (2 participants), sleep PDS 
at T4 (4 participants), and MFI at each time point had at least 3 outliers (with 5 distinct 
participants across all points). To evaluate the potential causes for the outliers, all outlier scores 
were assessed for accuracy by ensuring the data were accurately recorded in the spreadsheet and 
no typographical errors were found in the input. After reviewing the original data, it was 




To assess the influence the outliers may have had on the overall normality, the outliers 
were transformed using the Winsor method, which takes their current value and adjusts it to the 
1.5 IQR above the 75th percentile so that it is at the outermost portion of the whisker of the box 
plot but it is no longer considered an outlier.150 The statistical tests were run again using the 
Winsorized variables and all numerical, graphical, and normality test results were compared to 
the original output. 
For NDI and sleep PDS responses it was expected that there were outliers at T3 and T4. 
By these time points, many participants are dichotomized into the recovered or persistent groups 
and the data were shifted towards a non-normal distribution, which is different than the earlier 
times when the data were normally distributed. However, if someone still had severe symptoms 
at T3 or T4, they may be outside the 1.5 IQR, whereas at earlier time points when the data were 
evenly distributed those same scores were within the 1.5 IQR. Use of the Winsor method for 
NDI and sleep PDS responses indicated there were no changes in the skewness or kurtosis: 
however, the Q-Q plot for NDI at T3 was now normally distributed, and all other graphical 
evaluations were unchanged when compared to the untransformed data, as well, there was no 
change in the Shapiro-Wilk test. 
For BMI and MFI, the variables are not based upon symptoms, and it is unknown if the 
data were affecting the overall normality. Using the Winsor method, there were no changes in 
any of the normality tests for BMI. For MFI assessing the Q-Q plot at T2, the data were normally 
distributed, but all other graphical plots were unchanged, and the Shapiro-Wilk test was 
unchanged.  
With all these tests taken into consideration, there are a few variables that are not 




demonstrate this distribution at T3 and T4, and the majority of the normality tests and graphs do 
not demonstrate significant variations from normal, it is safe to state the data were normally 
distributed and parametric tests could be used in the analysis. For the other variables, based on 
the expected recovery rates of people following an MVC and the bimodal distribution of the 
data, it is was expected that some would be non-normally distributed. In this study, the variables 
that demonstrated a non-normal distribution were centered around T3 and T4 and included NDI, 
NPRS, sleep NDI, and sleep PDS. As earlier time points demonstrated normal distribution, there 
should be no concerns with using parametric tests during the statistical analysis.  
4.3 Specific Aim #1 
 The primary aim for this study was to evaluate the relationship between the independent 
variables (IV): MFI, sex, age, BMI, NPRS, NDI, sleep NDI, and sleep PDS responses on the 
dependent variable (DV) group membership that consisted of persistent symptoms and recovered 
amongst participants following an MVC. Group membership was based on total NDI scores at 
12 months and was separated into two groups: 1) persistent symptoms in anyone with an NDI 
10% and above, and 2) recovered as any person with an NDI score below 10%.  
 In this study, participants were divided into two groups (persistent and recovered) instead 
of the three group model previously described in the literature (recovered, mild, and severe).4 In 
the three-group model, which is also based on NDI scores, the recovered group is 0 to 8%, mild 
is classified from 10 to 28%, and moderate to severe is greater than 30%. The idea to use two 
groups instead of three was made for several reasons. The notation of persistent and recovered is 
more clinically applicable to those suffering with whiplash associated disorder (WAD). It may be 
that people that are coping with mild symptoms could (although there is the possibility that they 




are classified as moderate to severe. A second reason had to do with the large minimum 
detectable change (MDC) reported for the NDI; the MDC is the smallest change that must occur 
between two related scores to exceed the threshold of error.136 The MDC for the NDI has been 
reported to be as high as 19%,137 which essentially means that someone with a score of 12% 
could be in the same category as someone with 30% impairment. Therefore, using a cutoff of 
30% could inadvertently misrepresent the total number of people who could benefit from 
treatment. Finally, in evaluating the variables across the four time points in this study, when the 
variables were analyzed using the three-group model, there were several variables where the 
mild and moderate to severe categories resembled each other rather than demonstrating 
distinctive groups. However, the mild and severe groups appeared to be different when compared 






Figure 4.1 MFI across time by group 
 















Figure 4.2 Sleep NDI across time by group 
 
 












Figure 4.3 Sleep PDS across time by group 
 
Abbreviations: Sleep PDS; Sleep response on Post-traumatic Diagnostic Scale 
 
4.3.1 Baseline Demographics 
 Prior to evaluating the relationship between the IVs and the DV, the baseline 
demographics needed to be established, in addition, it needed to be determined if there were any 
differences between the groups at this time. To assess the variables, a series of tests were 
performed to establish the means for the groups and determine if any statistically significant 
differences between the groups were present. For the variables with interval or ratio level data 
(age, BMI, MFI, and NDI) an independent t-test was used,136 for ordinal level data (NPRS, sleep 
NDI, and sleep PDS) a Mann-Whitney U-test was used,136 and for categorical data (sex) a Chi-




  For the independent t-test, with the four variables evaluated, only MFI (p = 0.007) and 
NDI (p = 0.004) were found to be statistically different between the groups. See Table 4.1 for 
means and p-values for all interval and ratio level variables.  
Table 4.1: Baseline characteristics and differences for continuous data (independent t-test) 
Variable Means of recovered 
group  
(n=37) 




Age (years) 34.1 35.0 0.68 
BMI 25.27 25.15 0.90 
MFI T1 17.80 20.95 0.007* 
NDI T1 30.0 39.9 0.004* 
Abbreviations: BMI, Body Mass Index; MFI, Muscle Fatty Infiltrate; NDI, Neck Disability 
Index; * Reached statistical significance with alpha at 0.05. 
 
 A Mann-Whitney U test was used to evaluate differences between the groups for the 
variables with ordinal level data. Of the three variables assessed at baseline only sleep NDI was 
found to be significantly different between the groups (p = 0.027). See Table 4.2 for median 





Table 4.2: Baseline characteristics and differences for ordinal data (Mann-Whitney U test) 
Variable Median of recovered 
group  
(n=37) 





NPRS T1 5.0 5.0 0.20 
Sleep NDI T1 1.0 2.0 0.027* 
Sleep PDS T1 1.0 2.0 0.12 
Abbreviations: NPRS, Numeric Pain Rating Scale; Sleep NDI, Sleep response on Neck Disability 
Index; Sleep PDS, Sleep response on Post-traumatic Distress Scale; * Reached statistical 
significance with alpha at 0.05. 
 
A Chi-Square evaluated the relative proportions of males to females in the groups. Using 
this test and the Pearson Chi-Square statistic, there were proportionally more females in the 
persistent group (85%) than in the recovered group (57%), 2 = 9.54, p = 0.002. See Table 4.3 for 
the results from the Chi square, and Figure 4.4 for a graphical representation of differences 
between the groups. 
Table 4.3: Baseline characteristics for nominal data (Chi-Square test) 








Square statistic  
p - value 
Sex 21/16 51/9 9.54 0.002* 





Figure 4.4 Sex distribution between recovered and persistent symptoms 
 
  
The ordinal data was assessed for differences at baseline using non-parametric tests, 
however, when using logistic regression the variables need to be classified as either categorical 
or continuous prior to placing them in the model.144 Therefore, prior to running any analyses, the 
variables sleep NDI, sleep PDS, and the NPRS were examined to determine how to categorize 
them for the model. The sleep NDI and sleep PDS were examined in a similar manner as their 
scales were shorter, 0 to 5, and 0 to 3, respectively when compared to the NPRS which has a 
scale of 0 to 10.  
The sleep NDI and sleep PDS were initially examined as continuous variables by creating 
separate variables for each score on their scale (0 to 5 for NDI and 0 to 3 for PDS) and dummy 
codes to represent all but the single score that was evaluated. Prior to this evaluation, examining 




who reported a score of 5. Therefore, the scores of 4 and 5 were combined into one variable, and 
the final groupings for the sleep NDI were 0, 1, 2, 3, and 4/5. The sleep PDS scores did not have 
this issue and the groups were 0, 1, 2, and 3. Once the variables were created, individual logistic 
regression models were created for the sleep NDI and sleep PDS using the enter method with all 
variables placed in the model. The unstandardized beta coefficients were examined to determine 
if they were different across the responses. In both models, none of the scores demonstrated a 
statistically significant difference when compared to one another.  
The sleep NDI and sleep PDS were then examined as categorical variables. While 
evaluating the scores as a continuous variable it was noted that for both the sleep NDI and sleep 
PDS the response of 0 showed a negative beta value, which means that with that response there 
is a protection from developing persistent symptoms. On the other hand, all other scores reported 
positive beta values meaning that they were predictive of developing persistent symptoms. 
Therefore, the categorical cutoff for both the sleep NDI and sleep PDS were a score of 0 for one 
group, and all other scores (NDI 1 to 5, PDS 1 to 3) for the other group. Using these categories, 
separate logistic regression models were created using the enter method with the categorical 
variables described for sleep NDI and sleep PDS responses at T1. Both models demonstrated that 
the groups that had responses that were non-zero were predictors of persistent symptoms with 
positive beta values. 
The models were then compared using the likelihood ratio test to determine if there was a 
statistical difference between them. For both the sleep NDI and sleep PDS, the likelihood ratio 
test was found to be non-significant, which means that there was no difference in the way that 
the models predicted persistent symptoms; using categorical or continuous data gave the same 




across response scores, and the overall models were not significantly different from each other, it 
was determined that using the sleep scores as categorical variables was the best option for the 
creation of the final model.  
The NPRS is scored on a scale from 0 to 10, and it was initially examined on the 
contingency table and it was recognized that the data was spread much like a bell curve with few 
scores at either end and approximately 50% of the scores at 4 through 6. Therefore, each 
individual score could not be evaluated as it was for the sleep responses, and a single logistic 
regression model using the enter method and the NPRS scores as continuous with all scores 0 to 
10 was created. The results in the model showed a beta value that was positive, meaning that for 
increasing scores on the NPRS there was a relationship with an increased risk for developing 
persistent symptoms. 
From a categorical perspective, the NPRS was then broken into two groups, 0 to 5 for one 
group and 6 to 10 for the other which was based on previous research that found that 5.5 out of 
10 was the point which seemed to differentiate those who would progress to develop chronic 
symptoms.17 Using this variable, another logistic regression model was created and found to 
have a significant positive beta value for the group with higher scores indicating a relationship 
with persistent symptoms. 
When the two models were compared with the likelihood ratio test, the difference 
between them was not found to be significant meaning that the variables were similar when 
placed in the model. However, in opposition to the sleep responses, for the NPRS it was 
determined that since it has a larger scale 0 to 10 and the data is normally distributed across the 




The final evaluation procedure prior to building the logistic regression model for the 
baseline data was to determine whether any multicollinearity existed between any of the IVs. 
Because some of the variables are at the interval level and others are at the ordinal level, a 
Spearman s Rho correlation was used; because sex was defined as a categorical variable it was 
not part of the analysis. Although the sleep response scores from the NDI and PDS were used as 
categorical data in the model, their individual data points could be used as part of the correlation 
matrix to help determine if multicollinearity existed.  
Prior reports have defined multicollinearity as being present when the correlation 
coefficient is in the range of 0.70 to 0.80.143 A conservative approach is to recognize 
multicollinearity when the correlation coefficient is above 0.75 as it is believed that 0.80 is too 
strict of a cut off.143 If the cut off is too high, there is the potential to keep variables in the model 
that are essentially represent the same influence on the DV. With this assessment, the only 
variables in the correlation matrix that approached the 0.75 level was sleep NDI and sleep PDS 
(0.68). See Table 4.4 for all coefficient values.  
 Using two variables that measure the same construct likely will be associated with 
multicollinearity.143 Since the r value for the variables did not reach the 0.75 threshold (0.68), to 
further evaluate the potential for multicollinearity between sleep NDI and sleep PDS the 
relationship between them was evaluated at each of the four time points. A Spearman s Rho was 
performed comparing sleep NDI T1 to sleep PDS T1 (r = 0.68), sleep NDI T2 to sleep PDS T2 (r 
= 0.66), sleep NDI T3 to sleep PDS T3 (r = 0.76), and sleep NDI T4 to sleep PDS T4 (r = 0.72). 
With these correlation coefficients, it appears that multicollinearity is only present at T3. 
However, as sleep NDI and sleep PDS evaluate the same construct, sleep disturbance, albeit in a 




because they demonstrate multicollinearity at T3, it was deemed inappropriate to keep both 
variables in the final model. Given that the NDI scale is more readily available to practitioners 
and researchers, as well as its possible greater significance in this population based on its 
difference with the Mann-Whitney U tests at baseline, it was determined to keep the sleep NDI 
scale for inclusion in the model and discard the sleep PDS responses. 
Table 4.4 Multi-collinearity correlation coefficient of all IVs 
 BMI Age MFI T1 NPRS T1 Sleep NDI 
T1 
Age 0.24     
MFI T1 0.17 0.41    
NPRS T1 0.11 -0.05 0.001   
Sleep NDI 
T1 
-0.02 -0.03 0.25 0.47  
Sleep PDS 
T1 
-0.05 -0.19 0.07 0.27 0.68 
 Abbreviations: BMI, Body Mass Index; MFI, Muscle Fatty Infiltrate; NPRS, Numeric Pain 
Rating Scale, Sleep NDI, Sleep response on Neck Disability Index; Sleep PDS, Sleep response on 
Post-traumatic Distress Scale. 
 
4.3.2 Logistic Regression at Baseline  
As the overall theme of the study was exploratory, it was deemed preferential to err on 
the side of a Type I error (a false positive) rather than a Type II error (a false negative).136 If a 
Type I error were to be present then people may receive treatment that may not be justified, 
whereas a Type II error could create a scenario where those that may benefit from treatment may 
not receive appropriate care and could be harmed or at least have their suffering prolonged. 
Therefore, in order to minimize the risk of a Type II error, the alpha level of 0.10 was used 




or even potential significance, were included. As well, using a higher p-value may allow the 
entrance of some variables that may not be significant at the 0.05 level at baseline, but may reach 
that level over time.  
In addition to the increased alpha value, a backward conditional method for entering 
values into the logistic regression model was used; using a forward conditional method, variables 
require a more stringent criteria for being placed into the model.143 By allowing more variables 
into the model the likelihood of rejecting a variable (a Type II error) is reduced.    
For the logistic regression at baseline, the outcome of interest was to determine which 
IVs were predictive of the participants transition to persistent symptoms based on their NDI 
scores at 12-months post-MVC. All variables were put into the model and those at the 0.10 level 
of significance or below were kept for evaluation at the other three time points.  
However, prior to building the model, it was determined that using the NDI as a predictor 
of the DV was inappropriate because this analysis was examining the variables and the change in 
strength of the relationship with group membership over time. Given that the score of the NDI at 
12 months was used as the determining factor in group membership, it would be expected that 
the model at T4 would include only the NDI score, with 100% accuracy, thus rendering that 
portion of the analysis, and the influence of any other variables useless. 
Using the backward conditional method to create the initial model, the IVs at T1 BMI, 
age, and NPRS all were all found to be non-significant as predictors of the DV. See Table 4.5 for 
significance values at time of removal. The main effects for IVs at T1 sex, MFI, and sleep NDI 
were all found to have significance values below 0.10 and would be included in the model and 




beta values, OR and 95% CI for each variable. Within this model using these three variables, the 
pseudo R2 was calculated using the Nagelkerke R2 and reported as 0.27. The Nagelkerke R2 was 
used instead of the Cox and Snell R2 as it is reported on a 0 to 1.0 scale which corresponds more 
directly to a true R2, whereas the Cox and Snell reports on a scale from 0 to 0.75, thus the results 
will always be lower and are more difficult to interpret and compare.143 For being able to classify 
participants based on the variables in this model, an overall percentage of 76.3% were classified 
correctly with 85.0% correct for persistent symptoms and 62.2% correct for the recovered group. 
These results are held in relation to the constant model that states without any variables in the 
model that if all participants were classified as having persistent symptoms, the correct 
prediction would be reported 61.9% of the time.   
Table 4.5 Significance values for variables not included in final model at T1 









Table 4.6 p-value, unstandardized beta values, odds ratio, and confidence interval for main 
effect variables kept in model at T1. 
Variable p-value Unstandardized 
beta value 




95% CI for 
odds ratio 
Sex (female) 0.013 1.29 0.27 to 2.31 3.63 1.31 to 
10.05 
MFI 0.066 0.10 0.0 to 0.20 1.10 0.99 to 1.22 
Sleep NDI 0.016 1.48 0.28 to 2.67 4.38 1.32 to 
14.51 
Abbreviations: MFI, Muscle Fatty Infiltrate; NPRS, Numeric Pain Rating Scale; CI, Confidence 
Interval. 
 
Before the variables at T2 could be analyzed to evaluate the changes in magnitude of beta 
and OR, it needed to be recognized that the main effects may not fully explain the relationships 
between the variables and group membership. As well, it is possible that some of the variables 
that were found to be non-significant could have an influence when part of an interaction. 
Therefore, interaction effects between variables were evaluated in conjunction with the main 
effects that were previously assessed.  
Determining which variables to include as part of the interaction effects was difficult as 
the primary aim of the research was exploratory, and all the variables could theoretically be 
included. Within this study, all variables have been found in previous research to have at least 
some prognostic validity in determining persistent symptoms in people with WAD.17 However, 




reasonable amount, it was determined that only the variables that had a statistically significant 
difference between the groups, persistent symptoms and recovered, at baseline would be 
included as interactions. Therefore, the interactions included in this analysis were as follows: sex 
by MFI; sex by sleep NDI; and MFI by sleep NDI.  
Running a backward conditional method with the all IVs (sex, BMI, age, MFI, NPRS, 
and sleep NDI) as well as interactions (sex by MFI, sex by sleep NDI, and MFI by sleep NDI) 
the final predictors in the model for determining group membership were: sex, MFI, sleep NDI, 
and no interactions were found to be significant. When compared to the model with only the 
main effects, there was no difference between the two models as all the variables in the final 
model were the same and their unstandardized beta values were identical as well. In addition, the 
Nagelkerke R2 of 0.27 and the classification of groups (overall 76.3%, persistent group 85.0%, 
and recovered 62.2%) were all unchanged as well.  
 The percentages for correct prediction can also be reported as the sensitivity and 
specificity for the models as a way determine how accurate the predictions are for who will 
develop long-term symptoms and who will recover. The sensitivity of the test is based on the 
presence or absence of the variables in those with persistent symptoms and will provide evidence 
for a Type II error (a false negative). In this model, the sensitivity is 85%; this means that there is 
a 15% chance for a false negative. Thus, if someone does not have the variables present, (female 
sex, no sleep disturbances, and low MFI) it is likely they will have a true negative and fall into 
the recovered group. Specificity is based on presence or absence of the variables in those that are 
found to be recovered. In this model, the specificity is 62.2%, which means there is a 38.8% 




of a false positive hovers around 40%, it is recognized that the presence of the variables is not as 
strong an indicator for ruling someone into the persistent group.  
 Minimizing a Type II error was a focus of this project, as a false negative can be 
problematic for those that develop persistent symptoms as they may end up not receiving 
treatment which could benefit them. Therefore, being able to discriminate between the two 
groups is of the utmost importance. To assess the overall discrimination of the proposed model, a 
ROC curve was generated along with its AUC calculation.  
The purpose of the ROC curve and the AUC is to determine how well the variables help 
to discriminate between the two possible outcomes:143 recovered and persistent symptoms. The 
ROC curve is created by using a combination of true-positive and false-positive rates to predict 
the desired outcome.143 The ROC curve is a graphical representation of these rates, whereas the 
AUC, which ranges from 0.5 to 1.0, is the quantitative result of the ROC curve and can be used 
to state whether the discrimination of the variables is considered to have no discrimination (equal 
to 0.5), poor discrimination (greater than 0.5 and less than 0.7), acceptable discrimination 
(greater than or equal to 0.7 to less than 0.8), very good discrimination (greater than or equal to 
0.8 to less than 0.9), or excellent discrimination (greater than or equal to 0.9) results based on its 
output.143  See Figure 4.5 for ROC curve for the baseline variables used in the model. Using this 
data, the AUC was reported at 0.68, which is considered poor discrimination, and it had a 95% 






Figure 4.5 ROC curve for variables at time point 1 
 
 
Abbreviations: ROC; Receiver Operator Characteristic  
The two models previously evaluated, those with interaction effects and those without 
them, provided similar outputs. Even though no interaction effects were found to be significant 
predictors of persistent symptoms at baseline, there is no guarantee that they will remain non-
significant over time as variables generally do not function in isolation. Therefore, in analyzing 





4.4 Specific Aim #2 
 The second aim of this study was to determine if the predictive strength of the IVs (beta 
values, OR, 95% CI, and pseudo R2) reported in section 4.3.2 and their relationship with 
persistent symptoms associated with WAD changed in magnitude or direction at specified times 
over a 12 month period following the MVC.   
 At T2, T3, T4, the variables reported in the final model at baseline were used with the 
same statistical analysis previously described for the logistic regression to determine changes in 
magnitude or direction of the IVs prediction over time. A backward stepwise conditional logistic 
regression was used with an alpha level of 0.10, and all the IVs included: sex, MFI, sleep NDI, 
and the interactions of sex by MFI, sex by sleep NDI, and MFI by sleep NDI. 
4.4.1 Logistic Regression at Time Point #2  
 T2 was defined as 2 weeks post-MVC. From this analysis, two predictors were 
determined to have statistical significance in terms of predicting group membership: sex and 
MFI. With these variables the Nagelkerke R2 was reported to be 0.22. The classification of 
persistent symptoms and recovered reported a prediction of 70.1% correct overall, and it 
correctly identified 86.7% (sensitivity) of those with persistent symptoms and 43.2% 
(specificity) of recovered participants. See Figure 4.6 for the ROC curve for T2. Based on the 
ROC curve at T2, the AUC was a reported 0.69, which is a poor level of discrimination, a 95% 
CI of 0.58 to 0.80 which ranges from poor to very good, and it was statistically significant with a 





Figure 4.6 ROC curve for variables at time point 2 
 
 
Abbreviations: ROC; Receiver Operator Characteristic 
For the individual variables, sex (female), the p-value was 0.01, and an unstandardized 
beta value at 1.31, and OR of 3.71, with a 95% CI of 1.37 to 10.07. MFI had a p-value of 0.021, 
an unstandardized beta value of 0.13, OR of 1.14, and 95% CI of 1.03 to 1.26. Sleep NDI had a 
p-value of 0.14 and was thus not included in the final model at T2, and none of the interactions 
were found to be significant predictors either. See Table 4.7 for results from the variables 
included in the model. The variables not included in the model are reported in Table 4.8 along 




Table 4.7: p-value, unstandardized beta values, odds ratio, and confidence interval for 
variables kept in model at T2 
Variable p-value Unstandardized 
beta value 
95% CI for 
beta value 
Odds ratio 95% CI 
for odds 
ratio 
Sex (female) 0.008 1.31 0.31 to 2.31 3.71 1.37 to 
10.07 
MFI 0.021 0.13 0.03 to 0.23 1.14 1.03 to 
1.26 
Abbreviations: MFI, Muscle Fatty Infiltrate; CI, Confidence Interval. 
Table 4.8 Significance values for variables not included in final model at T2 
Variables Significance at point of removal 
Sex by MFI 0.92 
Sex by sleep NDI 0.47 
MFI by sleep NDI 0.50 
Sleep NDI 0.14 
Abbreviations: MFI, Muscle Fatty Infiltrate; Sleep NDI, Sleep response on Neck Disability 
Index; NPRS, Numeric Pain Rating Scale. 
 
4.4.2 Logistic Regression at Time Point #3  
 In this analysis, T3 was defined as 3 months post-MVC. The final variables included in 
the model at this time were: MFI, sex, and sleep NDI. With these variables, the Nagelkerke R2 
was 0.40. The correct classification of all participants using these variables was 79.4%, with 
88.3% correct for persistent symptoms (sensitivity) and 64.9% for the recovered group 




which is classified as acceptable, a 95% CI from 0.59 to 0.81, and these numbers range from 
poor to very good, and it was a statistically significant finding with a significance value of 0.001. 
Figure 4.7 ROC curve for variables at time point 3 
 
 
Abbreviations: ROC; Receiver Operator Characteristic 
For the variables at T3, MFI reported a p-value of 0.044, an unstandardized beta value of 
0.11, OR of 1.11, and a 95% CI of 1.00 to 1.24. Sex reported a p-value of 0.009, an 
unstandardized beta value of 1.50, OR of 4.48, and 95% CI of 1.45 to 13.87. Finally, sleep NDI 




2.77 to 21.66. See Table 4.9 for the results of these predictors. See Table 4.10 for all variables 
excluded from the model and their significance values at the time of exclusion.  
Table 4.9: p-value, unstandardized beta values, odds ratio, and confidence interval for 
variables kept in model at T3 
Variable p-value Unstandardized 
beta value 
95% CI for 
beta value 
Odds ratio 95% CI for 
odds ratio 
MFI 0.044 0.11 0.0 to 0.22 1.11 1.00 to 1.24 
Sex (female) 0.009 1.50 0.37 to 2.63 4.48 1.45 to 
13.87 
Sleep NDI < 0.001 2.05 1.02 to 3.08 7.75 2.77 to 
21.66 
Abbreviations: MFI, Muscle Fatty Infiltrate; NPRS, Numeric Pain Rating Scale; Sleep NDI, 
Sleep response on Neck Disability Index; CI, Confidence Interval. 
 
Table 4.10 Significance values for variables not included in final model at T3 
Variables Significance at point of removal 
Sex by MFI 0.77 
MFI by sleep NDI 0.23 
Sex by Sleep NDI  0.70 
Abbreviations: MFI, Muscle Fatty Infiltrate; Sleep NDI, Sleep response on Neck Disability 
Index. 
 
4.4.3 Logistic Regression at Time Point #4 
 For this analysis, T4 was defined as 12 months post-MVC. The variables included in the 




reported as 0.56. The correct classification of all participants was 85.6%, with persistent 
symptoms at 86.7% (sensitivity) and recovered group at 83.8% (specificity). See Figure 4.8 for 
ROC curve at T4. From this ROC curve the AUC is reported as 0.73 which is considered 
acceptable discrimination, the 95% CI ranges from 0.62 to 0.83 and these numbers are deemed 
poor to very good, and the results are statistically significant with a significance value of < 
0.001. 
Figure 4.8 ROC curve for variables at time point 4 
 
 




For each variable, sex had a p-value of 0.011, an unstandardized beta value of 1.69, OR 
of 5.42, and 95% CI of 1.48 to 19.82. MFI had a p-value of 0.027, an unstandardized beta value 
of 0.143, OR of 1.15, and 95% CI of 1.02 to 1.31. Finally, sleep NDI had a p-value of < 0.001, 
unstandardized beta value of 3.07, OR of 21.53, and 95% CI of 6.39 to 72.51. See Table 4.11 for 
the results of these predictors. See Table 4.12 for all the variables excluded from the model and 
their significance levels at the time of exclusion.   
Table 4.11: p-value, unstandardized beta values, odds ratio, and confidence interval for 
variables kept in model at T4 
Variable p-value Unstandardized 
beta value 
95% CI for 
beta value 
Odds ratio 95% CI 
for odds 
ratio 
Sex (female) 0.011 1.69 0.39 to 2.99 5.42 1.48 to 
19.82 
MFI  0.027 0.14 0.02 to 0.27 1.15 1.02 to 
1.31 
Sleep NDI < 0.001 3.07 1.85 to 4.28 21.53 6.39 to 
72.51 
Abbreviations: MFI, Muscle Fatty Infiltrate; NPRS, Numeric Pain Rating Scale; Sleep NDI, 






Table 4.12 Significance values for variables not included in final model at T4 
Variables Significance at point of removal 
Sex by MFI 0.77 
MFI by sleep NDI 0.34 
Sex by sleep NDI 0.77 
Abbreviations: MFI, Muscle Fatty Infiltrate; Sleep NDI, Sleep response on Neck Disability 
Index. 
 
 To examine how the overall model at each time point compared with one another, see 
Table 4.13.  
Table 4.13 Model summary across all four time points 













Time point 1 0.27 76.3 85.0 62.2 
Time point 2 0.22 70.1 86.7 43.2 
Time point 3 0.40 79.4 88.3 64.9 
Time point 4 0.56 86.6 86.7 83.8 
 
4.4.4 Comparisons Across Time 
 To assess changes in the variables across time, each variable s OR and 95% CI was 
evaluated in comparison to the previous time point. For a variable to be considered for this part 




symptoms for at least 3 of the 4 time points. If the variable was not significant at one of the time 
points, the OR and 95% CI that was reported at the previous time was used as a placeholder. This 
criterion was used to evaluate the variables sex, MFI, and sleep NDI response. MFI and sex were 
significant at all time points, and sleep NDI was significant at 3 of the 4 time points (it 
demonstrated non-significance at T2), with the lack of data at T2 for sleep NDI, the data 
collected at T1 was used for that portion of the analysis. 
 To determine if a significant change occurred regarding group membership prediction 
with either the OR or the CI, the metric was evaluated against the previous time point. To be 
considered statistically different from the previous time point, the OR must be beyond the range 
of the previous 95% CI; this should ensure a 95% chance that the two units are truly different. 
For the CIs, if there was no overlap between the two time points then they are said to be 
statistically different.  
 The first variable evaluated was MFI; see Table 4.14 for its OR and 95% CIs at each of 
the four time points and Figure 4.9 for the graphical representation. The data demonstrate that 
across all 4 time points that there was no significant difference for the OR or CI for MFI as none 
of the quantities fell beyond the 95% CI. 
 Finally, for MFI at T1 the p-value was 0.066 which is above the standard alpha of 0.05, 
but it was below the threshold of this study of 0.10. Because of this relatively larger p-value, the 
OR crossed the 1.0 threshold which normally indicates a non-significant finding, however, since 





Table 4.14 MFI odds ratio and confidence interval at all time points 
 Odds ratio 95% Confidence Interval 
Time point 1 1.10 0.99 to 1.22 
Time point 2 1.14 1.03 to 1.26 
Time point 3 1.12 1.00 to 1.24 
Time point 4 1.15 1.02 to 1.31 
 
 
Figure 4.9 Graphical representation of odds ratio and confidence interval for MFI across 
time. 
 
Sex was evaluated across time. Female sex as a main effect was a significant predictor of 
persistent symptoms group membership at all time points; see Table 4.15 for sex OR and 95% 
CIs at each of the four times and Figure 4.10 for its graphical representation. An evaluation of 
the data in the graph and table demonstrated that there was no significant change for sex in terms 




















Table 4.15 Sex odds ratio and confidence interval at all time points 
 Odds ratio 95% Confidence Interval  
Time point 1 3.63 1.31 to 10.05 
Time point 2 3.71 1.37 to 10.07 
Time point  4.48 1.45 to 13.87 
Time point 4 5.42 1.48 to 19.82 
 
Figure 4.10 Graphical representation of odds ratio and confidence interval for sex across 
time 
 
For sleep NDI, the data demonstrated it as a significant predictor of group membership at 
T1, T3, and T4 for its main effect. Because sleep NDI was non-significant at T2, the OR and 
95% CI from T1 were carried forward as a placeholder. See Table 4.16 for OR and 95% CIs for 




















 For evaluating differences across time, there were no differences noted for the CI or the 
OR when compared to the immediately preceding time point, but at T4 the OR was only 0.13 
away from being classified as a significantly different from T3 as the OR at T4 was 21.53 and 
the upper boundary of the 95% CI at T3 was 21.66. However, there was a statistically significant 
increase in the OR when T4 was compared to the 95% CI at T1. As this was an exploratory 
study, these results do lead to questions regarding the influence of sleep and persistent WAD 
symptoms over time that may need to be more thoroughly addressed.   
 
Table 4.16 Sleep NDI odds ratio and confidence interval at all time points 
 Odds ratio 95% Confidence interval  
Time point 1 4.38 1.32 to 14.51 
Time point 2 4.38 1.32 to 14.51 
Time point  7.75 2.77 to 21.66 






Figure 4.11 Graphical representation of odds ratio and confidence interval for sleep NDI 
across time 
 
4.5 Summary  
 This chapter provided the detailed results of the statistical analysis for the stud  Neck 
Muscle Composition in Persistent Whiplash Associated Disorder: Relationship with Neck-
Related Disabilit .  The normalit  tests used to assess the data were described. The overall view 
of the data at baseline is that the variables among the participants were normally distributed. 
Beyond the normality tests, there was the discussion for the use of two groups (persistent 
symptoms and recovered) in the analysis instead of the more commonly described three-group 
model. As well, the general view of the study was described as exploratory in nature; thus, to 
minimize Type II errors, the use of an elevated alpha level (0.10) was discussed in terms of 























 Regarding data at baseline, there were several variables that were different between the 
groups. These variables included MFI, NDI scores, sleep NDI responses, as well as the sex of the 
participants in the groups. The first research question aimed to identify which variables were 
significant at baseline for determining group membership at 12 months. Initially, the variables 
sex, MFI, and sleep NDI were found to be statistically significant for main effects, and no 
interaction effects were found to be significant.  
The second research question evaluated which variables, identified in the primary 
research question, changed in magnitude or direction over time. In general, the main effects for 
the variables MFI and sex were consistent across the time points, without any statistical 
significance noted. For sleep NDI response, there was a large increase in the odds ratio at T4 that 
was significantly different when compared to T1, but when compared to T3 it was not 
statistically different. As the effect size for the sleep NDI variable increases across time, it may 
be a variable of interest for future studies. As well, across time, there were no interaction effects 
that were found to be significant at any of the time points. Finally, the pseudo R2 for the overall 
model prediction of group membership increased from 0.27 at T1 to 0.56 at T4, as well as the 





Chapter 5: Discussion 
5.1 Introduction 
 The purpose of this chapter is to discuss the data presented in Chapter 4, specifically, 
recognizing how the data fits and expands our understanding of currently published literature 
regarding whiplash and its associated complexities. The first portion of the chapter reports which 
variables were found to be significant predictors of persistent symptoms at baseline. The second 
part of the chapter evaluates these variables across multiple time points, individually and as a 
complete model, both in terms of their effect sizes and their ability to discriminate between the 
two groups. Finally, the clinical significance of the findings are discussed, future research lines 
are proposed, and the limitations and delimitations that were present in the study are addressed. 
5.2 Specific Aim #1 
 The primary aim of this study was to establish the relationship between the independent 
variables (IV), body mass index (BMI), age, sex, cervical muscle fatty infiltrate (MFI), numeric 
pain rating scale (NPRS), and sleep response on the neck disability index (sleep NDI), and the 
dependent variable (DV) group membership following a motor vehicle crash (MVC) of 
persistent symptoms or recovered.  
5.2.1 Non-Significant Variables 
 From the results, the individual factors that were reported as having no significant 
difference between the groups at baseline as well as being non-significant in terms of prognosis 
of final group membership were BMI, age of the participant, and the participants score on the 
NPRS. In the literature, there is conflicting evidence as to the influence of the factors BMI and 




predictive relationship while others claim no association between the variables.151-153 However, 
for the NPRS, the results reported here contrast with multiple studies which report the variable as 
a strong predictor of a poorer outcome.77,151-153 
It has been theorized that those with an increased BMI may report higher levels of 
persistent symptoms following an MVC due to systemic inflammation, structural or mechanical 
changes due to body habitus, or psychosocial variables associated with being obese.111 As well, 
advancing age has been thought to be related to increased symptoms based on the potential for 
diminished bone health and degeneration of the structures within the neck that may become 
symptomatic following the trauma from the MVC.154 
Multiple systematic reviews have evaluated BMI and age in regard to WAD and 
persistent symptoms and reported them to be either non-significant as a predictor of group 
membership or described inconclusive results.151-153 The results from this study support the 
notion of both variables being non-significant predictors of group membership. Both variables 
were assessed at each of the 4 time points (T1 1-week; T2 2-weeks; T3 3-months; and T4 12-
months) and found to be non-significant at all points except for BMI at T4 when an 
unstandardized beta was reported of -0.182 and a 95% confidence interval (CI) of -0.35 to -
0.013. Interestingly, with the reported beta below zero, this result implies that an elevated BMI is 
protective against the development of persistent symptoms associated with WAD, but this goes 
against previously published theories which hypothesized an elevated BMI as a predictor of 
WAD.152 It is unknown exactly why the beta value would be less than zero, but it is possible that 
a larger body mass can protect the deeper structures from trauma that may occur in the MVC. 




result and it is possible that the result may be a statistical error related to the multiple tests run at 
all time points. 
One final point about BMI that was of interest in this study was that its correlation with 
cervical MFI was significant but weak with r values between 0.19 to 0.24. It could be concluded 
that a person with an elevated BMI would also have an elevated level of MFI, but that was not 
the case for these participants. With this weak correlation, along with the result that demonstrates 
that the levels of MFI that were present at baseline did not significantly change over the course 
of the 12 months, it appears MFI may be a predetermined individual trait that may influence the 
DV. The MFI present at baseline may be a result of genetics, hormones, or any numerous 
metabolic interactions;32 the implications of MFI on WAD will be discussed later in this chapter. 
 Within the inclusion and exclusion criteria for the study was the age range from 18 to 55. 
The theory behind the cutoff at 55 was to try to minimize the potential influence that 
degenerative changes may have on neck pain. It is not uncommon for people to have abnormal 
findings of their cervical spine on Magnetic Resonance Imaging (MRI) while being 
aymptomatic.111,155 But it is unknown if these abnormal findings on MRI can influence neck pain 
or disability following an MVC. There have been published reports that there is no relationship 
between degeneration and pain,111 whereas others claim an association between degeneration and 
neck pain, especially following a trauma.154 It has also been noted that as we age, especially 
above 55, there is the increased risk of decreased bone density, and this may affect symptoms 
that occur following a trauma such as an MVC.154  
Alternatively, it has been reported that neck pain in the general population tends to peak 
for people in their 30s and 40s.156 However, if degeneration is a primary cause for pain, then it 




have a lower incidence of neck pain. Given that the role of degeneration and its influence on 
neck pain is unresolved, the cut-off of 55 years old was used in this study to mitigate any 
potential influence it may have. The results of this study were therefore based on the participants 
being between 18 to 55 years old, and the variable was found to have no significant influence on 
group membership at 12 months, but it is unknown if these results hold true for people over the 
age of 55.  
 Although the results from BMI and age appear to align with previously cited literature, 
the results related to the NPRS were quite distinct. In this study at baseline, the NPRS was found 
to be neither different between the groups nor significant for predicting group membership at 12 
months as the variable had a reported p-value of 0.19 in the final model at baseline. This finding 
of non-significance as a predictor of future symptoms is in contrast to published articles and 
systematic reviews that report, with strong confidence, baseline NPRS scores as a strong 
predictor of chronic WAD symptoms ranging from 6 to 12-months post-MVC.17,77,103  
 A meta-analysis that evaluated high initial pain intensity (defined as pain rated as equal to 
or greater than 55 out of 100 on one scale or 6 out of 10 on shorter scales) as a predictor of future 
pain and disability from 11 separate studies reported an OR of 5.61 and a 95% CI from 3.74 to 
8.43.82 However, within these 11 studies, 2 reported a 95% CI that crossed the 1.0 threshold, and 
when this level is passed the results are often deemed non-significant. When an OR is greater 
than 1.0 it means that the variable is a predictor of the outcome, but when it is lower than 1.0 it 
indicates that if the variable is present the participant is protected from the chosen group 
associated with the DV.157 Thus, if the 95% CI crosses the 1.0 threshold, it implies that the 
variable is both protective and predictive. Since, the variable cannot be both, the finding is 




large CIs. Of the studies that did not cross the 1.0 threshold, the tightest 95% CI was 6.32 to 
12.38, and the widest was 2.54 to 30.72.82 With larger CIs, it is difficult to establish the precision 
of the reported OR  based on these studies. 
 Because of the differences in the results from this study when compared to previously 
cited literature it is important to understand why they exist; in this case, it may be due to the way 
the groups were allocated. Most studies will use a 3-group model for categorizing participants 
following an MVC (recovered, mild, and moderate-severe)19,77 and the NPRS is generally 
associated with the moderate to severe group. Studies that use a 2-group model have a score on 
the Neck Disability Index (NDI) of 30% or above as one group (moderate to severe) and below 
30% for NDI scores as the other group (recovered to mild).20 In this study, only 2-groups were 
used, but the cutoff of the NDI was 10% for those with persistent symptoms. Therefore, it is 
plausible that had the NDI of 30% been used in this study as the criteria for the DV, then the 
NPRS may have been found to be a strong predictive variable.  
 Another possibility for the differences between this study and some of the previous 
literature may be accounted for based on the outcome variable. In this study the NDI, a disability 
scale, was used as the DV, whereas in the previously cited meta-analysis, only 3 of the 11 studies 
used a disability scale as the DV: the other 8 used pain as the DV. It should be considered 
whether it is appropriate to use an IV at baseline to describe the same variable later but at that 
time calling it the DV, but this is what occurred when pain was used at baseline to predict pain at 
the end of the study in those previous studies. 
Finally, of the 3 studies that used the disability scale as the DV, all 3 had an OR for the 
NPRS higher than the meta-analysis average and the 95% CIs were quite wide, and one of the 




findings are in relation to the DV and may lead to a larger question about the relationship 
between pain and disability. 
 According to the International Association for the Study of Pain, pain is defined as an 
unpleasant sensory and emotional experience associated with actual or potential tissue damage or 
described in terms of such damage. 158 A person with a disability, as defined by the Americans 
with Disabilit  Act, is someone who has a ph sical or mental impairment that significantl  
impairs one or more major life activities. 159 It is not uncommon for someone who has pain to 
also be limited in any or all of their daily life activities, as the activities can consist of caring for 
themselves or family members, working on their computer, sleeping, or participating in 
recreational activities. The difficulty in assessing disability amongst a population has to do with 
the notion that people have different activities that they deem important. Thus, the limitations 
caused by the MVC can have a greater or lesser influence on their life and potentially their 
personal definition of disability.  
 If the NDI is used as a measure of disability, we must assume that the items assessed are 
part of that person s dail  activities as eight of the ten questions have to do with these; the other 
two questions are about headaches and their pain. The NDI, in its attempt to evaluate disability, 
asks broad questions regarding these activities. For example, the NDI tries to quantify how much 
their sleep is disturbed by asking specifically about their quantity of sleep loss, but it does not 
asses the overall the qualit  of sleep. As well, the NDI evaluates a person s headache frequenc  
and intensity, but it neglects to quantify the duration of the symptoms; or a question about the 
person s abilit  to perform their dail  work and the quantity performed without any assessment 




it may be too blunt, as there are many reasons why people may be having difficulty with their 
daily activities. 
 In previous studies using the NDI as the DV, often the score of significance was an NDI 
over 30%, and at this range it is likely that there is at least a modest amount of pain, and hence 
possibly the reason that the NPRS was a predictor for those with WAD. However, in what is 
normally considered the mild group, NDI 10 to 28%, there may be some disability such as 
difficulty with reading, driving, or concentrating, but there may not be much pain because WAD 
can present as a constellation of symptoms and not all are pain based. Symptoms associated with 
WAD have been stated to consist of not only neck pain, loss of range of motion, and tenderness 
to palpation, but also dizziness, cognitive difficulties, unsteadiness, depression, and anxiety, to 
name a few.2,3 All these symptoms have the potential to influence someone s dail  activities 
without any pain. Thus, the connection between neck pain and disability in those with WAD may 
not be straightforward and may be a strong reason for the inability of the NPRS to be used as a 
predictor of disability following an MVC in this study. As a result, when bringing these two 
groups together, as was done in this study with persistent symptoms greater than 10% on the 
NDI, the predictive capability of the NPRS may be lost at baseline and across the subsequent 
time points. 
 Using the NPRS as a prognostic variable to determine pain intensity may be appropriate 
as several systematic reviews and a meta-analysis demonstrate its effectiveness when pain is the 
DV. But using the NPRS as a predictor of future disability may need to be reexamined based on 
the limited results in this and other studies regarding the questionable relationship between the 




 Prior to examining the rest of the variables and their relation to the current literature, it 
would be beneficial to discuss some of the limitations in trying to describe the context of the 
results with published data. The primary difficulty in comparing these results has to do with the 
heterogeneity of the collection and reporting of previously published data.151-153 For example, 
studies talk about older age but do not often quantify what is meant by the term older.151 Also, 
the reporting of variables are sometimes referred to in the text as significant or non-significant 
while providing only p-values and not presenting any effect sizes; hence, it is unknown if the 
results have small, medium, or large effects.152 
 The other dilemma in comparing data is in the use of the term recovery. Across the 
literature, there are multiple ways to report recovery which include, but are not limited to self-
reporting of pain, headaches, limited strength or range of motion, levels of fatigue or confusion, 
or scores on various outcome measures such as the NDI.160 The variable used as the 
determination of recovery has the potential to influence the statistical analysis that the authors 
used in their study, which makes comparisons between studies that have different outcome 
variables difficult.160 In this study, an attempt has been made to evaluate outcomes related to the 
NDI as it is the most widely used outcome measure in clinics and research studies as well as 
having adequate psychometric properties for this population. 
5.2.2 Muscle Fatty Infiltrate 
 At baseline, the mean MFI was statistically different between the two groups, but this is 
in contrast to previous reports which showed at 1-week and 2-weeks post-MVC that MFI was 
not different between the groups based on their long-term prognosis.19,20 However, there were 
differences between this study and the previous results in terms of both measurements and 




In a report in 2011, MFI as measured by MRI demonstrated no difference between the 
groups of people with WAD at 2 weeks. But by 3 months, there was a significant difference 
between the groups that developed moderate-severe symptoms and those that recovered, and by 
6-months post-MVC these differences became even larger.19 However, there were several 
distinct differences between that study and the results reported here that may explain some of 
disparity. 
In the previous study, they used the more traditional categorizing of participants into 3 
groups based on their NDI score: 0 to 8% recovered, 10-28% mild, and greater than 30% for 
moderate-severe, and in that study the greatest difference for MFI was with the moderate-severe 
group when compared to the other two groups. The MFI for the moderate-severe group was 
significantly elevated when compared to both the mild and recovered groups at both 3 and 6 
months despite all the groups having equal quantities at baseline. In this study, there were only 2 
groups: recovered 0-8% and persistent symptoms greater than 10%; however, when participants 
were categorized into the 3 groups previously described both the mild and severe groups were 
equivalent but were significantly different from the recovered group at baseline. Therefore, it can 
be theorized that group categorizing can explain some of the discrepancy between these results.   
The second difference between the studies had to do with the collection of data via MRI. 
In the previous study, there was no mention of the strength of magnet used in the machine 1.5T 
vs 3.0T, and the researchers reported using a T1 image for quantification of MFI. In this study, a 
3T MRI was used and the 3D multi-echo Dixon fat/water imaging method was used to collect 
data on MFI in the participants. A comparison between the T1 and Dixon method showed that 
they are equivalent in their quantification of MFI,127 but the Dixon method results in faster 




improved imaging acquisition, it is theorized that using the Dixon method to visualize MFI may 
allow for differences between the groups to be viewed earlier when compared to the standard 
methods using T1-weighted sequences.20 It is this image acquisition that may explain why 
differences were viewed at 1 week in this study whereas they were not visible at 4 weeks in 
previous studies. 
In the second study in 2015, researchers reported the use of the dual-echo fat/water Dixon 
method to generate the images that allowed for the calculation of the MFI, but again, there were 
other differences which may have led to the contrast in results of MFI at baseline. First, in the 
2015 study, there was a 60% rate of non-compliance related to image acquisition with 20/89 
participants stating that they could not commit to the 3-month timeline and 26/89 who consented 
but did not follow up for their images. It is unknown if these dropouts affected the final statistical 
analysis, but given that some authors state that non-compliance greater than 20% can lead to 
bias, the 60% in this study does have some cause for concern.161 
The other primary area of discrepancy has to do with the categorization of the 
participants. In the 2015 study, participants were categorized into 2-groups based on their NDI 
scores at 3 months, but these two groups were recovered-mild symptoms with NDI of 0-28%, 
and moderate-severe symptoms with NDI greater than 30%. Categorizing the participants in this 
manner is in almost direct opposition to the way it was done in this study. In the standard 3-
group model which classified mild symptoms as 10-28%, the 2015 study combined the mild 
group with recovered group, but in this study the mild group was joined with the moderate-
severe group. The reasoning for combing the groups as they did, recovered and mild, was not 
specifically listed, but in the current study, the grouping of mild and severe was based on the 




well, it is theorized clinically that if patients have an NDI of 20%, they could easily be seeking 
treatment for their limitations and they may not consider themselves recovered. Thus, in this 
studies  2-group model, we were estimating when someone might begin to seek treatment based 
on their NDI scores and then place all those people in a single category. Finally, in order to 
minimize a Type II error (false negative) and to adjust for the large standard error (SE) that has 
been reported for the NDI, it was deemed more appropriate to combine the mild and severe 
rather than the mild and recovered. 
In this current data set, the mild and severe groups showed MFI levels that were similar 
and did not have any statistical difference between them at baseline or at any of the follow-up 
time points, but both groups were statistically different from the recovered group at all 4 time 
points. If the analysis had been run identically to the one in 2015 with the previously described 
categorization, there would have been no statistical difference between the groups.  
 One final difference between the current study and these two previous studies has to do 
with their interactions and analysis of the mediation of post-traumatic stress disorder (PTSD) and 
its potential influence on WAD. In this study, PTSD was not part of the analysis; thus, it is 
unknown how much of an effect it may have on the quantity of MFI, any potential interactions, 
or the long-term outcome for those with WAD. PTSD has been reported to be a mediating factor 
between MFI and chronic WAD,20 and in this study it may explain some of the differences 
between the groups as well as being a pre-existing vulnerability for those that develop chronic 
symptoms. It is unknown how the presence of PTSD may influence the levels of MFI, but a few 
theories put forth include an increased sympathetic response that can alter muscle tissue health or 




muscle morphology can potentially influence the biomechanics of the cervical spine and 
perpetuate persistent symptoms. 
It is not understood exactly how MFI will influence the biomechanics at the joints, but 
several theories exist. Similar to visceral fat, MFI is believed to release proinflammatory 
cytokines following a trauma, such as an MVC, that have the potential to influence muscle 
contractility.32,19 As well, MFI is also believed to alter the muscle fiber orientation and decrease 
the overall extensibility of the tissue which can explain decreases in strength and force 
production for these muscles.32 As MFI is deposited in the tissue, a form of pseudohypertrophy is 
seen within the muscle that is not visualized in healthy controls.162 The MFI is found more in the 
deep stabilizing muscles such as the longus coli in the flexor musculature and the multifidi and 
semispinalis cervicis in the posterior cervical muscles.18,34 It is possible that any or all of these 
factors can influence the joint mechanics and motor control of the cervical spine which may lead 
to persistent symptoms.  
The mechanical deficits of the cervical musculature following an MVC that have been 
reported in the literature include decreased endurance and activation of the deep cervical neck 
flexors, altered cervical muscle activation with upper extremity movements, increased joint 
position errors, and decreased range of motion.163-165 However, these deficits are also present in 
people with insidious onset neck pain166 despite those with WAD having elevated levels of MFI 
when compared to the insidious onset group.12 But, it is believed that those with WAD have 
motor deficits that are greater in magnitude165,166 and these differences may explain some of the 
symptoms that present in this group.  
Given that both those with insidious onset chronic neck pain and with WAD demonstrate 




within the cervical spine.166 However, in addition to the pain, MFI may also influence muscle 
activity and further propagate some of the disordered movement patterns that are present in those 
with WAD. The combination of both pain and elevated levels of MFI may explain why those 
with WAD have greater changes associated with their movement patterns when compared to 
healthy controls and insidious onset neck pain. 
In the anatomy of the cervical spine, there are numerous layers of muscles that contribute 
to the mobility and stability of the structure.167,168 As well, there is also significant overlap in the 
musculature related to motor control that allows for the precision of movement.169 Although MFI 
can likely affect the motor control and precision of movements, it is not expected to be the 
singular factor that will determine if someone has persistent symptoms associated with WAD. 
But, unlike some other variables associated with WAD symptoms, MFI is a variable that can be 
altered with treatment and specific exercises.96 Thus, it is an avenue for evaluation and treatment 
that has the potential to improve outcomes for those that are diagnosed with WAD. 
 In this study, at baseline, MFI was reported to have an unstandardized beta value of 0.10 
and a 95% CI of 0.00 to 0.20. What this means is that for every 1% increase in MFI, the log odds 
of a person developing persistent symptoms will increase by 0.10. At baseline, those that ended 
up in the recovered group had an average quantity of MFI of 17.8% while those in the persistent 
group had 20.95%, a difference of 3.15%. Therefore, if each 1% increase in MFI generates a 
0.10 increase in the logs odds of a person developing persistent symptoms with an average 
difference of 3.15%, a new beta value can be calculated as 0.10 * 3.15 = 0.315. With this 
unstandardized beta value, an OR of 1.37 is reported for a participant that has MFI that is 3.15% 




of developing persistent symptoms when compared to the recovered group based on their 
quantity of MFI.   
5.2.3 Females 
 At baseline, in this study, the female-to-male ratio was reported as being statistically 
different between the groups of persistent symptoms and recovered at 12-months post-MVC. In 
the recovered group, there was an N of 37 participants with 21 females and 16 males, while in 
the persistent symptoms there was an N of 60 with 51 females and 9 males. Beyond the 
differences at baseline, the female sex was found to be a statistically significant predictor of 
persistent symptoms at 12 months with an OR of 3.63 and a 95% CI 1.31 to 10.05 These results 
are not uncommon in the literature, but they are also not definitive, as multiple systematic 
reviews have looked at the sex of the vehicle occupants and found results varying from 
inconclusive, to no effect, to a significant moderate effect of the variable.108,151,152  
 There are multiple theories as to why the variable does not provide consistent results, 
with one being that it is simply not a strong variable of influence; accordingly, the results will 
fluctuate from study to study. In one meta-analysis, based on 14 previous studies the calculated 
OR was 1.64 with a 95% CI of 1.27 to 2.12,151 which means that for every one male that 
develops persistent symptoms, 1.64 females will develop them (to put it in a larger scale, for 
every 10 males who develop symptoms approximately 16 female will as well). These reports, 
although significant, are not large enough to provide clinical utility. With the OR not being large, 
it is easy to understand how some studies can report significant effects while others cite no 
relationship. 
 A second option for explaining why females represent a greater percentage of those with 




general, with all other variables accounted for, females will seek and receive more health care 
services than males.170 It is unknown exactly why females demonstrate an increased use of health 
care services when compared to males. One theory is that they are more aware of their symptoms 
and are more interested in maintaining their health, whereas others report that females experience 
more health-related issues (WAD could be in that category) that require medical attention and 
treatment.170  
The opposite side of the argument also needs to be examined, as rather than seeing 
women as having an increased use of health services, it is just as possible that men underutilize 
them.171 There are no definitive reasons as to why a man may not seek help for his health care 
needs, but some presumptions are that men view seeking help as an unacceptable option; they 
view themselves as tough and not needing care, or they see that seeking help exposes their 
vulnerability and they wish to keep that part of themselves hidden.171 It is certainly possible that 
it is a mix of both the females and males use of health care services, or lack thereof, that may 
influence the numbers of females that report with WAD. With all of this in mind, in this and 
many other studies, as participants are recruited from hospital emergency departments (ED), if a 
group of people are less likely to go to the ED (males) then they are less likely to be recruited 
and studied and may be underrepresented in the final analysis. 
 A final possibility for why there are more females in the persistent group has do with 
multiple factors that are associated with their anatomy when compared to males such as 
decreased muscle or body mass, or decreased height, both of which theoretically could influence 
outcomes.112,172 Within these theories is the notion that seats and safety features are generally 
developed based on the size of the average male driver regarding the stiffness of the seat or the 




to the occupant during an MVC and result in greater rates of injury and symptoms for those who 
do not meet the size standards for designing the cars. However, a systematic review reported 
high confidence that seat position had no influence on outcomes, but it was noted that the seat 
positions were self-reported and not objectively measured.17 On the other hand, in a study that 
objectively assessed head-restraint position, the authors reported that 93% of automobiles had 
head restraints that were less than optimally positioned,173 thus, the self-report method may not 
be appropriate when assessing this variable.  
Finally, some females may be the same size, or larger than males, and may have fewer 
injuries than their smaller female counterparts which could result in fewer injuries for this 
subgroup. Given that the previously mentioned systematic review did not report sex differences 
in relation to seat position, it is possible that the size differential between larger and smaller 
females, and the potential for more injuries in the smaller group, may be part of the reason why 
the role of female sex and its influence on persistent symptoms is difficult to fully ascertain.  
 With all these factors in consideration, small effect size, differences in health care 
utilization, and differences in anatomy, in this study, at baseline the variable sex had an OR of 
3.63 with a 95% CI of 1.31 to 10.05. The OR of 3.63 is twice as large as the OR reported in the 
previously cited meta-analysis of 1.64. Some of the difference between these OR may have to do 
with how persistent symptoms were reported in this study; NDI over 10% was considered 
persistent whereas other studies often used the 30% threshold. With a lower threshold for NDI, 
more people were classified as having persistent symptoms, 61%; if the 30% threshold were 
used, only 17% would have reported persistent symptoms at 12 months. Given that females are 
more likely to use health care services and that the participants were recruited from an ED, there 




may be higher in this data set. In this study, if the 30% threshold were used than 16 participants 
would be classified as having persistent symptoms and the male-to-female ratio would be 1 to 4, 
whereas using the 10% NDI threshold the ratio was 1 to 5.6; using the lower NDI threshold 
likely explains some of the increased reported OR in this study.  
 The purpose of the OR is to estimate the size of the effect the IV may have on the DV, 
whereas the CI is a report on the precision of the OR.157 In the results, looking at the effects of 
female sex on group membership, the 95% CI ranges from 1.31 to 10.05, which is not a precise 
measurement for the OR. The CI is stating that, with 95% confidence, the true OR may be as low 
as 1.31 (which is close to the previously cited meta-analysis) or as high as 10.05. We simply do 
not know the true value of the OR based on the data provided. Although the OR of 3.63 is 
statistically significant and generally larger than previously cited reports, the precision of this 
estimate is less than optimal and needs to be considered when evaluating it. Be that as it may, the 
sex of the occupant at baseline is still considered a significant variable in predicting long-term 
outcomes with an effect size at least as large as the previously cited meta-analysis, if not larger.   
5.2.4 Sleep Scores 
 For assessing sleep disturbances, the participants were categorized into two groups: one, 
no sleep disturbances due to the MVC, and two, any sleep disturbances due to the MVC. In this 
study, the sleep response was recorded from the item response on the NDI and was found to be 
significant in terms of differences between the groups, as well it was found to be a predictor for 
determining group membership at 12 months. In terms of the differences between the groups, the 
Mann-Whitney U-test reported a significance level of 0.027 with the recovered group reporting a 
median sleep response of 1 and the persistent group reporting a response of 2. Although, these 




prediction of 12-month group membership, the sleep NDI response reported a p-value of 0.016 
and an OR of 4.38 with a 95% CI 1.32 to 14.51, which means that if someone had any 
disturbance to their sleep due to the MVC, their odds of developing persistent symptoms 
increased 4.38 times.  
 In looking at the median responses and the scores of 1 and 2 for each group, clinically it 
is difficult to determine if there is much of a difference between them. Scoring on the NDI for 
sleep loss is provided in groups with 0 being no disturbance, a score of 1 is less than 1 hour of 
disturbed sleep, a score of 2 is between 1 and 2 hours of disturbed sleep, and a score of 3 is 
between 2 and 3 hours of disturbed sleep. Given the sleep NDI response for an individual, a 
score of 1 can span from a few minutes of sleep disturbances up to an hour, whereas a score of 2 
can range from 1 to 2 hours. As there is some overlap between the categories, (the 1-hour mark 
being in both scoring categories) the difference in the quantity of sleep loss may be nearly 2 
hours or as little as a few minutes, and as these scores are self-reported it is unknown just how 
much difference in sleep loss there is between the groups.  
The potential lack of clinical significance may have to do with the timing of the initial 
evaluation. Perhaps it was too soon for the differences to be fully realized. The primary 
recruitment for participants in this study was from the ED within 1 week of the MVC; thus, it 
can be hypothesized that the MVC was significant enough to warrant an immediate evaluation 
with a medical doctor. With this in mind, most participants will likely have some level of stress 
and anxiety related to the ED visit even if they are provided a clean bill of health, and it may be 
worse for those that continue to feel some symptoms. Although no research could be found that 
looked at sleep and pain associated with an acute (less than 1-week) MVC, there was research 




 In literature evaluating sleep and pain associated with trauma, with the traumas reported 
as recent orthopedic post-operative procedures, cardiovascular, and cancer treatments, as well as 
burn victims, the influence of pain and sleep disturbances were reported to be 
bidirectional.115,117,174 With a bidirectional relationship, the pain associated with the trauma can 
influence the quality of the sleep, while at the same time the quality of the sleep can affect the 
pain.174 However, it is believed that sleep loss and decreased quality of sleep influences pain 
more than the pain affects sleep.117,175 Unfortunately, the effect size is not stated and it is not well 
understood if it is a direct relationship or if there is a mediating factor.  
Although it is unknown exactly how pain and sleep interact in the acute state,117,174,175 it 
is theorized that post-operatively there is an endocrine, an autonomic, and an inflammatory 
response with the release of various cytokines and interleukins that can interrupt both slow wave 
sleep (SWS) pattern as well as rapid eye movement (REM) sleep.174 The stress response system 
can also release cortisol and adrenocortotropic hormones in response to the trauma and these also 
have the potential to influence the quality of the sleep cycle.174 
It is possible that the initial stress and trauma from the MVC can have a hormonal and 
endocrine response which can influence the quality of the participant s sleep. Since it is likely 
that most of the participants have some level of stress associated with the MVC, the sleep 
disturbances between the groups may only be different by a small margin at baseline.  
 In evaluating the OR and trying to understand the width of the 95% CI (1.32 to 14.51), 
the tool used to assess sleep disturbances should be evaluated. It is possible the sleep response on 
the NDI may be too blunt of a tool to fully articulate the predictive capabilities of sleep 
disturbances on persistent symptoms. The scoring for sleep disturbances on the NDI are based on 




no trouble sleeping, a score of 1 is less than 1 hour of sleep loss, and a score of 5 is 5 to 7 hours 
of sleep loss). The scoring provides a general overview of quantity of sleep, but a tool such as the 
Pittsburgh Sleep Quality Index (PSQI) may be able to distinguish subtleties that are not apparent 
when only looking at quantity.176 The PSQI asks 19 questions and evaluates seven distinct 
components of sleep including (1) sleep quality, (2) sleep latency, (3) sleep duration, (4) habitual 
sleep efficiency, (5) sleep disturbances, (6) sleep medication, and (7) daytime dysfunction.176  
In looking at post-operative patients, regarding pain and sleep loss, researchers did not 
demonstrate simply decreased quantity of sleep, but they showed specific patterns with deficits 
in both SWS and REM.174 REM and SWS are important in terms of both increasing the quality 
and restorative factors that are associated with sleeping, which is primarily maintaining 
homeostasis across multiple physiological systems.51,114,115 Thus, if following an MVC people 
are having diminished quality of sleep by alterations in their REM or SWS patterns, this can lead 
to not feeling rested after waking in the morning or to daytime drowsiness, even though their 
quantity of sleep is not significantly changed. Therefore, a tool such as the NDI that is only 
looking at quantity of sleep may not be able to detect changes immediately after the MVC and a 
more nuanced assessment of sleep architecture, such as the PSQI, may be needed to fully 
elucidate the problem at the 1-week time frame.  
 Finally, as the scores for sleep disturbances were pulled from a question within the NDI 
(and the NDI score at 12 months was used as the DV to determine final group membership), 
there is the concern for a significant correlation between this IV and the DV that may explain 
some of the effect size reported in the analysis. In assessing the relationship between the sleep 
NDI scores at baseline and NDI scores at 12 months, there was a significant correlation with an r 




the correlation can be considered to have little to no relationship,136 and likely does not explain 
the entire effect size, it should be considered as part of the factor for the result. This correlation 
will be considered further when looking at sleep scores at future time points.   
5.2.5 Interaction Effects 
 The purpose of looking for interaction effects was to determine whether the degree to 
which significance or effect size of any of the variables of influence changed based on the 
presence or value of another variable. Interactions were only considered between variables that 
were found to be significantly different between the groups at baseline; these variables were sex, 
MFI, and sleep NDI. Therefore, the three potential interactions were: sex by MFI, sex by sleep 
NDI, and MFI by sleep NDI. In the logistic model at baseline, none of the interactions were 
found to be significant.  
 In the current published literature, variables are often evaluated in isolation and their 
significance values and main effects are reported. There is some discussion on the interaction of 
variables, primarily PTSD and its interaction with variables associated with chronic WAD,19,103 
but this information is limited. In evaluating the interactions assessed in this study, none were 
found to be significant, but the variables simple main effects were significant, which may 
provide evidence for the notion that there is some component of these individual variables that 
may predispose a person to persistent symptoms. For example, for females it is unknown if their 
predisposition to persistent symptoms has to do with hormones, genetics, connective tissue 
strength, muscle mass, or increased use of health care services to name a few of the possible 
options. However, these avenues should be explored further to fully elucidate the understanding 




To further understand these variables in a clinical perspective, it was of interest to see if 
the output related to each variable would differ if the sexes were evaluated separately. Therefore, 
the data was split based on sex and the logistic regression was run with the variables MFI, sleep 
NDI, and an interaction of sleep NDI by MFI. In the final model for each sex, it was found that 
none of the variables, main effects or interactions were significant, but the distribution of the 
data is likely the reason for these results. The data split resulted in 72 females and 25 males, but 
it is unknown if this nearly 3 to 1 sex ratio was adequate to generate appropriate results. With 
this spilt, the distribution of the participants across the groups was likely not appropriate for a 
statistical analysis. For males, (Table 5.1) there were 4 observation cells and in 3 of the 4 cells 
there were 5 or fewer participants; for females (Table 5.2), in 2 of the 4 cells there were 6 or 
fewer participants. With such a small N in numerous cells, it is possible that the effect of the 
variables split by sex was not evident. 
 
Table 5.1 Classification table of predicted and observed group membership for males only. 
Male 
 Predicted recovered Predicted persistent 
symptoms 









Table 5.2 Classification table of predicted and observed group membership for females 
only. 
Female 
 Predicted recovered Predicted persistent 
symptoms 





To further assess the potential influence of female sex on the other variables, and to 
determine if it had a mediating effect on them, a logistic model was created using only MFI, 
sleep NDI, and the interaction of MFI and sleep NDI; thus sex was not included as part of the 
analysis. Running this analysis, the output was nearly identical to the one that had those variables 
and sex included; the beta value for MFI without sex was 0.11 and with sex it was 0.10, for sleep 
NDI without sex the beta was 1.49 and with sex in the model it was 1.48. It appears that the 
variable sex is not a mediating factor for sleep NDI or MFI on the DV.  
When sex is added into the model, there is a change in the overall classification table and 
an improvement in the specificity of the model. The sensitivity of the complete model with sex is 
85%, without sex in the model it is 86.7%, whereas the specificity with sex in the model is 
62.2% and without sex in the model it is 35.1%. Therefore, by adding sex into the model, the 
specificity increases by 27.1% without influencing the sensitivity. Consequently, by adding the 
female sex into the model there is an improvement in the prediction of the model for ruling 
people in to develop persistent symptoms when these variables are present. See Table 5.3 for the 




Table 5.3 Comparison of 2 models with and without sex included as a variable including 
beta value, overall prediction, sensitivity, and specificity.  















Model with sex included as a variable 
MFI 0.10 76.3 85.0 62.2 
Sleep NDI 1.48 
Model without sex as a variable 
MFI 0.11 67.0 86.7 35.1 
Sleep NDI 1.49 
Abbreviations: MFI, muscle fatty infiltrate; sleep NDI, sleep response on Neck Disability Index. 
5.2.6 Model Prediction  
 For overall prediction of the model, a variety of analyses were performed. The first was 
the reporting of the Nagelkerke R2, which is a report of the explained variance of the DV by the 
factors in the model. The second analysis was performed using a ROC curve and its associated 
AUC, which are graphical and quantitative evaluations of the model and its ability to 
discriminate between the two groups. Finally, there was the assessment of the model to predict 
the overall grouping of the participants as well as each subgroup: persistent symptoms 
(sensitivity) and the recovered group (specificity). 
In evaluating the model for its ability to predict persistent symptoms, the Nagelkerke R2 
was 0.27; the 0.27 reported for R2 means that 27% of the variance of the DV can be explained by 
these variables. Other measures for model prediction were the receiver operating characteristic 
(ROC) curve and its associated area under the curve (AUC) reported at 0.68; the 0.68 means that 




itself is considered to have poor discrimination of the groups, the results still can provide some 
benefit to patients and practitioners. While it can be argued that 73% of the variance is unknown 
based on this model (and this amount of variance may explain why this model is a poor 
predictors), of the variables that are in the model, both MFI and sleep disturbances may be 
amenable to treatment and can perhaps be a pathway for helping to prevent some people from 
developing symptoms. As well, recognizing that females have higher rates of WAD, when a 
female presents with sleep disturbances as well as elevated MFI levels clinicians may be more 
inclined to initiate treatment earlier than a male who does not have any of these factors.  
In assessing the ability of the model to predict specific group designations based on the 
presence of the variables, the reported sensitivity was 85.0% and the specificity was 62.2%. 
When comparing these to the previously reported CPR, there is a considerable drop in the 
specificity which was 99% for the CPR, and this implies that there is an increase in the false 
positives related to these variables. From a clinical perspective, this result means there is an 
increase in the number of people who do not develop persistent symptoms, but the model 
predicts that they will, thus, they may end up with unnecessary treatments. However, the 
sensitivity in the CPR was listed at 44%, so the 85% using this model will reduce the false 
negatives from 56% to 15%. Therefore, using this model there would be fewer people who end 
up developing persistent symptoms who previously would not be detected and now could end up 
being referred for treatment that may help to reduce the chronicity.  
5.3 Specific Aim #2 
 The second aim of this dissertation was to determine both if and how much the variables 
of interest changed over pre-determined time points: 2-weeks, 3 and 12-months post-MVC. In 




5.3.1 Main Effects 
The main effects for the variables of interest (sex, MFI, and sleep NDI) were found to be 
significant predictors of persistent symptoms at all time points except for sleep NDI at T2. As 
well, they demonstrated no significant change when compared to the immediately preceding time 
point; the changes were evaluated based on their beta values, ORs, and CIs. However, the sleep 
NDI at T4 was significantly different when compared to T1 for both the beta values and ORs and 
was nearly significant when evaluated against T3. Each variable however needs to be assessed to 
more fully comprehend how it responds across time.  
5.3.1.a Muscle Fatty Infiltrate 
 MFI was found to be a significant predictor of persistent symptoms at all four time 
points. See Table 5.4 for beta coefficient and 95% CI. To determine if a significant change 
occurred across time, all variables were assessed based on the mean of the OR and the 95% CI 
for each time point. The mean at each time point was compared to the 95% CI of the previous 
time point, and if it was beyond the CI than it was deemed to be significantly different. When 
MFI was evaluated in this way, at no time point was the mean of the MFI outside any of the 
previous time points 95% CI, thus it was determined that no significant change occurred across 





Table 5.4 MFI odds ratio and 95% CI across all time points for developing persistent 
symptoms 
 p-value Odds ratio for MFI 95% Confidence 
Interval 
Time point 1 0.07 1.10 0.99 to 1.22 
Time point 2 0.01 1.14  1.03 to 1.26 
Time point 3 0.04 1.12 1.00 to 1.24 
Time point 4 0.03 1.15 1.02 to 1.31 
Abbreviations: MFI, Muscle fatty infiltrate. 
 To further evaluate MFI across time, a split-plot repeated measures ANOVA was used to 
assess if any group by time changes occurred. From this analysis, there was no statistical 
difference within the groups from T1 to T4 for either recovered or persistent symptoms, but there 
was a significant difference between the groups at all four points. As well, a group by time 
interaction assessing changes between the groups was non-significant. The lack of significance 
means that there was no difference in the way the groups changed over time when compared to 





Figure 5.1 MFI T1 through T4 separated by groups. 
 
Abbreviations: MFI, Muscle Fatty Infiltrate. 
 
As it was reported that there was a difference between the groups at baseline in the 
quantity of MFI, it can be argued that the beta at baseline is the initial influence of the variable 
on the DV, and it does not significantly change over time. However, this result appears to 
contrast with the notion that MFI can be influenced by inflammation and trauma. 12,32 The 
inflammatory response, although it is a tightly regulated series of steps coordinated to assist in 
tissue healing, does fluctuate individually based on multiple variables such as age, genetics, and 




MFI for those with moderate to severe WAD following an MVC, and it was theorized that 
inflammation from the trauma may have played a part in those changes.20 However, if trauma 
and inflammation were to alter the quantity of MFI, it could be expected that the overall amount 
of MFI would increase and there would be within-group changes. In addition, if it were to 
change only for one group, then it is also possible to have a between group by time interaction, 
where one group changed significantly compared to the other, but neither of these results 
appeared. 
 Finally, to evaluate MFI further, the quantity of MFI was assessed between the sexes. No 
previous studies were found that directly assessed the quantities of cervical spine MFI in females 
compared to males, but there were several that looked at MFI within the lumbar spine, and in 
most of the muscles evaluated females had a greater quantity of MFI.179,180 In this report, females 
had a higher mean of MFI at 20.30% compared to 17.82% for males, but based on the size of 
their standard deviation, 5.9% for females and 4.6%, it appears the differences may not be 
statistically significant. To evaluate this variable between the sexes, an independent t-test was 
used to assess the mean differences. There was a statistically significant difference at T1, p = 
0.049, but at the other 3 time points there was no difference between the groups. Given that the 
quantity of MFI was not different between the sexes at 3 of the 4 time points may explain the 
previous findings that showed no difference in beta coefficients whether sex was included or not 
in the model. 
 Overall, it appears that the quantity of MFI is a significant predictor of group 
membership at 12 months, and the greater the quantity the larger the beta coefficient and OR for 
that person. Although it may be a smaller when compared to other variables, it does demonstrate 




5.3.1.b Female Sex 
 Female sex was a statistically significant variable at all time points and demonstrated 
ORs and CIs that were similar at all times, with a slight increase at T3 and T4; see Table 5.5 for 
ORs and 95% CIs across time. Based on the mean of the OR and the 95% CI at each time point, 
there was no significant change across time in the effect of this variable. 
Table 5.5 Odds ratio and 95% confidence interval for female sex to develop persistent 
symptoms across all time points.  
 p-value Odds ratio  95% Confidence 
interval 
Time point 1 0.01 3.63 1.31 to 10.05 
Time point 2 0.01 3.71 1.37 to 10.07 
Time point 3 0.01 4.48 1.45 to 13.87 
Time point 4 0.01 5.42  1.48 to 19.82 
 
Female sex is a variable that has been studied in numerous reports, but the results are not 
consistent. In general, the effect of the variable is considered inconclusive, but the confidence in 
this conclusion is low.17 However in this study, as was previously described, the DV was 
evaluated in a slightly different manner both in terms of using a dichotomous outcome rather 
than the continuous NDI score, as well as using NDI greater than 10% to represent persistent 
symptoms rather than the standard 30%. With these listed differences in consideration, it is 
possible that the OR and CI listed in this report for females is a more accurate representation of 
the overall prognostic power of this variable.  
As the OR and CI for T1 and T2 are almost identical, it is of interest to recognize the 




twice as large as those at T1 and T2. The OR is simply a mathematical standardization of the 
unstandardized beta coefficient by taking the mathematical constant e and raising it to the power 
of the beta. Because this is an exponential function, small deviations in the beta can have a larger 
influence on the OR. Thus, for T4, it has a slightly larger SE for the beta at T4 (0.66) compared 
to T1 (0.52), but this approximately 20% increase when applied exponentially results in a larger 
CI at T4 when compared to T1.  
However, it needs to be understood why the SE increases at T4. At T4, the groups are 
fully dichotomized and the full extent of the influence of the variable is known. At the previous 
time points, the influence of the variable can only be inferred from the data at that time point. 
However, at T4 because the two groups are fully separated, persistent symptoms and recovered, 
the two groups are at opposite ends of the continuum, which will result in a larger spread of the 
data and an increased SE.  
From the results of this study, it appears that the sex of the participant is a significant 
predictor of group membership at 12 months with an increased OR for developing persistent 
symptoms ranging from 3.63 to 5.42. These results do not imply that men do not develop chronic 
WAD or that being female assures that they will develop symptoms. Instead, it needs to be 
recognized that in conjunction with other variables, sex is one piece of the puzzle that can help 
determine who will develop chronic WAD. 
5.3.1.c Sleep NDI Response  
 The sleep NDI response is the final variable that was a significant predictor of persistent 
symptoms: It was significant at T1, T3, and T4 but not at T2. See Table 5.6 for ORs and 95% CIs 
for sleep NDI. Based on the criteria used in this study to determine a statistically significant 




there were no changes noted. However, the OR at T4 was beyond the upper boundary of the 95% 
CI at T1, which means that over time (from T1 and T4) there was a significant increase in the 
strength of the OR for being able to predict persistent symptoms. 
Table 5.6 Sleep NDI odds ratio and 95% confidence interval for developing persistent 
symptoms across all time points. 
 p-value Odds ratio 95% Confidence 
interval 
Time point 1 0.02 4.38  1.32 to 14.51 
Time point 2 0.14 (non-
significant) 
2.30 0.77 to 6.84 
Time point 3 <0.001 7.75 2.77 to 21.66 
Time point 4 <0.001 21.53 6.39 to 72.51 
Abbreviations: Sleep NDI, sleep response on Neck Disability Index.  
The T1 scores can likely be explained by the general sleep response following an acute 
injury. Following an acute MVC, there will likely be any of the following: an inflammatory 
reaction, increased pain, stress associated with car repairs, doctors  visits, missing work, or other 
factors that ma  influence someone s sleep. Understanding wh  and how these factors can 
influence someone s sleep likel  explains the reported results following an MVC. Recognizing 
the bidirectional relationship of sleep and chronic pain can also help understand why this 
variable can assist in predicting long-term persistent symptoms.  
 The lack of significance at T2, however, is more difficult to comprehend. To assess the 
variable at this time point, a McNemar test was used to determine if there was a difference in the 
proportions of participants between T1 and T2 who reported sleep disturbances. The McNemar 




the overall sleep NDI response was similar: At T1 82.5% (80 participants) reported sleep 
disturbances while at T2 it was 79.4% (77 participants). However, from T1 to T2, 6 participants 
transitioned from sleep disturbance to the no-sleep disturbance group while 3 participants 
regressed from no difficulties sleeping to having disturbances. Based on the proximity of the two 
evaluations, less than 1 week from the MVC for T1 and 2 weeks for T2, as well as the previously 
described factors that can influence sleep, this lack of significance was expected. 
 However, it was still not understood why sleep NDI was non-significant at this time point 
and thus further evaluation was required. The evaluation occurred by way of running the 
backward conditional logistic regression and inputting each variable individually, starting with 
sleep NDI.  Creating a model using only the variable sleep NDI at T2 provided a final model 
with a significance value of 0.028 and an OR of 3.12. When sex was added into the model, the 
results were essentially unchanged. Yet, when MFI was added into the model the significance of 
sleep NDI was lost and it was removed from the model. It is unknown why these results exist or 
why they occur only at T2, perhaps MFI has a greater, or at least more consistent, influence on 
group membership when compared to sleep NDI. However, at the other 3 time points, T1, T3, 
and T4, the addition or removal of either of the other variables, sex or MFI, or any of the three 
interactions had no influence on sleep NDI as its beta value, OR, 95% CI, and significance levels 
were essentially unchanged. Thus, we cannot say for certain how MFI may influence the 
significance of sleep NDI.  
 Nevertheless, when the sleep NDI variable was evaluated based on other groups, 
female/male or high and low-MFI rates, a trend arose. The data were separated into male and 
female and the McNemar test was run between each time point: T1 and T2, T2 and T3, and T3 




sleep NDI response rate. As well, previous research has found that MFI levels at 20.5% or higher 
to be a significant predictor of persistent symptoms at 12 months.20 Thus when the sleep NDI 
was distributed into these groups (above and below 20.5%) and the McNemar test was run, there 
was a significant change in the sleep NDI response between T2 and T3, but only for those with 
MFI above 20.5%. Hence, in both males and those with MFI below 20.5%, there was no change 
in their sleep NDI across time points; this non-significance exists between T1 and T2, T2 and T3, 
T3 and T4, as well as between T1 and T4.  
 With each group the significance change occurred between T2 and T3, and it only in the 
groups that were previously cited as being predictors of persistent symptoms, female and 
elevated MFI, because of this, it appears that there is some degree of relationship. However, as 
these variables were worked into each model individually, it does not appear that any single 
variable acts as an effect mediator, nor was any interaction effect noted. Therefore, it is unknown 
if higher levels of MFI cause sleep disturbances or vice versa. As well, females generally have 
increased rates of MFI compared to males which may influence these results, so at this time we 
cannot determine a cause-and-effect relationship between these variables, but it is an area that 
could be studied in greater depth. 
 The final aspect of sleep NDI to acknowledge was the increasing OR and beta value 
reported across the four time points with T4 having the largest effect, as well it was outside of 
the upper boundary for the 95% CI at T1. This result implies that between T1 and T4 there was a 
significant increase in the OR in predicting persistent symptoms. By T4, many of the previously 
listed factors such as inflammation, stress, and pain have been at least reduced if not eliminated 
for some of the people, but others will continue to be afflicted by some of these and may 




NDI may be attributed to its being an item response of the NDI which is used to categorize the 
patients at T4 (this potential limitation will be discussed in section 5.6).  
At T1, 80 participants were reported as having difficulties with sleeping and at T4 that 
number was 60; at T4 60 participants were determined to have persistent symptoms. Using a 
Spearman s Rho correlation between sleep NDI response and final group membership, at T1 the 
r value was 0.31 and at T4 it was 0.61, and both had significance values of 0.002 or below. Thus, 
it appears that as time passes, the correlation between these two variables grows in strength, 
which may partially explain the increased OR for this variable as a predictor. However, the OR 
for sleep NDI does have a large 95% CI (6.39 to 72.51); thus, it is unknown how precise this 
measurement is. 
5.3.2 Interaction Effects 
 For being a predictor of persistent symptoms, there were no significant interaction effects 
noted at T1, or any of the other time points. Although there were no significant interactions 
discovered, there were a few findings noted between the variables that were of interest. 
 The first finding to be discussed occurred at T2 regarding how the sleep NDI variable 
was removed from the final model when MFI was added as a variable. It was of interest because 
this adjustment to the variable s significance occurred only at this time point, and at no other 
time did the addition or removal of either of these variables influence the final model. It would 
be of interest to obtain a greater understanding of sleep disturbances through a more nuanced 
assessment, such as the PSQI, rather than simply asking about quantity lost. For example, a 
relationship between sleep latency or medication usage, to name a few, may exist whereas the 





 The second finding of interest had to do with the effect sizes of the variables. There were 
consistent results across the time points, especially for sex and MFI, and these results were not 
influenced by the inclusion or exclusion of any of the other variables. This consistency implies 
that the main effects of these variables are independent of the other variables, and there are no 
mediation effects between any of these items. Knowing that these variables have a consistent 
result and are independent of other variables can provide clinical utility for health care 
practitioners who work with this population.   
5.3.3 Model Prediction 
 For the Nagelkerke R2, the explained variance increased across the time points. See Table 
5.7 for the reported R2 across time. It is noted that there is a slight decrease in the statistic at T2, 
but this is likely due to the elimination of the sleep NDI variable, when this was forced into the 
model, in addition to sex and MFI, the R2 was 0.24. As there are no CIs or SE listed for this 
statistic, it is impossible to determine if there is a statistical difference between the time points.  
Table 5.7 Nagelkerke R2 across all time points. 
 Time point 1 Time point 2 Time point 3 Time point 4 
Nagelkerke R2 0.27 0.22 0.40 0.56 
 
In an analysis of the results, the slight difference between T1 and T2 would be expected 
based on the short time interval between the two, yet a gradual increase across time implies that 
the strength of these variables  effect on the DV becomes larger. As the effect sizes of both sex 
and MFI remained stable across time, the increase in R2 is likely related to the increasing effect 




association between chronic pain and sleep disturbances and could be of benefit as we look for 
ways to treat and care for these patients. Unfortunately, as was previously described, the 
relationship between sleep and chronic pain is bidirectional; it is unknown at this time which 
way treatment should be focused to improve outcomes.  
 The overall percentage of those correctly predicted as well as those predicted for group 
membership followed a similar pattern to the R2 in which the numbers were relatively stable 
across time, with a slight increase by T4, and a slight dip at T2. See Table 5.8 for overall 
prediction, sensitivity, and specificity across time points.  
Table 5.8 Percentage of correct prediction for overall group membership, sensitivity, and 
specificity. 
 Time point 1 Time point 
2 
Time point 3 Time point 
4 
Overall percentage correctly 
predicted for both groups 
76.3 70.1 79.4 85.6 
Sensitivity (percentage predicted 
for persistent symptoms) 
85.0 86.7 88.3 86.7 
Specificity (percentage predicted 
for recovered group) 
62.2 43.2 64.9 83.8 
 
 If all participants are classified as having persistent symptoms, the percentage of correct 
prediction would be 61.9% (this is called the constant model). By using the variables sex, MFI, 
and sleep NDI, that number is increased by nearly 15% (76.3%), or it can be recognized that 
38%% of those who were not correctly classified were placed into their proper group. By 




develop persistent symptoms sooner rather than later, and hopefully get them into a treatment 
program that will benefit them. 
 Based on the effect sizes of MFI and sex, it seems that the influence of these variables is 
similar across time in terms of predicting outcomes. In looking at T4, generating logistic models 
while excluding one of the variables, MFI or sex, the overall prediction, sensitivity, and 
specificity are changed only slightly. However, when sleep NDI is removed from the model 
while keeping MFI and sex, the sensitivity is unchanged, while the specificity drops from 83.8% 
to 40.5%, and the overall prediction drops from 85.6% to 69.1%. Therefore, it appears that MFI 
and sex will increase the overall prediction rate from the constant model of 61.9% to 69.1%, (an 
increase of 7.2%), while sleep NDI increases it from 69.1% to 85.6% (an increase of 16.5%). 
These results provide further evidence of the growing influence of sleep disturbances on 
persistent symptoms.  
 According to the T1 results, sex and sleep NDI have similar effect sizes with an estimated 
OR of 3.63 and 4.68, respectively. When each one is individually removed from the model at this 
time point, their influence is similar: there is a nearly 25% drop in specificity and a 7% to 9% 
drop in the overall prediction. At T1 with removal of MFI from the model, there is a decrease in 
sensitivity of nearly 7% and a 4% drop in overall prediction. These results suggest that the 
female sex has a greater influence on persistent symptoms earlier in the process, but by later time 
points, the effect is overshadowed by the growing effect size of the sleep NDI variable. 
Additionally, MFI, although not as large as the other variables, does demonstrate a significant 
and consistent effect size across all time points, which does not completely explain why some 




 Finally, the model s predictive capabilities were evaluated using ROC curve and AUC. 
The AUC for each time point, along with its associated 95% CI are listed in Table 5.9. An 
analysis of the AUC for each time point reveals minimal change across time in the ability of 
these variables to discriminate between groups as the overall results range from 0.68 to 0.73. 
With these results, the overall ability of these variables to discriminate between the groups is 
considered poor to acceptable. At no time do any of the results move beyond one of the 
boundaries of a previous 95% CI, therefore, there does not appear to be a significance change 
across time.  
Table 5.9 The area under the curve and 95% confidence intervals for each time point. 
 Time point 1 Time point 2 Time point 3 Time point 4 
Area under the 
curve 
0.68 0.69 0.70 0.73 
95% confidence 
interval 
0.57 to 0.79 0.58 to 0.80 0.59 to 0.81 0.62 to 0.83 
 
 Although the AUC for these variables is considered only poor to acceptable, it is also 
recognized that other variables that were not evaluated in this study, such as PTSD103, have a 
recognized relationship with the development of persistent symptoms. It would be of interest to 
see how some of the variables from this study, especially with the adjustment in the way 
persistent symptoms were categorized, may interact or be affected by the inclusion of PTSD in 
this model. It is recognized that sleep disturbances are a core finding in people with PTSD181, so 
it would be of interest to see how these two variables may interact or if the effect sizes are 




 Because WAD is a complex condition with numerous signs and symptoms, it is not 
expected that a few single variables will be able to provide excellent discrimination between 
people who recover and those who develop persistent symptoms. However, with the results from 
this study, it can be recognized that these variables do have an influence that explains a portion 
of the overall variance of the DV, even if the discrimination between the groups is limited. With 
this knowledge, these variables can be included in future studies to help build and understand 
models that will not only help us to determine who will develop persistent symptoms earlier but 
will hopefully lead to improved treatment strategies for those people.  
5.4 Clinical Significance 
 While the use of only these variables to help discriminate between groups may be 
limited, the information discovered in this study has clinical utility. Primarily, two of the three 
variables, sex and sleep disturbances, can be assessed very rapidly and consistently. For MFI, 
until more clinically friendly methods of assessment are available (or MFI is reported in 
radiological repots), and in order to minimize Type II errors, clinically it can be safe to assume 
that a person will require exercises to minimize MFI.   
 Previous studies have attempted to create clinical prediction rules (CPR) that can be used 
by practitioners to help determine who will develop persistent symptoms.77 However, in the 
derivation of the CPR some of the factors discovered were high ratings on the NDI as well as 
elevated scores on the hyperarousal scale of the post-traumatic distress scale. The issue with 
using the NDI as a predictor variable is that it was used as the determining factor for group 
membership of the DV; the researchers used the baseline NDI to predict future NDI scores. In 
addition, hyperarousal is a subjective measure that has personal and cultural differences that may 




treatment, whereas MFI quantities can be influenced by specific exercises and sleep hygiene has 
the potential to be improved through education and postural/mechanical changes. Therefore, 
these variables may provide more clinical usefulness to practitioners. 
 Finally, adjusting the way the persistent group was recognized placed an emphasis on 
minimizing the false negatives. The goal was to avoid missing people who may benefit from 
treatment following an MVC. As the sensitivity was never below 85%, with the use of these 
factors, there is only a 15% chance that people who will develop persistent symptoms will be 
misdiagnosed.  
5.5 Future Research 
 The results from this study have generated an improved understanding of the effect of 
MFI, sex, and sleep disturbances on persistent WAD symptoms. However, there is still a 
significant amount of research that needs to be completed to more fully understand these 
variables and their influence on WAD. 
 Although elevated levels of MFI demonstrate a significant and consistent effect across 
time on persistent symptoms, it is unknown how or why some people demonstrate increased 
levels. It needs to be understood if MFI is a result of environmental influences such as exercise 
history, diet, or stress levels, if it is simply a matter of genetics, or a combination of both. By 
more fully understanding the origin of MFI, especially in relation to WAD, we can have a greater 
understanding of future treatment approaches. 
 MFI is not generally reported by radiologists when they read an MRI, and this is due to 
two primary reasons. The first is that MFI has generally not been understood regarding its 




no clinical utility. The other issue with MFI is that up until recently it was very time consuming 
to hand calculate the quantities present in a person s neck (the researcher in charge of calculating 
MFI in this study reported it took approximately 20 minutes per scan). However, recent research 
has used artificial intelligence for segmenting and calculating MFI within the cervical spine, and 
it has been reported to be as accurate as humans and it can perform the task in less than 60 
seconds.182 Therefore, as the speed of MFI calculations and the its effect on persistent symptoms 
both improve, it should be a variable that is reported by radiologist regularly and used by 
clinicians to help drive decisions.  
 It is recognized that not all people will have an MRI of their neck following a whiplash 
injury, thus having alternative ways to evaluate MFI can be beneficial to the clinician and 
patient. One possibility is to evaluate MFI with an ultrasound which can be used by clinicians 
when they have been trained and have the proper equipment. Although no studies have been 
completed looking at the cervical spine, one study has looked at evaluating MFI in shoulder 
muscles with an MRI and ultrasound, and a strong correlation (r=0.90) between the two was 
reported.183 If a clinician does not have access to MRI results or an ultrasound, as MFI has been 
associated with decreased strength and motor control in the cervical spine, it would be of interest 
to see if clinical tests (deep neck flexor strength or joint position error) will be able to determine 
elevated quantities of MFI that can increase the likelihood of developing persistent symptoms. 
As a result, assessing MFI with ultrasound or manual muscle or joint position tests could provide 
benefit for patients diagnosed with WAD.  
 Reported in this dissertation, at baseline the variables of MFI, sex, and sleep disturbances 
accounted for 27% of the explained variance of the final group membership, these results were 




to improve the model by seeing how the addition of known BPS variables (PTSD, anxiety, 
depression) will help to explain the overall variance of the final model. 
 Finally, from a treatment perspective, as both MFI and sleep disturbances can potentially 
be influenced by specific treatments, it would be of interest to see if treatments focused towards 
them will influence outcomes. Training specific muscles can help to decrease the quantity of 
MFI, but it is unknown how this influences outcomes in those with WAD. As well, sleep 
disturbances can be addressed from a biomechanical perspective with an understanding of sleep 
posture, but also sleep hygiene education such as decreasing stress and consistent bedtimes can 
influence both quantity and the quality of a person s sleep. However, it is not known how these 
will specifically influence people with WAD, thus, a future study evaluating these treatment 
strategies can illuminate their potential benefit. 
5.6 Limitations and Delimitations 
A primary limitation in this study was assessing potential participants for the presence of 
WAD as there is no gold standard used to make this distinction. As this a condition that is 
primarily based upon a person s s mptoms and experiences, we are reliant on participants being 
truthful about their condition, their current symptoms, and their level of disability.  
Beyond making a firm diagnosis, using the NDI as a tool to determine persistent 
symptoms was another limitation. The problem with this tool is that there is no formal definition 
of what it means to be recovered; as a result, it is unknown whether the NDI truly can evaluate 
those who are recovered compared with those who have persistent symptoms.160 The term 
recovery has been associated with pain, headaches, fatigue, loss of range of motion, or symptoms 




is no standardization for what the most appropriate DV is to use or even for what levels within 
the DVs to use for categorizing people into a recovered or symptomatic group. For example, 
following an MVC, a person may have no pain in their neck or head but still feel that they have 
difficulty concentrating. Some practitioners may consider this person recovered, whereas others 
ma  not; it appears that determining whether someone is recovered is a matter of an individual s 
definition or opinion. Although the NDI is not a perfect tool, it is commonly used by 
practitioners and it does attempt to evaluate numerous areas of function  to quantif  a person s 
impairment; hence, it was deemed appropriate to use for this study. 
 Another potential limitation within the NDI that has been previously discussed is the way 
it assesses each individual subsection. For example, in evaluating headaches, it asks about 
frequency and severity, and rather than assessing each component individually, the two factors 
are placed together. One selection is I have severe headaches which come frequentl .  Such a 
selection does not allow for the possibility of having severe headaches that come on infrequently; 
there is no category that allows for a mixture of the two variables. Furthermore, for the greatest 
impairment, the selection is I have headaches all the time.  It is unknown whether it is worse 
for someone to have a slight headache all day or a severe headache several times a day. 
However, according to the scoring schema of the NDI, the indication of headaches all the time 
(regardless of intensity) is classified as the worst.  
In this study, the primary item response of the NDI that was evaluated dealt with sleep 
disturbance. It has already been discussed that this variable only assesses the quantity of sleep 
loss and does not evaluate the quality of sleep or the restfulness that a person obtains from 
sleeping. Although such a distinction may be of interest in future studies, in particular evaluating 




deemed appropriate to use the single question to determine sleep disturbances associated with the 
quantity of sleep lost.   
 Other limitations within this study exist such as people not participating in the study due 
to being unaware of it (they were not approached in the hospital or they did not see the social 
media posts), they lacked the transportation to travel back and forth for the serial imaging, or 
they did not feel they had the time (they could not leave work or obtain child care) to attend the 
sessions. This group of non-participants may represent a small but meaningful subgroup of 
respondents. As well, although a previous MVC was a source of exclusion, a history of non-
specific neck pain or neck injuries associated to other mechanisms (sports or falls) were not a 
source of exclusion and it is unknown if these would influence the outcomes. Unfortunately, 
adding these as exclusion criteria could severely limit the participant pool and would likely skew 
the average age to a much younger group thereby limiting the overall interpretation of the results. 
With limitations that are both unknown and unable to be controlled, the interpretation of the 
results will be limited as a cause and effect relationship cannot be stated and we are therefore 
restricted to recognizing correlational relationships. 
Delimitations also needed to be managed in order to create the models based on these 
variables. One of the primary issues first encountered was how to categorize the participants into 
the two groups, recovered and persistent symptoms, this was an issue because it is not known at 
what percentage on the NDI someone is considered to have mild symptoms. In one study, 
recovered is said to be 10% and below; thus, mild is above 10% and below 30%.77 In other 
studies the recovered group was below 10%, while mild included 10% to below 30%.19 
Evaluating which percentage cutoff to be considered mild or recovered may seem trivial, but in 




resulted in 60 participants being assigned to the persistent symptoms group and 37 to the 
recovered group. If those same people had been considered recovered, there would have been 48 
in the persistent symptoms group and 49 in the recovered group, and this may have altered the 
statistical analysis. However, since one of the goals of this study was to minimize false 
negatives, it was determined the best option was to set the mild symptoms at 10% for their final 
NDI score.   
A statistical delimitation within this study is recognized by the fact that the sleep NDI 
score was used to predict future NDI scores, and this can lead to an inflation of the effect size of 
the variable due to the IV being an item response of the DV. However, two primary concepts 
kept this variable within the study. The first was related to a previous report that noted that a 
brief 5-item NDI was as statistically sound and responsive as the standard 10-item survey.140 
With the 5-item survey it was determined that the sleep response item was not necessary to 
determine a person s function. As a result, the sleep response score can be thought of as an 
independent measure not fully associated with the persons function as measured by the NDI.  
Further justification for using the sleep NDI as an IV was strengthened when the 
correlation between the sleep NDI scores from T1 to T4 and the NDI T4 score were evaluated. 
The r values for the scores were T1 (0.28), T2 (0.19), T3 (0.50), and T4 (0.67). All r values 
except T2 had a significance level below 0.05. The correlation, although significant, ranged only 
from weak to modest.136 With its limited strength as a correlation coefficient, as well as a 
previous report that noted that sleep NDI was not a necessary part of the functional assessment, it 
was considered appropriate to use the sleep response item as a variable of prediction. 
Other delimitations include the use of ordinal data with sleep response scores and the 




scores and to use the NPRS as continuous data, these were still transformations of the variables 
that may have had an influence on the outcome.  
Finally, in this study, we were not able to input data into the model from psychosocial 
stressors such as PTSD, depression, or anxiety, which have been found to have an influence on 
persistent symptoms.82,103 Future studies should work to combine known psychosocial variables, 
such as PTSD, along with the variables reported in this study to determine the most robust model 
for predicting future outcomes.  
5.7 Summary 
 WAD is not a new phenomenon, it has been a reported condition before automobiles 
were even manufactured due to injuries on the railway.46 Nowadays, WAD following an MVC is 
a common condition seen in a physical therapy practice with an estimated 1 to 2.5 million cases 
occurring each year in the United States.52,53 However, even with patient management and 
treatment strategies that are based on significant quantities of research and advanced diagnostics 
that attempt to understand WAD and its complexities, studies consistently demonstrate that 
approximately 50% of these patients will continue to have symptoms at least 6 to 12-months 
post-MVC.77  
 Some of the struggles with managing the patient with WAD are likely due to the intricate 
biopsychosocial interactions that affect each person and can result in a myriad of signs and 
symptoms including but not limited to neck pain, headaches, loss of range of motion, numbness, 
tingling, confusion, lethargy, insomnia, or difficulty concentrating.2,3 The possibility that any or 
all of these may be present in any person, or be present in any number of combinations, makes it 




 However, before we can begin to treat these patients, we need to determine who will 
develop persistent symptoms. Currently, most of our clinical diagnostics have been focused on 
determining who will have moderate to severe symptoms 6 to 12-months post-MVC. In the 
derivation of a CPR, the variables of older age ( > 35 years old), elevated scores on the 
hyperarousal subscale of the post-traumatic stress distress scale (> 6), or elevated NDI scores (> 
40) were the variables found to be the strongest predictors of the moderate to severe category.77 
In this CPR, they also determined who was likely to move to full recovery defined as an NDI of 
less than 10%. In this section of the study the authors reported that an NDI at or below 32 as well 
as age below 35 were predictors of full recovery. However, there were many pathways and 
combinations of the variables that did not lead to a recognition of who will be fully recovered or 
develop persistent symptoms.  
 Therefore, in this study, one of the primary aims was to determine who will develop 
persistent symptoms regardless if they were considered mild or moderate to severe. To achieve 
this goal, a two-group model of persistent symptoms and recovered was used; participants were 
categorized based on their NDI scores at 12 months with those below 10% labeled as recovered, 
while those with 10% or above were considered to have persistent symptoms. 
When determining which variables to use as predictors in this study, the NDI was 
strongly considered based on its strength as a predictive variable for persistent symptoms. 
However, because the NDI is the tool used to determine group membership at 12 months, it was 
deemed inappropriate to use as an IV in the logistic regression model. Therefore, other variables 
that have been found to have at least some relationship with chronic WAD were evaluated in the 
model, and they were evaluated across multiple time points to determine if their strength of 




were assessed. In addition to these main effects, interaction effects between variables that were 
different between the groups at baseline were also evaluated, and these included sex by MFI, sex 
by sleep NDI, and MFI by sleep NDI. 
As this study was exploratory in nature, there was an emphasis on minimizing false 
negatives and ensuring all variables that were predictive would be included in the final model; 
thus, the parameters for inclusion were modified accordingly. Some of the adjustments to the 
statistical analysis included an elevated alpha level, reducing the level at which the score on the 
NDI was used to determine persistent symptoms (10% compared to 30%), and the use of the 
more lenient backwards conditional method for entering the variables in the logistic regression 
model. Therefore, if a variable was not found to be a significant predictor of group membership 
given these liberal standards, it was determined that they have little effect on group 
discrimination. From this model, the primary variables  main effects that were found to be 
predictors of persistent symptoms were MFI, sex, and the sleep NDI responses; no interactions 
were found to be significant at any of the time points. 
MFI is a variable that has been found consistently in higher quantities in people who 
develop moderate to severe chronic WAD when compared to those who recover.18,34 In previous 
literature, MFI has been found to be equal across groups at baseline and is reported to be in 
greater quantities in those who develop persistent moderate to severe symptoms in as little as 2 
weeks and these differences maintain through at least 6 months.19 Additionally, the reported 
effect size for MFI has been reported to range from medium to large, but this is often based on 
evaluating participants in the moderate to severe group when their NDI was only above 30%.19,20 
In the results from this study, MFI was found to be different between the groups at 




time. Its effect size was also considered to be small, which is different from the medium and 
large effect sizes previously reported. Although these results differ from the previous literature, it 
may not be unanticipated based on the different categorization of the subjects. Regardless of the 
specific effect size, it appears that MFI is a consistent factor in the development of chronic 
WAD. In the future, MFI should be recognized as an important element in research that attempts 
to predict those who will develop persistent symptoms as well as in studies that evaluate best 
methods for treating people with the condition.      
 Sex is a variable that has not been found to be as consistent as MFI as a predictor of 
persistent symptoms,17 but in this study, it was reported to have significant main effects across 
all four time points along with consistent effect sizes. This variable, although it is not amenable 
to changes during treatment, does provide some benefit to the treating clinician as they attempt to 
determine who will develop chronic WAD symptoms and may require treatment.  
 The sleep NDI response evaluates the amount of sleep disturbance a person is reporting. 
In the literature, there is some research and discussion about sleep disturbances as a predictor of 
persistent symptoms,119,120 but its effect size has been reported as small and even these results are 
inconclusive.17 However, in the past few years there has been an increase in research into the role 
of chronic sleep disturbances and its influence on chronic pain.117 As our understanding of sleep 
disturbances and its bidirectional relationship with chronic pain is further developed, recognizing 
how it can be a part of the chronic WAD presentation will become clearer. With the results from 
this study, it appears that sleep disturbances function as an important predictor in developing 
chronic WAD, and whether it is a lot or just a little sleep loss, the odds of developing persistent 
symptoms increase. Additionally, the relationship between sleep loss and persistent symptoms 




that evaluate those with WAD should consider sleep as a strong predictive variable that needs to 
be assessed, and it would be of interest to further delineate the subcategories of sleep 
disturbances (not just quantity of sleep loss) to understand how they may influence persistent 
symptoms.  
 These variables, although providing some information into the inner workings of WAD, 
are not definitive in their ability to predict group membership as the R2 of the models listed 
ranged from 0.27 to 0.56. Thus, there appears to be a large amount of variance of the DV that is 
not explained by these variables. Additionally, the ability of these models to discriminate 
between the two groups was considered poor to acceptable, depending on the time point.  
 The results from this study demonstrate that some variables, sex and MFI, provide 
consistent effects across time on their influence on the development of chronic WAD, whereas 
sleep NDI appears to strengthen in its effect size as time progresses. However, the overall model 
prediction is still quite limited and needs further refinement to help discriminate between groups. 
Nonetheless, future studies that are attempting to predict who will develop persistent symptoms 
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Part 46 of Title 45 of the Code of Federal Regulations (45 CFR 46) revised June 18, 1991. 
 
Cc: Joshua Cleland, PT, PhD 








































































































































Appendix C: Demographics Collection Form 
INITIAL QUESTIONNAIRE 




Title:                 Name: D.O.B.:  Gender: M / F 
Address: 
                                                                        Postcode: 
Phone (H): Phone (W): 
Mobile/Cell: Email: 
Social-Security-Number (SSN): *  
* The Accounting Services at Northwestern University will be given your name, address, and 
Social Security Number in order to issue a check for your study participation. Study payments 
are considered taxable income and reportable to the IRS. A Form 1099 will be sent to you if 
your total payments are $600 or more in a calendar year. 
Please fill in the contact details for 2 people (a relative, and a friend) who are not living with 
you. This information is only to be used to help us to find you if we lose contact. 
Name: Relationship: 
Address: 
                                                                      Postcode: 





                                                                      Postcode: 





Please fill in the contact details for your regular Primary Care Physician (PCP) below 




ACCIDENT HISTORY  
 
Date of Accident: _____/_____/_____ 
 
1. At the time of the accident were you: 
 The driver    The front seat passenger 
 A back seat passenger  Riding a motorbike 
2. Did you know the accident was coming?     Yes   No  
 
3. Was the collision:    Rear end    Rear and front end 
 Front end    Side impact 
4. Was the vehicle you were in stationary at the time of impact?   Yes         No 
INITIAL SYMPTOMS 
 
1. Following the car accident, did your neck pain start:   Immediately 
 Within 24 hours 
 After 24 hours 
 





3. Did the restriction in movement start:     Immediately 




 After 24 hours 
 
4. Did you lose consciousness immediately after the accident?  Yes    No 
 






1. Have you had any major surgery or other injuries (e.g. back or neck pain)?   Yes 
  No 
 





2. Do you have any other medical conditions?      Yes 
  No 
 






3. Have any of the following investigations been performed for your neck pain?     
            


















4. What treatments have you received for your neck pain since your accident? 
 
Type of treatment Number of sessions 
 Physical Therapy _______ 
 Chiropractic _______ 
 Massage _______ 
 Acupuncture _______ 
 Other: _____________________ _______ 
 Other: _____________________ _______ 










This question can assist us in understanding how inflammation can affect your condition.  
 
5. Approximate date of your last normal menstrual period (females only): 
_____/_____/_____   
 
 Check if not applicable:   
SYMPTOMS 
 
1. Please mark on the body chart below where you feel pain or any other symptoms e.g. 











2. On the scale below please estimate the typical intensity of your neck pain over the past 
24 hours. 
 
   
No Pain  Worst Pain 
Imaginable   
 
3. With respect to your whiplash injury, compared to straight after you had your 
accident, how would you describe yourself these days? (circle the most appropriate) 
 
-5 -4 -3 -2 -1 0 1 2 3 4 5 









i. Do you usually have headaches (i.e. prior to the accident)?  Yes    No 
If YES, since the whiplash injury, are the usual headaches:  The same 
          Worse 
 




i. Do you usually experience dizziness / unsteadiness (i.e. prior to the accident)?  
           Yes  
  No 
If YES, is the dizziness / unsteadiness since the whiplash injury?    
            The same 
 Worse 
 
ii. Do you have whiplash related dizziness / unsteadiness?   Yes    No 
          
Please be assured that the information asked on this form will remain anonymous at all 
times. It is collected for statistical purposes only.  
 
 
1. Working Status:    Employed (Occupation 
_____________________________) 
 Self Employed (Occupation 
__________________________) 
       Home Duties 
       Unemployed 






2. If employed/self employed, are you:  
       Currently working usual hours 
 Working reduced hours due to whiplash injury 
IF REDUCED, indicate percentage of usual hours 
______% 
 Not working due to whiplash injury 
 
3. Have you lodged a compensation claim:     No 
          Worker s compensation 
          Third Party claim 
          Other ______________________ 
 






Please indicate the highest grade you completed at school: ____________________ ______ 
 
Please list any further qualifications and/or trades you have gained since leaving school, 
including their full-time duration: 
 
 Qualification 1:    Length of Course      
 
 Qualification 2:    Length of Course     
  
 Qualification 3:    Length of Course     
 






List medications you are taking for: 
      Name   Strength 
 Number  














Appendix D: Informed Consent 
 
Northwestern University 
Department of Physical Therapy & Human Movement Sciences 
Consent Form and HIPAA Authorization for Research 
PROTOCOL TITLE: Neuromuscular Mechanisms Underlying Poor Recovery from Whiplash 
Injuries 
PRINCIPAL INVESTIGATOR: James M. Elliott, PT, PhD 
SUPPORTED BY: N National Institutes of Health (NIH); R01HD079076 
Introduction 
You are being asked to take part in a research study. This document has important information 
about the reason for the study, what you will do if you choose to be in this research study, and 
the way we would like to use information about you and your health. 
Conflict of Interest Disclosure 
The following disclosure is made to give you an opportunity to decide if this relationship will 
affect your willingness to participate in this research study: 
Dr. Elliott, the person responsible for the conduct of this research study and another study 
member, Professor Todd Parrish, have equity interests in a medical consulting company, PainID, 
LLC. You have the right to discuss this study with another person who is not part of the research 
team before making your decision whether or not to be in the study. 
What is the reason for doing this study? 
The primary purpose of this study is to increase our understanding of injury to the spinal cord, 
and how this is related to muscle weakness and changes in muscles, reflexes and other symptoms 
you may have. We are also interested in researching the molecular changes within a blood 
sample that are associated with the bod s response to stress and the recover  process after a 
motor vehicle collision (MVC) It is hoped that such knowledge will help us develop more 
effective treatment methods for spinal cord injury and other trauma to the spine, such as 
whiplash. You are being asked to participate in this research study because you had a MVC that 
resulted in neck pain. 
How many people will take part in this study? 
The study investigators hope to enroll 100 subjects at Northwestern University. 
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What will you do if you choose to be in this study? 
Screening: 
If you agree to participate, you will undergo a series of questions performed by one of the 
stud s investigators to determine if ou are eligible to participate in this stud . The screening 
will last approximately 10 minutes and requires you to answer a series of questions related to 
your current pain levels and provide information related to your MVC. Also, pertinent medical 
history will be discussed. If your participation is not appropriate or safe, you cannot participate 
in this study. 
Testing: 
This study will involve two types of testing and one blood draw. The MRI portion of the study 
will take place at the Northwestern University Department of Radiology (710 N. Fairbanks Ct. 




session will last approximately 1 hour and will take place at less than one-week post MVC and 
then again at 2-weeks, 3-months and 1-year post MVC. The second portion of the study will take 
place at 645 N Michigan Ave, 8th floor. This testing may be performed on the same or on 
separate days, and involves testing of your reflexes/muscle strength. The testing session will last 
approximately 1 hour and will take place at 2-weeks, 3-months, and 1-year post MVC. The two 
types of sessions should be completed within 1 week of each other. Your total participation will 
involve a total of four MRI sessions and three reflex testing sessions over a time period of a year. 
This study uses magnetic resonance imaging (MRI) to look at the spinal cord and muscles 
throughout the body. Magnetic resonance imaging is a type of imaging scan that use magnetic 
fields and radio waves to make a picture of the spinal cord and surrounding muscles allowing us 
to look the structure of the muscles throughout your body. 
In order to make sure the MRI procedures will be safe, you will be asked to fill out a screening 
form before starting the study. It is important that you tell the researchers in this study if you 
have any history of: 
 Metal fragments in your eyes or face. 
 Implantation of any electronic devices such as (but not limited to) cardiac pacemakers, 
cardiac defibrillators, cochlear implants or nerve stimulators. 
 Surgery on the blood vessels of your brain or the valves of the heart 
 Claustrophobia (fear of enclosed places) 
 Pregnant 
The following is a more specific description of what is involved in this study: 
Two small blood samples will be collected from you using a single blood draw, for a total of one 
tablespoon of blood. These samples can be obtained at the time blood is drawn by the ED staff as 
part of your clinical evaluation, or as a separate draw. If a separate blood draw, this will be done 
by either the ED tech or by the research associate who is trained in phlebotomy. Please note the 
blood draw is an optional element of the study. You may still participate in the study if you 
refuse to have your blood drawn. 
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Research with blood, tissue or body fluids (specimens) can help researchers understand how the 
human body works. Research can also answer other questions by using specimens. Researchers 
may develop new tests to find diseases, or new ways to treat diseases. In the future, research may 
help to develop new products, such as drugs. Specimens are commonly used for genetic 
research. Sometimes researchers collect and store many specimens together and use them for 
different kinds of research, or share them with other scientists; this is called a specimen 
repositor  or biobank.  
The purpose of this particular repository or biobank is to have the opportunity in the future to 
look for genes, the expression of genes, proteins, or metabolites, or other molecular differences 
within blood samples that are associated with the bod s response to stress and the recover  
process after motor vehicle collision. The specimens will be coded with a number, and will not 
identify you. The specimen number may be linked to certain information about you (such as age 
and sex), but will not be linked to personally identifying information such as your name, address, 
or social security number. It is not known at this time who (researchers) may be allowed access 
to the samples. In the future, the above biological data may be shared with commercial entities if 




recovery after motor vehicle collisions. If research done with your samples helps to develop new 
products in the future, you will not be paid. Because the samples will not identify you, you will 
be unable to withdraw them or have them destroyed. 
These blood samples will be stored on the campus of Northwestern and later shipped in batches 
to a Biospecimen Processing Facility at the University of North Carolina. Samples will be 
banked indefinitely for future biological analyses examining the recovery process after motor 
vehicle collision. 
In an effort to better understand the mechanical impacts of a motor vehicle accident and injuries 
to the neck, we are working with an accident reconstructionist. With your approval, we will ask 
for photos of the car accident and/or may send a member of the research team to take photos of 
the car. There will be no information on the photos that can be used to identify you. This is an 
optional element to the study. You may still participate if you do not agree to submit the photos. 
You will be asked to undergo a MRI of your neck and leg muscles. We will ask you to complete 
a questionnaire related to the amount of pain and symptoms you are having at the time of the 
assessment as well as information related to your overall wellbeing. This questionnaire may be 
completed in a paper form or sent to you via a secure web application used for managing online 
surveys and databases. You will be asked to change into a hospital gown or surgical scrubs. 
Next, you will be asked to lie down on the scanner table. A moveable table will position you into 
the center of the magnet. In order to take the pictures, an imaging device will be placed over your 
neck and legs. You can speak to the researcher by talking out loud. If at any time or for any 
reason, you wish to stop the exam, you may do so by squeezing a rubber ball in your hand. 
The MRI portion of the exam will take pictures of your spinal cord and the muscles in your leg 
and neck while you lay comfortably on your back inside the MRI tube. The images of your 
muscles allows us to observe any specific changes in the structure of your muscles as well as any 
changes that may occur inside your spinal cord; where the nerves that supply information to your 
muscles are situated. The expected time for this MRI scan is approximately one hour. 
For the assessment of the strength in your leg muscles, you will be seated in an experimental 
chair with adjustable straps across your trunk and upper legs to comfortably maintain proper 
posture. Your foot will be comfortably secured into a rigid support that is connected to a 
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computer. The computer measures any muscle forces and torques that you create during a 
maximal effort contraction of our lower leg, similar to pushing our foot on the gas pedal  of 
your car and also lifting your toes up. Then, self-adhesive surface electrodes will be applied to 
your skin of your leg so that a brief electrical impulse can be applied while you produce a brief 
(4-5 seconds) maximal effort muscle contraction with your lower leg muscles. The expected time 
of this test is approximately 30 minutes. 
For the assessment of reflexes, you will be seated in the same experimental chair as detailed 
above. Your foot will once again be comfortably secured into a rigid support that is connected to 
a computer. The computer measures any muscle forces and torques that you create with your leg 
muscles during a brief electrical impulse applied to your foot. Self-adhesive surface electrodes 
will be applied to your leg and used to measure any reflex muscle activity produced by the brief 
electrical stimulation applied to your foot. The expected time of this test is approximately 30 
minutes. 




We will also ask that wear a small activity tracker that is clipped to your waistbandfor a period of 
two consecutive weeks. The device will record your step activity level. The monitoring device 
will be provided to you after the second and third visits. We ask that you mail back the 
pedometer to the study investigators via certified mail. You will be provided with the postage 
paid mailing materials at your second and third visits. Please note wearing the pedometer is an 
optional element of the study. You may still participate in the study if you decide not to wear the 
pedometer. 
What are some of the possible risks and discomforts? 
Your participation in this study may involve the following risks: 
Venipuncture: The risks of taking blood include pain, a bruise at the point where the blood is 
taken, 
redness and swelling of the vein and infection, and a rare risk of fainting. Care will be taken to 
avoid 
these complications. 
Surface electrodes: The self-adhesive surface electrodes used to record muscle activity may 
produce minor irritation of the skin. The possibility of irritation will be minimized by cleaning 
the skin with alcohol before and after application of the electrodes. 
Electrical stimulation electrodes: The self-adhesive electrodes may induce some discomfort, 
although a comfortable level of stimulation will be found before performing the muscle 
contractions. There will be many rest periods to reduce the possibility of discomfort from the 
stimulation and the experiment will be discontinued if you report the significant discomfort. 
Undergoing MRI scans may result in you feeling claustrophobic during the exam. In addition to 
feeling claustrophobic, some participants may find the experience to be loud in noise. However, 
our protocols include steps to ensure we significantly reduce the risk of these effects. For 
example, you will be provided with a hand-held rubber ball and instructed to squeeze should you 
feel uncomfortable during the exam. Once the ball is squeezed, an alarm will sound and the 
operator will stop the exam immediately. In addition, you will be provided with earplugs or 
earphones in order to reduce the noise of the MRI machine. 
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What are the Possible Benefits for Me or Others? 
There may be no direct benefit to you by your participation in this research study. These 
procedures are entirely experimental and are not intended to provide any specific medical 
diagnosis or treatment. It is hoped that the results of this study will enhance our understanding 
and ultimately, treatments to prevent or reduce the development of chronic pain following 
whiplash injury. 
What other procedures or courses of treatment might be available to me? 
You have the alternative to choose not to participate in this research study. There are no 
satisfactory alternative procedures/assessments for this study. Of course, you may terminate your 
involvement in the experiment at any time for any reason. 
Tissue or blood samples stored for future research 
Allowing for the storage and future testing of your tissue and blood samples will involve no cost 
to you. Your sample will be used only for research and will not be sold. The research done with 
your tissue and blood sample may lead to the development of new products in the future. No 




Are there any financial costs to being in this study? 
There are no costs to you for being in this study. 
Will I receive payment for participation in this study? 
You will receive $25 for completing each of the four MRI sessions. Another $25 will be paid for 
completing each of the three strength/reflex sessions. Once all sessions are completed, a total of 
$175 will be paid to you. Payments will be made by cash or check. The check will be mailed via 
standard US mail approximately 3-4 weeks following each visit. If you decide to withdraw from 
the study you will be paid only for the testing sessions that you complete. The Accounting 
Services at Northwestern University will be given your name, address, and Social Security 
Number in order to issue a check for your study participation. Study payments are considered 
taxable income and reportable to the IRS. A Form 1099 will be sent to you if your total payments 
are $600 or more in a calendar year. 
NOTE: In the event any clinically important abnormalities are discovered on the MRI, the PI will 
immediately request the images be reviewed by a board-certified radiologist who is not involved 
in the study. The results of which will be promptly sent to the participant who will be encouraged 
to follow-up with his/her primary care physician. The PI will cover any/all costs associated with 
the Radiologist interpretation of the films. 
If I have questions or concerns about this research study, whom can I call? 
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You can call us with your questions or concerns. If you have any illness or injury during your 
time on this study, you should call us promptly. Dr. James Elliott is the person in charge of this 
research study. Dr. Elliott can be reached at 312-503-2304 during Monday through Friday 7am- 
5pm. You can also call the study coordinator, Marie Wasielewski, at 630-688-4193 with any 
questions about this research study. 
What are my rights as a research subject? 
If you choose to be in this study, you have the right to be treated with respect, including respect 
for your decision whether or not you wish to continue or stop being in the study. You are free to 
choose to stop being in the study at any time. 
Choosing not to be in this study or to stop being in this study will not result in any penalty. 
Specifically, your choice not to be in this study will not negatively affect your right to any 
present or future medical treatment to which you are otherwise entitled. 
If you want to speak with someone who is not directly involved in this research, or have 
questions about your rights as a research subject, please contact the Northwestern University 
Institutional Review Board (IRB) Office. You can call them at 312-503-9338. 
You may also contact the Rehabilitation Institute of Chicago Corporate Compliance Office at 
312-238-2805 
What else do I need to know? 
A federal law, called the Genetic Information Nondiscrimination Act (GINA), generally makes 
it illegal for health insurance companies, group health plans, and most employers to discriminate 
against you based on your genetic information. This law generally will protect you in the 
following ways: 
 Health insurance companies and group health plans may not request your genetic 
information that we get from this research. 




when making decisions regarding your eligibility or premiums. 
 Employers with 15 or more employees may not use your genetic information that we get 
from this research when making a decision to hire, promote, or fire you or when setting 
the terms of your employment. 
Be aware that this federal law does not protect you against genetic discrimination by companies 
that sell life insurance, disability insurance, or long-term care insurance. 
HIPAA Authorization 
We are committed to respect your privacy and to keep your personal information confidential. 
When choosing to take part in this study, you are giving us the permission to use your personal 
health information that includes health information in your medical records and information that 
can identify you. For example, personal health information may include your name, address, or 
phone number. Your health information we may collect and use for this research includes: 
 All information in a medical record 
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 Medical history 
 Lab tests, or certain health information indicating or relating to a particular condition as 
well diaries and questionnaires 
 Genetic health information: DNA, RNA 
Once we have the health information listed above, we may share some of this information with 
the following offices or entities outside of Northwestern University and its clinical partners (or 
affiliates): the Northwestern University Institutional Review Board Office and Office for 
Research Integrity; the US Office of Research Integrity; the US Office for Human Research 
Protections; the US Food and Drug Administration. 
Any research information shared with outside entities will not contain your name, address, 
telephone or social security number or any other personal identifier unless disclosure of the 
identifier is necessary for review by such parties or is required by law or University policy 
[except that such information may be viewed by the Study sponsor and its partners or contractors 
at the Principal Investigator s office]. 
 Authorized members of the Northwestern University workforce, who may need to see 
your information, such as administrative staff members from the Office for Research, 
Office for Research Integrity and members of the Institutional Review Board. 
 Clinical affiliates, including but not limited the Rehabilitation Institute of Chicago (RIC), 
Northwestern Medical Group (NMG), Northwestern Memorial Hospital (NMH), 
Northwestern Lake Forest Hospital (NLFH), and the Ann & Robert H. Lurie Children s 
Hospital of Chicago (Lurie Children s). Your participation in this clinical trial ma  be 
tracked in an electronic database and may be seen by investigators running other trials 
that you are enrolled in and by your healthcare providers. 
 Other University research centers and University contractors who are also working on the 
study 
Those persons who get your health information may not be required by Federal privacy laws 
(such as the Privacy Rule) to protect it. Some of those persons may be able to share your 
information with others without your separate permission. 
The results of this study may also be used for teaching, publications, or for presentation at 




will protect your identity. 
Certificate of Confidentiality 
The principal investigator has a Certificate of Confidentiality from the federal government. A 
Certificate of Confidentiality helps protect the privacy of human research participants enrolled in 
studies that collect sensitive information. Certificates protect against legal demands, such as 
court orders and subpoenas, for information that could identify you in this study. For additional 
information about Certificates of Confidentiality see 
http://grants.nih.gov/grants/policy/coc/faqs.htm. 
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We will do everything we can to keep others from learning about your participation in this study. 
To further help us protect your privacy, we have obtained a Certificate of Confidentiality from 
the United States Department of Health and Human Services (DHHS). 
With this Certificate, we cannot be forced (for example by court order or subpoena) to disclose 
information that may identify you in any federal, state, local, civil, criminal, legislative, 
administrative, or other proceedings. The researchers will use the Certificate to resist any 
demands for information that would identify you, except to prevent serious harm to you or 
others, and as explained below. 
You should understand that a Certificate of Confidentiality does not prevent you, or a member of 
your family, from voluntarily releasing information about yourself, or your involvement in this 
study. 
If an insurer or employer learns about your participation, and obtains your consent to receive 
research information, then we may not use the Certificate of Confidentiality to withhold this 
information. This means that you and your family must also actively protect your own privacy. 
You should understand that we will in all cases, take the necessary action, including reporting to 
authorities, to prevent serious harm to yourself, children, or others. For example, in the case of 
child abuse or neglect. 
Please note that: 
 You do not have to sign this consent form. If you do not, it will not affect your treatment by 
health care providers, or the payment or enrollment in any health plans, or affect your 
eligibility for benefits. However, you will not be allowed to take part in this research study. 
 You ma  change our mind and take back  (revoke) this consent at an  time. Even if ou 
revoke this consent, the Principal Investigator may still use or share health information that 
was obtained about you before you revoked your consent as needed for the purpose of this 
study. To revoke your consent for the use of your health information, you must do so in 
writing to: 
James Elliott, PT, PhD 
Northwestern University 
Department of Physical Therapy and Human Movement Sciences 
645 N Michigan Av Suite 1100 
Chicago, IL 60611 
 Unless you revoke your consent, it will not expire. 







The following research activities are optional, meaning that you do not have to agree to them in 
order to participate in the research study. Please indicate your willingness to participate in these 
optional activities by placing your initials next to each activity. 
I agree I disagree 
_______ _______ 
The researcher may collect or take photos of the damaged vehicle to aid 
with data analysis. The researcher will not share these photos with 
anyone outside of the immediate study team. 
_______ _______ 
The researcher may take a blood sample taken during the study. These 
samples will be retained in non-identifiable form, meaning that there will 
be no information associated with the blood or samples that will allow 
anyone to readily ascertain my identity. 
_______ _______ 
The researcher may ask me to wear a pedometer clipped to my waistband 
for two weeks to record my physical activity. The information collected 
will not have any personal identifying information and will not be shared 
with anyone outside the immediate study team. 
_______ _______ 
The researcher may contact me in the future to see whether I am 
interested in participating in other research studies. 








Appendix E: Neck Disability Index 
 
Neck Disability Index 
This questionnaire has been designed to give us information as to how your neck pain has 
affected your ability to manage in everyday life. Please answer every section and mark in each 
section only the one box that applies to you. We realise you may consider that two or more 
statements in any one section relate to you, but please just mark the box that most closely 
describes your problem. 
Section 1: Pain Intensity 
£ I have no pain at the moment 
£ The pain is very mild at the moment 
£ The pain is moderate at the moment 
£ The pain is fairly severe at the moment 
£ The pain is very severe at the moment 
£ The pain is the worst imaginable at the moment 
Section 2: Personal Care (Washing, Dressing, etc.) 
£ I can look after myself normally without causing extra pain 
£ I can look after myself normally but it causes extra pain 
£ It is painful to look after myself and I am slow and careful 
£ I need some help but can manage most of my personal care 
£ I need help every day in most aspects of self care 
£ I do not get dressed, I wash with difficulty and stay in bed 
Section 3: Lifting 
£ I can lift heavy weights without extra pain 
£ I can lift heavy weights but it gives extra pain 
£ Pain prevents me lifting heavy weights off the floor, but I can manage if they are 
conveniently placed, for example on a table 
£ Pain prevents me from lifting heavy weights but I can manage light to medium 
weights if they are conveniently positioned 
£ I can only lift very light weights 
£ I cannot lift or carry anything 
Section 4: Reading 
£ I can read as much as I want to with no pain in my neck 
£ I can read as much as I want to with slight pain in my neck 
£ I can read as much as I want with moderate pain in my neck 
£ I can t read as much as I want because of moderate pain in m  neck 
£ I can hardly read at all because of severe pain in my neck 
£ I cannot read at all 
Section 5: Headaches 
£ I have no headaches at all 
£ I have slight headaches, which come infrequently 
£ I have moderate headaches, which come infrequently 
£ I have moderate headaches, which come frequently 
£ I have severe headaches, which come frequently 
£ I have headaches almost all the time 




£ I can concentrate fully when I want to with no difficulty 
£ I can concentrate fully when I want to with slight difficulty 
£ I have a fair degree of difficulty in concentrating when I want to 
£ I have a lot of difficulty in concentrating when I want to 
£ I have a great deal of difficulty in concentrating when I want to 
£ I cannot concentrate at all 
Section 7: Work 
£ I can do as much work as I want to 
£ I can only do my usual work, but no more 
£ I can do most of my usual work, but no more 
£ I cannot do my usual work 
£ I can hardly do any work at all 
£ I can t do an  work at all 
Section 8: Driving 
£ I can drive my car without any neck pain 
£ I can drive my car as long as I want with slight pain in my neck 
£ I can drive my car as long as I want with moderate pain in my neck 
£ I can t drive m  car as long as I want because of moderate pain in m  neck 
£ I can hardly drive at all because of severe pain in my neck 
£ I can t drive m  car at all 
Section 9: Sleeping 
£ I have no trouble sleeping 
£ My sleep is slightly disturbed (less than 1 hr sleepless) 
£ My sleep is mildly disturbed (1-2 hrs sleepless) 
£ My sleep is moderately disturbed (2-3 hrs sleepless) 
£ My sleep is greatly disturbed (3-5 hrs sleepless) 
£ My sleep is completely disturbed (5-7 hrs sleepless) 
Section 10: Recreation 
£ I am able to engage in all my recreation activities with no neck pain at all 
£ I am able to engage in all my recreation activities, with some pain in my neck 
£ I am able to engage in most, but not all of my usual recreation activities because of 
pain in my neck 
£ I am able to engage in a few of my usual recreation activities because of pain in 
my neck 
£ I can hardly do any recreation activities because of pain in my neck 
£ I can t do an  recreation activities at all 
Score: /50 Transform to percentage score x 100 = %points 
Scoring: For each section the total possible score is 5: if the first statement is marked the section 
score = 0, if the last statement is marked it = 5. If all ten sections are 
completed the score is calculated as follows: Example:16 (total scored) 
50 (total possible score) x 100 = 32% 
If one section is missed or not applicable the score is calculated: 16 (total scored) 
45 (total possible score) x 100 = 35.5% 
Minimum Detectable Change (90% confidence): 5 points or 10 %points 
NDI developed by: Vernon, H. & Mior, S. (1991). The Neck Disability Index: A study of 
reliability and validity. Journal of Manipulative and Physiological Therapeutics. 14, 409-415 
